"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,CA,A1,CA 2951802 A1,038-584-634-877-201,2016-01-07,2016,CA 2951802 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,A WIND TURBINE BLADE,"A wind turbine blade is described having a serrated trailing edge. Flow straightening vanes are provided on the serrations, to prevent a lateral or side flow over the edges of the serrations, which are preferably provided at incidence to the flow over the wind turbine blade. The vanes can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the vanes can be provided as a trailing edge panel for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/038-584-634-877-201,Patent Application,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06;;F01D5/14;;F15D1/10,,0,0,,,,PENDING
2,DK,T3,DK 3390812 T3,181-393-098-226-861,2020-10-26,2020,DK 16816661 T,2016-12-16,EP 15200683 A;;EP 2016081558 W,2015-12-17,SPLITTERPLADEINDRETNING TIL EN SAVTAKKET VINDMØLLEVINGE,,LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/181-393-098-226-861,Granted Patent,no,0,0,9,9,0,F03D1/0675;;F03D1/0675;;F03D1/0641;;F05B2240/30;;F05B2240/30;;F05B2250/18;;F05B2250/183;;F05B2260/96;;F05B2280/6003;;Y02E10/72,F03D1/06,,0,0,,,,ACTIVE
3,MA,B1,MA 40346 B1,107-204-242-890-507,2019-07-31,2019,MA 40346 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,Pale d'éolienne,"La présente invention concerne une pale d'éolienne possédant un bord de fuite dentelé. Des aubes directrices d'écoulement sont disposées sur les dentelures, de manière à empêcher un écoulement latéral sur les bords des dentelures, qui sont de préférence disposées de manière incidente par rapport à l'écoulement sur la pale d'éolienne. Les aubes peuvent être formées d'un seul tenant avec les dentelures, ou attachées aux dentelures existantes en tant que solution de rattrapage. Les dentelures dotées des aubes peuvent être fournies sous la forme d'un panneau de bord de fuite pour une fixation au bord de fuite d'une pale d'éolienne existante.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/107-204-242-890-507,Granted Patent,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
4,CN,A,CN 106471245 A,196-425-019-396-490,2017-03-01,2017,CN 201580036381 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,A wind turbine blade,"A wind turbine blade is described having a serrated trailing edge. Flow straightening vanes are provided on the serrations, to prevent a lateral or side flow over the edges of the serrations, which are preferably provided at incidence to the flow over the wind turbine blade. The vanes can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the vanes can be provided as a trailing edge panel for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/196-425-019-396-490,Patent Application,no,6,3,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
5,WO,A1,WO 2017/103192 A1,068-464-495-409-484,2017-06-22,2017,EP 2016081558 W,2016-12-16,EP 15200683 A,2015-12-17,SPLITTER PLATE ARRANGEMENT FOR A SERRATED WIND TURBINE BLADE,"A wind turbine blade (10) is described having a serrated trailing edge (20). Splitter plates (106) are provided on the blade, to reduce operational noise. Each splitter plate (106) is arranged to extend at least partly into a space in between adjacent serrations. The splitter plates can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the splitter plates can be provided as a trailing edge panel (108) for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/068-464-495-409-484,Patent Application,yes,6,4,9,9,0,F03D1/0675;;F05B2240/30;;F05B2250/18;;Y02E10/72;;F03D1/0641;;F03D1/0675;;F05B2240/30;;F05B2250/183;;F05B2260/96;;F05B2280/6003,F03D1/06,,0,0,,,,PENDING
6,US,A1,US 2020/0277931 A1,178-771-207-409-235,2020-09-03,2020,US 201616062342 A,2016-12-16,EP 15200683 A;;EP 2016081558 W,2015-12-17,SPLITTER PLATE ARRANGEMENT FOR A SERRATED WIND TURBINE BLADE,"A wind turbine blade ( 10 ) is described having a serrated trailing edge ( 20 ). Splitter plates ( 106 ) are provided on the blade, to reduce operational noise. Each splitter plate ( 106 ) is arranged to extend at least partly into a space in between adjacent serrations. The splitter plates can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the splitter plates can be provided as a trailing edge panel ( 108 ) for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,LM WP PATENT HOLDING A/S (2018-06-27),https://lens.org/178-771-207-409-235,Patent Application,yes,67,2,9,9,0,F03D1/0675;;F03D1/0675;;F03D1/0641;;F05B2240/30;;F05B2240/30;;F05B2250/18;;F05B2250/183;;F05B2260/96;;F05B2280/6003;;Y02E10/72,F03D1/06,,0,0,,,,ACTIVE
7,WO,A1,WO 2016/001420 A1,054-792-998-979-678,2016-01-07,2016,EP 2015065233 W,2015-07-03,EP 14175557 A,2014-07-03,A WIND TURBINE BLADE,"A wind turbine blade is described having a serrated trailing edge. Flow straightening vanes are provided on the serrations, to prevent a lateral or side flow over the edges of the serrations, which are preferably provided at incidence to the flow over the wind turbine blade. The vanes can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the vanes can be provided as a trailing edge panel for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/054-792-998-979-678,Patent Application,yes,4,8,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,PENDING
8,EP,B1,EP 3164599 B1,054-267-894-246-837,2019-04-17,2019,EP 15734154 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,A WIND TURBINE BLADE,,LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/054-267-894-246-837,Granted Patent,yes,4,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
9,CA,C,CA 2951802 C,028-292-987-217-105,2023-06-27,2023,CA 2951802 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,A WIND TURBINE BLADE,"A wind turbine blade is described having a serrated trailing edge. Flow straightening vanes are provided on the serrations, to prevent a lateral or side flow over the edges of the serrations, which are preferably provided at incidence to the flow over the wind turbine blade. The vanes can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the vanes can be provided as a trailing edge panel for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/028-292-987-217-105,Granted Patent,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06;;F01D5/14;;F15D1/10,,0,0,,,,PENDING
10,US,A1,US 2017/0107970 A1,183-866-777-503-402,2017-04-20,2017,US 201515317218 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,A Wind Turbine Blade,"A wind turbine blade is described having a serrated trailing edge. Flow straightening vanes are provided on the serrations, to prevent a lateral or side flow over the edges of the serrations, which are preferably provided at incidence to the flow over the wind turbine blade. The vanes can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the vanes can be provided as a trailing edge panel for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS;;LW WP PATENT HOLDING AS,ARCE CARLOS,LM WP PATENT HOLDING A/S (2017-01-10),https://lens.org/183-866-777-503-402,Patent Application,yes,64,7,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
11,US,A1,US 2018/0037435 A1,145-100-306-947-106,2018-02-08,2018,US 201715476779 A,2017-03-31,US 201715476779 A;;US 201662370713 P,2016-08-04,WIRE CADDY,"A toolbox-size device contains wire spools that are supported by both a cradle and a removable axial spindle. This dual support contributes to solving several problems involved with manual wire deployment devices. Particular object spatial and size relationships can include those of the cradle, spindle, spool diameter, spool hub, arbor-opening diameter, enclosure size, and exit aperture location. This provides a solution to reliably and smoothly deploy electrical wire manually from a hand-carried device. The cradle holds spools generally in place when the axial spindle is removed to add or remove spools. The dual support system allows the use of spools with damaged flanges normally not possible with a cradle-based system.",ARCE CARLOS,ARCE CARLOS,,https://lens.org/145-100-306-947-106,Patent Application,yes,0,0,2,2,0,B65H49/24;;B65H2701/36;;B65H49/322;;B65H49/325;;B65H75/40;;B65H2701/36;;B65H49/322;;B65H49/325;;B65H49/24,B65H75/40;;B65H75/14;;B65H75/44,,0,0,,,,INACTIVE
12,US,B2,US 10781788 B2,054-487-420-546-517,2020-09-22,2020,US 201515317218 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,Wind turbine blade,"A wind turbine blade is described having a serrated trailing edge. Flow straightening vanes are provided on the serrations, to prevent a lateral or side flow over the edges of the serrations, which are preferably provided at incidence to the flow over the wind turbine blade. The vanes can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the vanes can be provided as a trailing edge panel for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,LM WP PATENT HOLDING A/S (2017-01-10),https://lens.org/054-487-420-546-517,Granted Patent,yes,38,1,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
13,US,B1,US 9884738 B1,048-185-468-031-677,2018-02-06,2018,US 201715476779 A,2017-03-31,US 201715476779 A;;US 201662370713 P,2016-08-04,Wire caddy,"A toolbox-size device contains wire spools that are supported by both a cradle and a removable axial spindle. This dual support contributes to solving several problems involved with manual wire deployment devices. Particular object spatial and size relationships can include those of the cradle, spindle, spool diameter, spool hub, arbor-opening diameter, enclosure size, and exit aperture location. This provides a solution to reliably and smoothly deploy electrical wire manually from a hand-carried device. The cradle holds spools generally in place when the axial spindle is removed to add or remove spools. The dual support system allows the use of spools with damaged flanges normally not possible with a cradle-based system.",ARCE CARLOS,ARCE CARLOS,,https://lens.org/048-185-468-031-677,Granted Patent,yes,6,1,2,2,0,B65H49/24;;B65H2701/36;;B65H49/322;;B65H49/325;;B65H75/40;;B65H2701/36;;B65H49/322;;B65H49/325;;B65H49/24,B65H49/32;;B65H75/14;;B65H75/40;;B65H75/44,,0,0,,,,INACTIVE
14,EP,A1,EP 3181895 A1,073-836-192-798-561,2017-06-21,2017,EP 15200683 A,2015-12-17,EP 15200683 A,2015-12-17,SPLITTER PLATE ARRANGEMENT FOR A SERRATED WIND TURBINE BLADE,"A wind turbine blade (10) is described having a serrated trailing edge (20). Splitter plates (106) are provided on the blade, to reduce operational noise. Each splitter plate (106) is arranged to extend at least partly into a space in between adjacent serrations. The splitter plates can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the splitter plates can be provided as a trailing edge panel (108) for attachment to the trailing edge of an existing wind turbine blade.
",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/073-836-192-798-561,Patent Application,yes,8,4,9,9,0,F03D1/0675;;F03D1/0675;;F03D1/0641;;F05B2240/30;;F05B2240/30;;F05B2250/18;;F05B2250/183;;F05B2260/96;;F05B2280/6003;;Y02E10/72,F03D1/06,,0,0,,,,DISCONTINUED
15,BR,A2,BR 112016030174 A2,073-287-772-912-069,2017-08-22,2017,BR 112016030174 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,pá de turbina eólica,"pá de turbina eólica uma pá de turbina eólica é descrita tendo uma borda de fuga serrilhada. as palhetas de alinhamento de fluxo são proporcionadas nas serrilhas, para evitar um fluxo lateral sobre as bordas das serrilhas, que são preferencialmente proporcionadas em incidência ao fluxo sobre a pá de turbina eólica. as palhetas podem ser formadas integralmente com as serrilhas, ou ligadas a serrilhas existentes como uma solução retro adaptadora. as serrilhas com as palhetas podem ser proporcionadas como um painel de borda de fuga para anexar a borda de fuga de uma pá de turbina de vento existente.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/073-287-772-912-069,Patent Application,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,,,0,0,,,,ACTIVE
16,EP,A1,EP 3390812 A1,190-986-440-077-559,2018-10-24,2018,EP 16816661 A,2016-12-16,EP 15200683 A;;EP 2016081558 W,2015-12-17,SPLITTER PLATE ARRANGEMENT FOR A SERRATED WIND TURBINE BLADE,,LM WP PATENT HOLDING AS,ARCE CARLOS,LM WIND POWER A/S (2022-03-23),https://lens.org/190-986-440-077-559,Patent Application,yes,0,0,9,9,0,F03D1/0675;;F03D1/0675;;F03D1/0641;;F05B2240/30;;F05B2240/30;;F05B2250/18;;F05B2250/183;;F05B2260/96;;F05B2280/6003;;Y02E10/72,F03D1/06,,1,0,,,See references of WO 2017103192A1,ACTIVE
17,ES,T3,ES 2736501 T3,061-699-373-495-996,2020-01-02,2020,ES 15734154 T,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,Una pala de turbina eólica,"Una pala de turbina eólica (10) que tiene un contorno perfilado que incluye un lado de presión y un lado de aspiración, y un borde delantero (18) y un borde trasero (20) con una cuerda que tiene una longitud de cuerda que se extiende entre los mismos, extendiéndose la pala de turbina eólica (10) en una dirección a lo largo de la envergadura entre un extremo de raíz y un extremo de punta, comprendiendo la pala de turbina eólica una pluralidad de estrías (100) proporcionadas a lo largo de al menos una parte del borde trasero (20) de la pala (10), comprendiendo además la pala de turbina eólica (10) al menos una aleta enderezadora de flujo (106), estando dicha al menos una aleta enderezadora de flujo (106) dispuesta para enderezar el flujo sobre dicha superficie de dichas estrías (100), caracterizada por que las estrías (100) tienen un espesor sustancialmente uniforme y la al menos una aleta enderezadora de flujo (106) sobresale de la superficie de dichas estrías (100).",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/061-699-373-495-996,Granted Patent,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
18,CN,A,CN 108603485 A,033-760-721-456-788,2018-09-28,2018,CN 201680082127 A,2016-12-16,EP 15200683 A;;EP 2016081558 W,2015-12-17,SPLITTER PLATE ARRANGEMENT FOR A SERRATED WIND TURBINE BLADE,"A wind turbine blade (10) is described having a serrated trailing edge (20). Splitter plates (106) are provided on the blade, to reduce operational noise. Each splitter plate (106) is arranged to extend at least partly into a space in between adjacent serrations. The splitter plates can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the splitter plates can be provided as a trailing edge panel (108) for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/033-760-721-456-788,Patent Application,no,5,0,9,9,0,F03D1/0675;;F03D1/0675;;F03D1/0641;;F05B2240/30;;F05B2240/30;;F05B2250/18;;F05B2250/183;;F05B2260/96;;F05B2280/6003;;Y02E10/72,F03D1/06,,0,0,,,,ACTIVE
19,MA,A,MA 40346 A,181-203-867-994-399,2017-05-10,2017,MA 40346 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,PALE D'ÉOLIENNE,"<!--startfragment-->la présente invention concerne une pale d'éolienne possédant un bord de fuite dentelé. Des aubes directrices d'écoulement sont disposées sur les dentelures, de manière à empêcher un écoulement latéral sur les bords des dentelures, qui sont de préférence disposées de manière incidente par rapport à l'écoulement sur la pale d'éolienne. Les aubes peuvent être formées d'un seul tenant avec les dentelures, ou attachées aux dentelures existantes en tant que solution de rattrapage. Les dentelures dotées des aubes peuvent être fournies sous la forme d'un panneau de bord de fuite pour une fixation au bord de fuite d'une pale d'éolienne existante.<!--endfragment-->",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/181-203-867-994-399,Unknown,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
20,EP,B1,EP 3390812 B1,101-991-464-089-042,2020-07-22,2020,EP 16816661 A,2016-12-16,EP 15200683 A;;EP 2016081558 W,2015-12-17,SPLITTER PLATE ARRANGEMENT FOR A SERRATED WIND TURBINE BLADE,,LM WP PATENT HOLDING AS,ARCE CARLOS,LM WIND POWER A/S (2022-03-23),https://lens.org/101-991-464-089-042,Granted Patent,yes,5,0,9,9,0,F03D1/0675;;F05B2240/30;;F05B2250/18;;Y02E10/72;;F03D1/0641;;F03D1/0675;;F05B2240/30;;F05B2250/183;;F05B2260/96;;F05B2280/6003,F03D1/06,,1,0,,,"VATHYLAKIS ALEXANDROS: ""Reduction of broadband trailing edge noise by serrations"", PHD DISSERTATION BRUNEL UNIVERSITY LONDON, BRUNEL UNIVERSITY, 1 January 2015 (2015-01-01), XP055960682, [retrieved on 20220913]",ACTIVE
21,BR,B1,BR 112016030174 B1,123-030-154-011-675,2022-07-19,2022,BR 112016030174 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,PÁ DE TURBINA EÓLICA,"PÁ DE TURBINA EÓLICA Uma pá de turbina eólica é descrita tendo uma borda de fuga serrilhada. As palhetas de alinhamento de fluxo são proporcionadas nas serrilhas, para evitar um fluxo lateral sobre as bordas das serrilhas, que são preferencialmente proporcionadas em incidência ao fluxo sobre a pá de turbina eólica. As palhetas podem ser formadas integralmente com as serrilhas, ou ligadas a serrilhas existentes como uma solução retro adaptadora. As serrilhas com as palhetas podem ser proporcionadas como um painel de borda de fuga para anexar a borda de fuga de uma pá de turbina de vento existente.",LM WP PATENT HOLDING AS,CARLOS ARCE,,https://lens.org/123-030-154-011-675,Granted Patent,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
22,WO,A1,WO 2013/045601 A1,142-612-178-218-485,2013-04-04,2013,EP 2012069169 W,2012-09-28,EP 11007928 A;;EP 11007934 A,2011-09-29,A WIND TURBINE BLADE,"A wind turbine blade is described wherein the blade has an adjustable flow modulating profile at the trailing edge of the blade. The profile has at least one array of projecting flow modulation elements which can act to modulate airflow and associated turbulent noise at the trailing edge. The elements of the array can be adjusted during operation of a wind turbine having such a blade to provide for controlled noise modulation, which does not require complicated redesign and/or retrofitting procedures. Examples of adjustments include translational movement of the array of elements, variation of element shape, flexibility, etc. The adjustment may be passively and/or actively controlled.",LM WIND POWER AS,ARCE CARLOS,,https://lens.org/142-612-178-218-485,Patent Application,yes,9,15,1,1,0,F03D7/022;;F03D7/0296;;F05B2240/31;;F05B2240/311;;F05B2260/96;;Y02E10/72,F03D7/02,,0,0,,,,PENDING
23,BR,A8,BR 112016030174 A8,178-998-814-766-994,2021-06-22,2021,BR 112016030174 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,pá de turbina eólica,"pá de turbina eólica uma pá de turbina eólica é descrita tendo uma borda de fuga serrilhada. as palhetas de alinhamento de fluxo são proporcionadas nas serrilhas, para evitar um fluxo lateral sobre as bordas das serrilhas, que são preferencialmente proporcionadas em incidência ao fluxo sobre a pá de turbina eólica. as palhetas podem ser formadas integralmente com as serrilhas, ou ligadas a serrilhas existentes como uma solução retro adaptadora. as serrilhas com as palhetas podem ser proporcionadas como um painel de borda de fuga para anexar a borda de fuga de uma pá de turbina de vento existente.",LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/178-998-814-766-994,Patent Application,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
24,DK,T3,DK 3164599 T3,055-344-631-823-009,2019-07-22,2019,DK 15734154 T,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,En vindmøllevinge,,LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/055-344-631-823-009,Granted Patent,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
25,PL,T3,PL 3164599 T3,122-699-836-272-264,2019-09-30,2019,PL 15734154 T,2015-07-03,EP 14175557 A;;EP 15734154 A;;EP 2015065233 W,2014-07-03,A WIND TURBINE BLADE,,LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/122-699-836-272-264,Patent Application,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,PENDING
26,US,B2,US 11067057 B2,124-969-379-317-702,2021-07-20,2021,US 201616062342 A,2016-12-16,EP 15200683 A;;EP 2016081558 W,2015-12-17,Splitter plate arrangement for a serrated wind turbine blade,"A wind turbine blade ( 10 ) is described having a serrated trailing edge ( 20 ). Splitter plates ( 106 ) are provided on the blade, to reduce operational noise. Each splitter plate ( 106 ) is arranged to extend at least partly into a space in between adjacent serrations. The splitter plates can be formed integrally with the serrations, or attached to existing serrations as a retrofit solution. The serrations with the splitter plates can be provided as a trailing edge panel ( 108 ) for attachment to the trailing edge of an existing wind turbine blade.",LM WP PATENT HOLDING AS,ARCE CARLOS,LM WP PATENT HOLDING A/S (2018-06-27),https://lens.org/124-969-379-317-702,Granted Patent,yes,71,0,9,9,0,F03D1/0675;;F03D1/0675;;F03D1/0641;;F05B2240/30;;F05B2240/30;;F05B2250/18;;F05B2250/183;;F05B2260/96;;F05B2280/6003;;Y02E10/72,F03D1/06,,1,0,,,"Extended European Search Report dated May 27, 2016 in corresponding European Patent Application No. EP 15200683.9.",ACTIVE
27,TR,T4,TR 201909371 T4,094-737-719-749-247,2019-07-22,2019,TR 201909371 T,2015-07-03,EP 14175557 A,2014-07-03,Bir rüzgar türbini kanadı.,"Tırtıllı bir arka kenarı bulunan bir rüzgar türbini kanadı açıklanmıştır. Tırtıllar üzerinde, tırtılların kenarları üzerinden bir yanlamasına veya yan akımı önlemek üzere, tercihen rüzgar kanadı türbini üzerinden akıma geliş açısında sağlanmış olan akım düzeltme kanatçıkları sağlanmıştır. Kanatçıklar tırtıllar ile entegre biçimde oluşturulabilir, ya da bir güçlendirme çözümü olarak, mevcut tırtıllara tutturulabilir. Kanatçıkları olan tırtıllar mevcut bir rüzgar türbini kanadının arka kenarına tutturulmak için bir arka kenar paneli olarak sağlanabilir.",LM WP PATENT HOLDING AS,CARLOS ARCE,,https://lens.org/094-737-719-749-247,Granted Patent,no,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
28,EP,A1,EP 3164599 A1,170-347-898-961-69X,2017-05-10,2017,EP 15734154 A,2015-07-03,EP 14175557 A;;EP 2015065233 W,2014-07-03,A WIND TURBINE BLADE,,LM WP PATENT HOLDING AS,ARCE CARLOS,,https://lens.org/170-347-898-961-69X,Patent Application,yes,0,0,18,18,0,F03D1/0641;;F05B2240/121;;F05B2240/12;;F05B2240/122;;F05B2240/12;;F05B2240/121;;F05B2230/23;;F05B2240/21;;F05B2240/30;;F03D1/0641;;Y02E10/72;;Y02P70/50;;F05B2240/3062;;F05B2240/12;;F05B2240/122;;F05B2240/121;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F05B2230/23;;F05B2240/21;;F05B2240/30,F03D1/06,,0,0,,,,ACTIVE
29,FR,A,FR 781848 A,175-670-706-074-036,1935-05-22,1935,FR 781848D A,1934-11-13,FR 781848T A,1934-11-13,Roue élastique pour véhicules,,,ARCE CARLOS MANUEL,,https://lens.org/175-670-706-074-036,Granted Patent,no,0,0,1,1,0,B60B9/00,B60B9/00,,0,0,,,,EXPIRED
30,US,A1,US 2022/0163012 A1,035-052-493-834-729,2022-05-26,2022,US 202017430215 A,2020-02-17,EP 19157644 A;;EP 2020054119 W,2019-02-18,Noise reducer for a wind turbine rotor blade,"The present invention relates to a wind turbine rotor blade assembly comprising a rotor blade and a noise reducer ( 70 ) configured on the rotor blade. The noise reducer ( 70 ) comprises a plurality of aligned spine members ( 72 ), each spine member having a length and comprising a first section ( 74 ) extending along a first part of the length of the spine member, and a second section ( 76 ) extending along a second part of the length of the spine member, wherein the first section ( 74 ) has a higher stiffness than the second section ( 76 ).",LM WIND POWER AS,LEÓN CARLOS ARCE,LM WINDPOWER A/S (2021-06-17),https://lens.org/035-052-493-834-729,Patent Application,yes,9,2,7,7,0,F03D1/0675;;F03D7/0296;;F05B2240/30;;F05B2260/96;;Y02E10/72;;F05B2240/3042;;F03D1/0633;;F03D1/0675;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
31,US,A,US 4301892 A,046-229-366-934-962,1981-11-24,1981,US 60373075 A,1975-08-11,US 60373075 A,1975-08-11,Device for the ascension and descension of high altitudes,"In a preferred embodiment, a fire emergency descent device utilizing straps is securable onto a persons back, and a spool-mounted line (wire) is controllably releasable through overhead wire guide supports adjustable to alter the hanging position of the strapped-in person, and rate of descent being controllable either manually by a manually-adjustable variable valve and a second valve normally preset to correspond to a persons weight to controllably regulate release of compressed air from a piston cylinder housing in which air becomes compressed by piston action resulting from spinning of the spool (spindle) during descent.",ARCE CARLOS L,ARCE CARLOS L,,https://lens.org/046-229-366-934-962,Granted Patent,yes,12,17,1,1,0,A62B1/10;;A62B1/10,A62B1/10,182/233,0,0,,,,EXPIRED
32,DK,T3,DK 3696402 T3,070-194-449-968-685,2022-10-24,2022,DK 19157644 T,2019-02-18,EP 19157644 A,2019-02-18,STØJFORMINDSKER TIL ET VINDMØLLEROTORBLAD,,LM WIND POWER AS,ARCE LEÓN CARLOS,,https://lens.org/070-194-449-968-685,Granted Patent,no,0,0,7,7,0,F03D1/0675;;F03D7/0296;;F05B2240/30;;F05B2260/96;;Y02E10/72;;F05B2240/3042;;F03D1/0633;;F03D1/0675;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
33,CN,A,CN 113412368 A,053-337-736-825-766,2021-09-17,2021,CN 202080014948 A,2020-02-17,EP 19157644 A;;EP 2020054119 W,2019-02-18,NOISE REDUCER FOR A WIND TURBINE ROTOR BLADE,"The present invention relates to a wind turbine rotor blade assembly comprising a rotor blade and a noise reducer (70) configured on the rotor blade. The noise reducer (70) comprises a plurality of aligned spine members (72), each spine member having a length and comprising a first section (74) extending along a first part of the length of the spine member, and a second section (76) extending along a second part of the length of the spine member, wherein the first section (74) has a higher stiffness than the second section (76).",LM WIND POWER AS,ARCE LEON CARLOS,,https://lens.org/053-337-736-825-766,Patent Application,no,0,0,7,7,0,F03D1/0675;;F03D7/0296;;F05B2240/30;;F05B2260/96;;Y02E10/72;;F05B2240/3042;;F03D1/0633;;F03D1/0675;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
34,US,A,US 2078554 A,093-365-953-698-395,1937-04-27,1937,US 74467734 A,1934-09-19,AR 2078554X A,1933-11-06,Elastic wheel for vehicles in general,,MANUEL ARCE CARLOS,MANUEL ARCE CARLOS,,https://lens.org/093-365-953-698-395,Granted Patent,no,0,0,1,1,0,B60B9/04;;B60B9/04,B60B9/04,,0,0,,,,EXPIRED
35,MA,A,MA 52700 A,015-971-186-015-581,2021-03-31,2021,MA 52700 A,2019-02-18,MA 52700 A,2019-02-18,RÉDUCTEUR DE BRUIT POUR UNE PALE DE ROTOR DE TURBINE ÉOLIENNE,,LM WIND POWER AS,LEÓN CARLOS ARCE,,https://lens.org/015-971-186-015-581,Unknown,no,0,0,1,1,0,Y02E10/72,F03D1/06;;F03D7/02,,0,0,,,,PENDING
36,EP,A1,EP 3696402 A1,191-215-982-109-245,2020-08-19,2020,EP 19157644 A,2019-02-18,EP 19157644 A,2019-02-18,NOISE REDUCER FOR A WIND TURBINE ROTOR BLADE,"The present invention relates to a wind turbine rotor blade assembly comprising a rotor blade and a noise reducer (70) configured on the rotor blade. The noise reducer (70) comprises a plurality of aligned spine members (72), each spine member having a length and comprising a first section (74) extending along a first part of the length of the spine member, and a second section (76) extending along a second part of the length of the spine member, wherein the first section (74) has a higher stiffness than the second section (76).
",LM WIND POWER AS,LEÓN CARLOS ARCE,,https://lens.org/191-215-982-109-245,Patent Application,yes,6,0,7,7,0,F03D1/0675;;F03D7/0296;;F05B2240/30;;F05B2260/96;;Y02E10/72;;F05B2240/3042;;F03D1/0633;;F03D1/0675;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
37,US,B2,US 11661918 B2,043-211-558-457-14X,2023-05-30,2023,US 202017430215 A,2020-02-17,EP 19157644 A;;EP 2020054119 W,2019-02-18,Noise reducer for a wind turbine rotor blade,"The present invention relates to a wind turbine rotor blade assembly comprising a rotor blade and a noise reducer ( 70 ) configured on the rotor blade. The noise reducer ( 70 ) comprises a plurality of aligned spine members ( 72 ), each spine member having a length and comprising a first section ( 74 ) extending along a first part of the length of the spine member, and a second section ( 76 ) extending along a second part of the length of the spine member, wherein the first section ( 74 ) has a higher stiffness than the second section ( 76 ).",LM WIND POWER AS,LEÓN CARLOS ARCE,LM WINDPOWER A/S (2021-06-17),https://lens.org/043-211-558-457-14X,Granted Patent,yes,12,2,7,7,0,F03D1/0675;;F03D7/0296;;F05B2240/30;;F05B2260/96;;Y02E10/72;;F05B2240/3042;;F03D1/0633;;F03D1/0675;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,2,0,,,"International Search Report dated Apr. 20, 2020 for application No. PCT/EP2020/054119.;;European Search Report dated Aug. 19, 2019 for application No. EP 19157644.6.",ACTIVE
38,EP,B1,EP 3696402 B1,132-143-060-537-550,2022-07-20,2022,EP 19157644 A,2019-02-18,EP 19157644 A,2019-02-18,NOISE REDUCER FOR A WIND TURBINE ROTOR BLADE,,LM WIND POWER AS,ARCE LEÓN CARLOS,,https://lens.org/132-143-060-537-550,Granted Patent,yes,4,0,7,7,0,F03D1/0675;;F03D7/0296;;F05B2240/30;;F05B2260/96;;Y02E10/72;;F05B2240/3042;;F03D1/0633;;F03D1/0675;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
39,CY,T1,CY 1116676 T1,118-404-397-169-947,2017-03-15,2017,CY 151100778 T,2015-09-07,EP 11778689 A;;EP 10251681 A,2010-09-29,ΣΥΝΘΕΣΗ ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΑΓΩΓΗ ΤΗΣ ΥΠΟΓΟΝΙΜΟΤΗΤΑΣ,Ένα προϊόν περιλαμβάνοντας ορμόνη διέγερσης ωοθυλακίων (FSH) και ανθρώπινη χοριονική γοναδοτροπίνη (hCG) για την αγωγή της υπογονιμότητας.,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/118-404-397-169-947,Granted Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,ACTIVE
40,SM,B,SM T201500237 B,132-912-518-323-436,2015-10-30,2015,SM 201500237 T,2015-09-30,IB 2011002541 W;;EP 10251681 A,2010-09-29,Compsizione per l'uso in un trattamento contro l'infertilità,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/132-912-518-323-436,Unknown,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,,,0,0,,,,PENDING
41,CA,A1,CA 3048746 A1,179-613-041-930-129,2018-07-19,2018,CA 3048746 A,2018-01-12,EP 17151173 A;;EP 2018050736 W,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises a number of noise reducing elements projecting from a base part. A plurality of airflow modifying elements are attached to or integrated into the noise reducing elements. The airflow modifying elements extend from a local first end to a local second end along at least one of the first and second side surfaces. The airflow modifying elements has a height of no more than two-thirds of the boundary layer thickness and spacing of no more than one-thirds of the boundary layer thickness. The noise reducing elements are preferably serrations. The airflow modifying elements are preferably vanes projecting perpendicularly from the side surface of the noise reducing elements.,LM WIND POWER INT TECH II APS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/179-613-041-930-129,Patent Application,no,0,0,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
42,DK,T3,DK 2621517 T3,017-806-295-684-139,2015-09-14,2015,DK 11778689 T,2011-09-28,EP 10251681 A;;IB 2011002541 W,2010-09-29,Sammensætning til anvendelse i behandling af infertilitet,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/017-806-295-684-139,Granted Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,ACTIVE
43,HR,T1,HR P20150968 T1,042-007-193-929-065,2015-10-09,2015,HR P20150968 T,2011-09-28,EP 10251681 A;;EP 11778689 A;;IB 2011002541 W,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/042-007-193-929-065,Granted Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,ACTIVE
44,EP,B1,EP 2621517 B1,090-882-505-094-914,2015-06-17,2015,EP 11778689 A,2011-09-28,EP 10251681 A;;IB 2011002541 W;;EP 11778689 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/090-882-505-094-914,Granted Patent,yes,5,1,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,11,9,055-400-281-517-32X;;021-107-906-143-190;;056-456-511-096-196;;142-870-873-493-325;;097-283-378-443-113;;041-921-009-513-368;;008-988-236-999-441;;093-479-163-552-565;;044-456-865-492-465,10.1210/jcem.87.3.8322;;11889180;;10.1210/jc.87.3.1156;;10.1007/bf02213694;;7949832;;10.1093/humrep/13.11.3023;;9853849;;2528570;;10.1093/oxfordjournals.humrep.a136964;;10.1093/humrep/17.8.2009;;12151429;;10593393;;10.1016/s0015-0282(99)00426-4;;10.1210/jcem.84.8.5884;;10443656;;10.1210/jc.84.8.2659;;10.1093/humupd/8.6.543;;12498424;;10.1016/j.fertnstert.2011.06.069;;21839437,"FILICORI ET AL.: ""Stimulation and Growth of Antral Ovarian Follicles by Selective LH Activity Administration in Women"", J. CLIN. ENDOCRINOL. METAB., vol. 87, no. 3, 2002, pages 1156 - 1161, XP008004363;;PAULSON ET AL.: ""Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: Physiologic observations and preliminary experience"", J. ASSIST. REPROD. GENET., vol. 11, no. 1, 1994, pages 28 - 32, XP000876515;;DEVROEY ET AL.: ""A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon)."", HUMAN REPROD., vol. 13, no. 11, 1998, pages 3023 - 3031, XP001118782;;ASHKENAZI ET AL.: ""The value of GnRH analogue therapy in IVF in women with unexplained infertility"", HUMAN REPROD., vol. 4, no. 6, 1989, pages 667 - 669, XP002666590;;FILICORI ET AL.: ""Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration"", HUMAN REPROD., vol. 17, no. 8, 2002, pages 2009 - 2015, XP055267457;;FILICORI ET AL.: ""Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea"", FERTIL. STERIL., vol. 72, no. 6, 1999, pages 1118 - 1120, XP055267458;;FILICORI ET AL.: ""Luteinizing Hormone Activity Supplementation Enhances Follicle-Stimulating Hormone Efficacy and Improves Ovulation Induction Outcome"", J. CLIN. ENDOCRINOL. METAB., vol. 84, no. 8, 1999, pages 2659 - 2663, XP002191016;;FILICORI ET AL.: ""The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction"", HUMAN REPROD. UPDATE, vol. 8, no. 6, 2002, pages 543 - 557, XP055267461;;PROPST ET AL.: ""Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration"", FERTIL. STERIL., vol. 96, no. 4, 2011, pages 898 - 904, XP028301098;;SHIRISH N, DAFTARI, AMEET PATKI: ""Reproductive Endocrinology and Infertility"", 2009, BI PUBLICATIONS PVT LTD., ISBN: 9788172253226, article DAFTARY ET AL., pages: 206, XP055267521;;""Gonal-f 75 IU (5.5 micrograms) Summary of Product Characteristics"", EUROPEAN MEDICINES AGENCY, pages 1 - 207, XP055267553, Retrieved from the Internet <URL:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000071/WC500023748.pdf>",INACTIVE
45,MX,A,MX 2019008272 A,163-680-948-751-769,2019-09-09,2019,MX 2019008272 A,2018-01-12,EP 17151173 A;;EP 2018050736 W,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE.,This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises a number of noise reducing elements projecting from a base part. A plurality of airflow modifying elements are attached to or integrated into the noise reducing elements. The airflow modifying elements extend from a local first end to a local second end along at least one of the first and second side surfaces. The airflow modifying elements has a height of no more than two-thirds of the boundary layer thickness and spacing of no more than one-thirds of the boundary layer thickness. The noise reducing elements are preferably serrations. The airflow modifying elements are preferably vanes projecting perpendicularly from the side surface of the noise reducing elements.,LM WIND POWER INT TECH II APS,CARLOS ARCE;;JESPER MADSEN,,https://lens.org/163-680-948-751-769,Patent Application,no,0,0,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
46,ES,T3,ES 2547233 T3,196-588-582-477-931,2015-10-02,2015,ES 11778689 T,2011-09-28,EP 10251681 A;;IB 2011002541 W,2010-09-29,Composición para su uso en el tratamiento de la esterilidad,"Producto que comprende hormona estimulante del folículo (FSH) y gonadotropina coriónica humana (hCG) para su uso en el tratamiento de la esterilidad, en el que la FSH es para su administración a una dosis de, o una dosis equivalente a, de 75 a 250 UI de FSH al día comenzando en el día uno de tratamiento y continuando durante de dos a veinte días; y la hCG es para su administración a una dosis de, o una dosis equivalente a, de 75 a 160 UI de hCG al día comenzando en el día uno de tratamiento y continuando durante de dos a veinte días.",FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/196-588-582-477-931,Granted Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,ACTIVE
47,BR,A2,BR 112019014433 A2,083-658-660-946-785,2020-04-14,2020,BR 112019014433 A,2018-01-12,EP 2018050736 W;;EP 17151173 A,2017-01-12,pá de turbina eólica que compreende um dispositivo de redução de ruído do bordo de fuga,esta invenção se refere a um dispositivo de redução de ruído e uma pá de turbina eólica compreende tal dispositivo de redução de ruído. o dispositivo de redução de ruído compreende vários elementos redutores de ruído que se projetam de uma parte de base. uma pluralidade de elementos modificadores de fluxo de ar é fixada ou integrada aos elementos redutores de ruído. os elementos modificadores de fluxo de ar se estendem de uma primeira extremidade local até uma segunda extremidade local ao longo de pelo menos uma dentre a primeira e a segunda superfícies laterais. os elementos modificadores de fluxo de ar têm uma altura de não mais de dois terços da espessura da camada limítrofe e espaçamento de não mais de um terço da espessura da camada limítrofe. os elementos redutores de ruído são preferencialmente serrilhados. os elementos modificadores de fluxo de ar são preferencialmente palhetas que se projetam perpendicularmente a partir da superfície lateral dos elementos redutores de ruído.,LM WIND POWER INT TECH II APS,CARLOS ARCE;;JESPER MADSEN,,https://lens.org/083-658-660-946-785,Patent Application,no,0,0,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D1/06;;F03D7/02,,0,0,,,,ACTIVE
48,US,A1,US 2019/0353142 A1,097-412-165-467-697,2019-11-21,2019,US 201816477022 A,2018-01-12,EP 17151173 A;;EP 2018050736 W,2017-01-12,WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises a number of noise reducing elements projecting from a base part. A plurality of airflow modifying elements are attached to or integrated into the noise reducing elements. The airflow modifying elements extend from a local first end to a local second end along at least one of the first and second side surfaces. The airflow modifying elements has a height of no more than two-thirds of the boundary layer thickness and spacing of no more than one-thirds of the boundary layer thickness. The noise reducing elements are preferably serrations. The airflow modifying elements are preferably vanes projecting perpendicularly from the side surface of the noise reducing elements.,LM WIND POWER US TECH APS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/097-412-165-467-697,Patent Application,yes,0,3,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D1/06;;F03D7/02,,0,0,,,,DISCONTINUED
49,CR,A,CR 10334 A,176-463-634-491-117,2008-12-01,2008,CR 10334 A,2008-10-01,CR 10334 A,2008-10-01,COLECTOR SOLAR LAMINADO,"El diseno es un equipo destinado, principalmente, a calentar agua mediante la utilizacion de la radiacion solar, dicho equipos se ubica principalmente, en los techos de edificicaciones industriales, residenciales o comerciales.",JUAN CARLOS RODRIGUEZ ARCE,JUAN CARLOS RODRIGUEZ ARCE,,https://lens.org/176-463-634-491-117,Patent Application,no,0,0,1,1,0,,F28D3/00,,0,0,,,,DISCONTINUED
50,WO,A1,WO 2018/130641 A1,036-672-307-241-561,2018-07-19,2018,EP 2018050736 W,2018-01-12,EP 17151173 A,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises a number of noise reducing elements projecting from a base part. A plurality of airflow modifying elements are attached to or integrated into the noise reducing elements. The airflow modifying elements extend from a local first end to a local second end along at least one of the first and second side surfaces. The airflow modifying elements has a height of no more than two-thirds of the boundary layer thickness and spacing of no more than one-thirds of the boundary layer thickness. The noise reducing elements are preferably serrations. The airflow modifying elements are preferably vanes projecting perpendicularly from the side surface of the noise reducing elements.,LM WIND POWER INT TECH II APS;;LM WIND POWER US TECH APS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/036-672-307-241-561,Patent Application,yes,12,2,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
51,HR,T4,HR P20150968 T4,078-650-439-300-38X,2023-11-10,2023,HR P20150968 T,2011-09-28,EP 10251681 A;;EP 11778689 A;;IB 2011002541 W,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/078-650-439-300-38X,Amended Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,ACTIVE
52,FI,T4,FI 2621517 T4,160-135-020-771-428,2024-01-03,2024,FI 11778689 T,2011-09-28,EP 10251681 A;;IB 2011002541 W,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/160-135-020-771-428,Unknown,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61P15/08;;A61K38/24,,0,0,,,,PENDING
53,PT,E,PT 2621517 E,052-562-211-315-776,2015-10-16,2015,PT 11778689 T,2011-09-28,EP 10251681 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,SAEZ JOAN CARLOS ARCE,,https://lens.org/052-562-211-315-776,Granted Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,ACTIVE
54,ES,T3,ES 2951066 T3,097-226-853-472-626,2023-10-17,2023,ES 17151173 T,2017-01-12,EP 17151173 A,2017-01-12,Una pala de turbina eólica que comprende un dispositivo de reducción de ruido en el borde de salida,"Esta invención se refiere a un dispositivo reductor de ruido y una pala de turbina eólica comprende dicho dispositivo reductor de ruido. El dispositivo reductor de ruido comprende varios elementos reductores de ruido que sobresalen de una parte de base. Una pluralidad de elementos modificadores del flujo de aire están unidos o integrados en los elementos reductores de ruido. Los elementos modificadores del flujo de aire se extienden desde un primer extremo local hasta un segundo extremo local a lo largo de al menos una de las superficies laterales primera y segunda. Los elementos modificadores del flujo de aire tienen una altura de no más de dos tercios del espesor de la capa límite y una separación de no más de un tercio del espesor de la capa límite. Los elementos reductores de ruido son preferentemente dentados. Los elementos modificadores del flujo de aire son preferiblemente paletas que se proyectan perpendicularmente desde la superficie lateral de los elementos reductores de ruido. (Traducción automática con Google Translate, sin valor legal)",LM WIND POWER AS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/097-226-853-472-626,Granted Patent,no,0,0,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
55,CN,A,CN 110139981 A,130-087-737-055-697,2019-08-16,2019,CN 201880006332 A,2018-01-12,EP 17151173 A;;EP 2018050736 W,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises a number of noise reducing elements projecting from a base part. A plurality of airflow modifying elements are attached to or integrated into the noise reducing elements. The airflow modifying elements extend from a local first end to a local secondend along at least one of the first and second side surfaces. The airflow modifying elements has a height of no more than two-thirds of the boundary layer thickness and spacing of no more than one-thirds of the boundary layer thickness. The noise reducing elements are preferably serrations. The airflow modifying elements are preferably vanes projecting perpendicularly from the side surface of thenoise reducing elements.,LM WIND POWER INT TECH II APS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/130-087-737-055-697,Patent Application,no,6,0,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
56,WO,A1,WO 2019/038313 A1,128-321-115-292-509,2019-02-28,2019,EP 2018072608 W,2018-08-22,EP 17187522 A,2017-08-23,A WIND TURBINE BLADE AND A METHOD OF OPERATING SUCH A WIND TURBINE BLADE,"This invention relates to an airfoil modifying device, a wind turbine blade and a method of modifying an airfoil profile of the wind turbine blade. The airfoil modifying device comprises a deformable element connected to a filler element, both configured to deform between a retracted position and an extended position. The airfoil modifying device is passively deformed by the local air pressure acting on the blade surface and thus the airfoil modifying device.",LM WIND POWER INT TECH II APS;;LM WIND POWER US TECH APS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/128-321-115-292-509,Patent Application,yes,7,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,PENDING
57,HK,A1,HK 1206626 A1,145-181-798-227-806,2016-01-15,2016,HK 15107299 A,2014-01-03,EP 10251681 A,2010-09-29,COMPOSITION FOR CONTROLLED OVARIAN STIMULATION,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/145-181-798-227-806,Patent Application,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K/;;A61P/,,0,0,,,,PENDING
58,HU,T2,HU E025514 T2,185-028-956-178-107,2016-02-29,2016,HU E11778689 A,2011-09-28,EP 10251681 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/185-028-956-178-107,Amended Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,PENDING
59,EP,A1,EP 3348826 A1,078-793-199-085-34X,2018-07-18,2018,EP 17151173 A,2017-01-12,EP 17151173 A,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,"This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises a number of noise reducing elements projecting from a base part. A plurality of airflow modifying elements are attached to or integrated into the noise reducing elements. The airflow modifying elements extend from a local first end to a local second end along at least one of the first and second side surfaces. The airflow modifying elements has a height of no more than two-thirds of the boundary layer thickness and spacing of no more than one-thirds of the boundary layer thickness. The noise reducing elements are preferably serrations. The airflow modifying elements are preferably vanes projecting perpendicularly from the side surface of the noise reducing elements.
",LM WP PATENT HOLDING AS,ARCE CARLOS;;MADSEN JESPER,LM WIND POWER A/S (2022-03-23),https://lens.org/078-793-199-085-34X,Patent Application,yes,8,7,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
60,MA,A,MA 44705 A,181-596-624-683-430,2019-02-27,2019,MA 44705 A,2017-01-12,MA 44705 A,2017-01-12,PALE DE TURBINE ÉOLIENNE COMPRENANT UN DISPOSITIF DE RÉDUCTION DE BRUIT DE BORD DE FUITE,,LM WP PATENT HOLDING AS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/181-596-624-683-430,Unknown,no,0,0,1,1,0,Y02E10/72,F03D1/06;;F03D7/02,,0,0,,,,PENDING
61,PL,T5,PL 2621517 T5,070-163-921-518-150,2024-01-29,2024,PL 11778689 T,2011-09-28,EP 10251681 A;;EP 11778689 A;;IB 2011002541 W,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/070-163-921-518-150,Unknown,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,PENDING
62,PL,T3,PL 2621517 T3,074-647-477-467-970,2015-12-31,2015,PL 11778689 T,2011-09-28,EP 10251681 A;;EP 11778689 A;;IB 2011002541 W,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/074-647-477-467-970,Patent Application,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61P15/08;;A61K38/24,,0,0,,,,PENDING
63,CL,U1,CL 2010001232 U1,071-790-729-720-358,2011-09-02,2011,CL 2010001232 U,2010-11-10,CL 2010001232 U,2010-11-10,"Pupitre tecnologico que es semejante en dimensiones y utilidad a un pupitre escolar y se compone principalmente de una mesa compuesta por una cubierta rectangular o semi rectangular, comprende la base de la mesa contiene en su interior un computador que por medio de un mecanismo de elevacion sube hacia la superficie de la cubierta.","Pupitre tecnológico que es semejante en dimensiones y utilidad a un pupitre escolar y se compone principalmente de una mesa compuesta por una cubierta rectangular o semi rectangular, comprende la base de la mesa contiene en su interior un computador que por medio de un mecanismo de elevación sube hacia la superficie de la cubierta en forma automática.",MICHAUD ARCE CARLOS GUILLERMO,MICHAUD ARCE CARLOS GUILLERMO,,https://lens.org/071-790-729-720-358,Unknown,no,0,0,1,1,0,,A47B21/00;;A47B41/00,,0,0,,,,PENDING
64,BR,B1,BR 112019014433 B1,053-465-230-098-828,2023-10-17,2023,BR 112019014433 A,2018-01-12,EP 2018050736 W;;EP 17151173 A,2017-01-12,Pá de turbina eólica que compreende um dispositivo de redução de ruído do bordo de fuga,esta invenção se refere a um dispositivo de redução de ruído e uma pá de turbina eólica compreende tal dispositivo de redução de ruído. o dispositivo de redução de ruído compreende vários elementos redutores de ruído que se projetam de uma parte de base. uma pluralidade de elementos modificadores de fluxo de ar é fixada ou integrada aos elementos redutores de ruído. os elementos modificadores de fluxo de ar se estendem de uma primeira extremidade local até uma segunda extremidade local ao longo de pelo menos uma dentre a primeira e a segunda superfícies laterais. os elementos modificadores de fluxo de ar têm uma altura de não mais de dois terços da espessura da camada limítrofe e espaçamento de não mais de um terço da espessura da camada limítrofe. os elementos redutores de ruído são preferencialmente serrilhados. os elementos modificadores de fluxo de ar são preferencialmente palhetas que se projetam perpendicularmente a partir da superfície lateral dos elementos redutores de ruído.,LM WIND POWER INT TECH II APS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/053-465-230-098-828,Granted Patent,no,0,0,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D1/06;;F03D7/02,,0,0,,,,ACTIVE
65,DK,T4,DK 2621517 T4,159-971-582-487-136,2023-11-20,2023,DK 11778689 T,2011-09-28,EP 10251681 A;;IB 2011002541 W,2010-09-29,SAMMENSÆTNING TIL ANVENDELSE I BEHANDLINGEN AF INFERTILITET,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/159-971-582-487-136,Amended Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,ACTIVE
66,EP,B1,EP 3348826 B1,155-404-810-316-480,2023-05-03,2023,EP 17151173 A,2017-01-12,EP 17151173 A,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,,LM WIND POWER AS,ARCE CARLOS;;MADSEN JESPER,LM WIND POWER A/S (2022-03-23),https://lens.org/155-404-810-316-480,Granted Patent,yes,5,0,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
67,HK,A1,HK 1188114 A1,134-969-265-142-636,2014-04-25,2014,HK 14100046 A,2014-01-03,IB 2011002541 W;;EP 10251681 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/134-969-265-142-636,Patent Application,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61P/;;A61K/,,0,0,,,,PENDING
68,EP,A1,EP 2842567 A1,170-788-326-791-393,2015-03-04,2015,EP 14192349 A,2011-09-28,EP 10251681 A;;EP 11778689 A;;EP 14192349 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,"A product comprising follicle stimulating hormone (FSH) and human chorionic gonadotropin (hCG) for the treatment of infertility.
",FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/170-788-326-791-393,Patent Application,yes,5,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,10,7,055-400-281-517-32X;;021-107-906-143-190;;056-456-511-096-196;;142-870-873-493-325;;157-742-370-335-26X;;157-742-370-335-26X;;041-327-727-454-807,10.1210/jcem.87.3.8322;;11889180;;10.1210/jc.87.3.1156;;10.1007/bf02213694;;7949832;;10.1093/humrep/13.11.3023;;9853849;;2528570;;10.1093/oxfordjournals.humrep.a136964;;10.1016/s0003-0465(15)32004-8;;10.1016/s0003-0465(15)32004-8;;10.1213/00000539-194101000-00064,"FILICORI M ET AL: ""STIMULATION AND GROWTH OF ANTRAL OVARIAN FILLICLES BY SELECTIVE LH ACTIVITY ADMINISTRATION IN WOMEN"", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, vol. 87, no. 3, 1 March 2002 (2002-03-01), pages 1156 - 1161, XP008004363, ISSN: 0021-972X, DOI: 10.1210/JC.87.3.1156;;PAULSON R J ET AL: ""ADDITION OF A GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONIST AND EXOGENOUS GONADOTROPINS TO UNSTIMULATED IN VITRO FERTILIZATION (IVF) CYCLES: PHYSIOLOGIC OBSERVATIONS AND PRELIMINARY EXPERIENCE"", JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, PLENUM PUBLISHING, US, vol. 11, no. 1, 1 January 1994 (1994-01-01), pages 28 - 32, XP000876515, ISSN: 1058-0468, DOI: 10.1007/BF02213694;;MANNAERTS B: ""A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY TO ASSESS THE EFFICACY OF THE GONADOTROPHIN-RELEASING HORMONE ANTAGONIST GANIRELIX (ORG 37462) TO PREVENT PREMATURE LUTEINIZING HORMONE SURGES IN WOMEN UNDERGOING OVARIAN STIMULATION WITH RECOMBINANT FOLLICLE STIMULATING HORMONE (PUREGON). THE GANIRELIX"", HUMAN REPRODUCTION, OXFORD UNIVERSITY PRESS, GB, vol. 13, no. 11, 1 January 1998 (1998-01-01), pages 3023 - 3031, XP000876538, ISSN: 0268-1161, DOI: 10.1093/HUMREP/13.6.1461;;ASHKENAZI J ET AL: ""The value of GnRH analogue therapy in IVF in women with unexplained infertility."", HUMAN REPRODUCTION (OXFORD, ENGLAND) AUG 1989 LNKD- PUBMED:2528570, vol. 4, no. 6, August 1989 (1989-08-01), pages 667 - 669, XP002666590, ISSN: 0268-1161;;""Remington's Pharmaceutical Sciences"", 1975, MATT PUBLISHING COMPANY, pages: 1405 - 1412,146;;""national formulary XIV"", 1975, AMERICAN PHARMACEUTICAL ASSOCIATION;;""Remington's Pharmaceutical Sciences"", 1975, MATT PUBLISHING COMPANY, pages: 1405 - 1412,146;;""the national formulary XIV"", 1975, AMERICAN PHARMACEUTICAL ASSOCIATION;;GOODMAN; GILMAN'S: ""THE PHARMACOLOGICAL BASIS FOR THERAPEUTICES"";;""REMINGTON; THE SCIENCE AND PRACTICE OF PHARMACY"", pages: 780 - 820",PENDING
69,ES,T3,ES 2923392 T3,073-517-988-480-286,2022-09-27,2022,ES 18758613 T,2018-08-22,EP 17187522 A;;EP 2018072608 W,2017-08-23,Una pala de turbina eólica y un método para operar dicha pala de turbina eólica,"Esta invención se refiere a un dispositivo de modificación de superficie aerodinámica, una pala de turbina eólica y un método para modificar un perfil de superficie aerodinámica de la pala de turbina eólica. El dispositivo modificador de perfil aerodinámico comprende un elemento deformable conectado a un elemento de relleno, ambos configurados para deformarse entre una posición retraída y una posición extendida. El dispositivo de modificación del perfil aerodinámico se deforma pasivamente por la presión de aire local que actúa sobre la superficie del álabe y, por lo tanto, el dispositivo de modificación del perfil aerodinámico. (Traducción automática con Google Translate, sin valor legal)",LM WIND POWER AS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/073-517-988-480-286,Granted Patent,no,0,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,ACTIVE
70,EP,A1,EP 2621517 A1,104-243-908-056-184,2013-08-07,2013,EP 11778689 A,2011-09-28,EP 10251681 A;;IB 2011002541 W;;EP 11778689 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/104-243-908-056-184,Patent Application,yes,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,INACTIVE
71,EP,B2,EP 2621517 B2,181-241-957-962-742,2023-10-11,2023,EP 11778689 A,2011-09-28,EP 10251681 A;;IB 2011002541 W;;EP 11778689 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/181-241-957-962-742,Granted Patent,yes,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,3,3,093-479-163-552-565;;064-869-809-207-35X;;012-071-193-977-460,10.1093/humupd/8.6.543;;12498424;;10.1016/j.fertnstert.2006.12.051;;17434503;;10.1016/j.fertnstert.2005.02.033;;16084861,"FILICORI ET AL.: ""The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction"", HUMAN REPROD. UPDATE, vol. 8, no. 6, 2002, pages 543 - 557;;Van Horne et al/ (2007) Fertil Steril, 88(4) 1010-1013;;Filicori et al (2005); Fertil Steril 84(2) 275-284",INACTIVE
72,DK,T3,DK 3348826 T3,046-675-222-532-075,2023-08-07,2023,DK 17151173 T,2017-01-12,EP 17151173 A,2017-01-12,EN VINDMØLLEVINGE SOM OMFATTER EN STØJREDUCERENDE BAGKANTSINDRETNING,,LM WIND POWER AS,ARCE CARLOS;;MADSEN JESPER,,https://lens.org/046-675-222-532-075,Granted Patent,no,0,0,11,11,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;F03D1/0641;;F03D7/0296;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
73,SI,T1,SI 2621517 T1,195-973-564-124-395,2015-10-30,2015,SI 201130584 T,2011-09-28,EP 10251681 A;;IB 2011002541 W;;EP 11778689 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/195-973-564-124-395,Granted Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/00;;A61P15/00,,0,0,,,,ACTIVE
74,WO,A1,WO 2012/042381 A1,067-023-214-006-452,2012-04-05,2012,IB 2011002541 W,2011-09-28,EP 10251681 A,2010-09-29,COMPOSITION FOR CONTROLLED OVARIAN STIMULATION,A product comprising follicle stimulating hormone (FSH) and human chorionic gonadotropin (hCG) for the treatment of infertility.,FERRING BV;;ARCE SAEZ JOAN CARLOS,ARCE SAEZ JOAN CARLOS,,https://lens.org/067-023-214-006-452,Patent Application,yes,5,13,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61P15/08;;A61K38/24,,9,6,055-400-281-517-32X;;021-107-906-143-190;;056-456-511-096-196;;142-870-873-493-325;;058-070-182-330-658;;041-327-727-454-807,10.1210/jcem.87.3.8322;;11889180;;10.1210/jc.87.3.1156;;10.1007/bf02213694;;7949832;;10.1093/humrep/13.11.3023;;9853849;;2528570;;10.1093/oxfordjournals.humrep.a136964;;10.1016/s0015-0282(97)81391-x;;9130884;;10.1213/00000539-194101000-00064,"FILICORI M ET AL: ""STIMULATION AND GROWTH OF ANTRAL OVARIAN FILLICLES BY SELECTIVE LH ACTIVITY ADMINISTRATION IN WOMEN"", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, vol. 87, no. 3, 1 March 2002 (2002-03-01), pages 1156 - 1161, XP008004363, ISSN: 0021-972X, DOI: DOI:10.1210/JC.87.3.1156;;PAULSON R J ET AL: ""ADDITION OF A GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONIST AND EXOGENOUS GONADOTROPINS TO UNSTIMULATED IN VITRO FERTILIZATION (IVF) CYCLES: PHYSIOLOGIC OBSERVATIONS AND PRELIMINARY EXPERIENCE"", JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, PLENUM PUBLISHING, US, vol. 11, no. 1, 1 January 1994 (1994-01-01), pages 28 - 32, XP000876515, ISSN: 1058-0468, DOI: DOI:10.1007/BF02213694;;MANNAERTS B: ""A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY TO ASSESS THE EFFICACY OF THE GONADOTROPHIN-RELEASING HORMONE ANTAGONIST GANIRELIX (ORG 37462) TO PREVENT PREMATURE LUTEINIZING HORMONE SURGES IN WOMEN UNDERGOING OVARIAN STIMULATION WITH RECOMBINANT FOLLICLE STIMULATING HORMONE (PUREGON). THE GANIRELIX"", HUMAN REPRODUCTION, OXFORD UNIVERSITY PRESS, GB, vol. 13, no. 11, 1 January 1998 (1998-01-01), pages 3023 - 3031, XP000876538, ISSN: 0268-1161, DOI: DOI:10.1093/HUMREP/13.6.1461;;ASHKENAZI J ET AL: ""The value of GnRH analogue therapy in IVF in women with unexplained infertility."", HUMAN REPRODUCTION (OXFORD, ENGLAND) AUG 1989 LNKD- PUBMED:2528570, vol. 4, no. 6, August 1989 (1989-08-01), pages 667 - 669, XP002666590, ISSN: 0268-1161;;""Fertil Steril"", vol. 67, 1997, AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE, pages: 817 - 821;;""Remington's Pharmaceutical Sciences"", 1975, MATT PUBLISHING COMPANY, pages: 1405 - 1412,146;;""national formulary"", 1975, AMERICAN PHARMACEUTICAL ASSOCIATION;;""GOODMAN and GILMAN's THE PHARMACOLOGICAL BASIS FOR THERAPEUTICES"";;""REMINGTON; THE SCIENCE AND PRACTICE OF PHARMACY"", pages: 780 - 820",PENDING
75,SI,T2,SI 2621517 T2,088-061-446-396-575,2023-11-30,2023,SI 201130584 T,2011-09-28,EP 10251681 A;;IB 2011002541 W;;EP 11778689 A,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/088-061-446-396-575,Amended Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/00;;A61P15/00,,0,0,,,,ACTIVE
76,RS,B1,RS 54214 B1,154-367-746-474-284,2015-12-31,2015,RS P20150576 A,2011-09-28,EP 10251681 A;;IB 2011002541 W,2010-09-29,COMPOSITION FOR USE IN TREATING INFERTILITY,"Proizvod koji sadrži folikulostimulirajući hormon (FSH) i humani horionski gonadotropin (hCG) za upotrebu u lečenju infertiliteta naznačeno time što je FSH za primenu u dozi od, ili dozi ekvivalentnoj, 75 do 250 IJ FSH na dan počinjući prvog dana tretmana i nastavljajući tokom dva do dvadeset dana; i hCG koji je za primenu u dozi od, ili dozi ekvivalentnoj, 75 do 160 IJ hCG na dan počinjući prvog dana tretmana i nastavljajući tokom dva do dvadeset dana. Prijava sadrži još 12 patentnih zahteva.",FERRING BV,ARCE SAEZ JOAN CARLOS,,https://lens.org/154-367-746-474-284,Granted Patent,no,0,0,26,26,0,A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06,A61K38/24;;A61P15/08,,0,0,,,,ACTIVE
77,DK,T3,DK 3673171 T3,088-812-560-621-689,2022-08-08,2022,DK 18758613 T,2018-08-22,EP 17187522 A;;EP 2018072608 W,2017-08-23,VINDMØLLEVINGE OG FREMGANGSMÅDE TIL AT DRIVE EN SÅDAN VINDMØLLEVINGE,,LM WIND POWER AS,ARCE CARLOS LEÓN;;MADSEN JESPER,,https://lens.org/088-812-560-621-689,Granted Patent,no,0,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,ACTIVE
78,CN,A,CN 110945235 A,167-210-934-538-819,2020-03-31,2020,CN 201880054468 A,2018-08-22,EP 17187522 A;;EP 2018072608 W,2017-08-23,A WIND TURBINE BLADE AND A METHOD OF OPERATING SUCH A WIND TURBINE BLADE,"This invention relates to an airfoil modifying device, a wind turbine blade and a method of modifying an airfoil profile of the wind turbine blade. The airfoil modifying device comprises a deformableelement connected to a filler element, both configured to deform between a retracted position and an extended position. The airfoil modifying device is passively deformed by the local air pressure acting on the blade surface and thus the airfoil modifying device.",LM WIND POWER INT TECH II APS,ARCE CARLOS LEON;;MADSEN JESPER,,https://lens.org/167-210-934-538-819,Patent Application,no,12,1,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,PENDING
79,BR,A2,BR 112020003889 A2,068-984-021-021-700,2020-09-01,2020,BR 112020003889 A,2018-08-22,EP 2018072608 W;;EP 17187522 A,2017-08-23,lâmina de turbina eólica e método de operação de tal lâmina de turbina eólica,"a presente invenção refere-se a um dispositivo de modificação de aerofólio, uma lâmina de turbina eólica e um método para modificar um perfil de aerofólio da lâmina de turbina eólica. o dispositivo de modificação de aerofólio compreende um elemento deformável conectado a um elemento de preenchimento, ambos configurados para se deformarem entre uma posição retraída e uma posição estendida. o dispositivo de modificação de aerofólio é passivamente deformado pela pressão de ar local que atua na superfície de lâmina e, portanto, pelo dispositivo de modificação do aerofólio.",LM WIND POWER INT TECH II APS,CARLOS LEÓN ARCE;;JESPER MADSEN,,https://lens.org/068-984-021-021-700,Patent Application,no,0,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,ACTIVE
80,BR,B1,BR 112020003889 B1,166-184-847-115-17X,2023-11-07,2023,BR 112020003889 A,2018-08-22,EP 2018072608 W;;EP 17187522 A,2017-08-23,Lâmina de turbina eólica e método de operação de tal lâmina de turbina eólica,"a presente invenção refere-se a um dispositivo de modificação de aerofólio, uma lâmina de turbina eólica e um método para modificar um perfil de aerofólio da lâmina de turbina eólica. o dispositivo de modificação de aerofólio compreende um elemento deformável conectado a um elemento de preenchimento, ambos configurados para se deformarem entre uma posição retraída e uma posição estendida. o dispositivo de modificação de aerofólio é passivamente deformado pela pressão de ar local que atua na superfície de lâmina e, portanto, pelo dispositivo de modificação do aerofólio.",LM WIND POWER INT TECH II APS,CARLOS LEÓN ARCE;;MADSEN JESPER,,https://lens.org/166-184-847-115-17X,Granted Patent,no,0,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,ACTIVE
81,US,A1,US 2021/0079885 A1,076-632-473-930-367,2021-03-18,2021,US 201816640291 A,2018-08-22,EP 17187522 A;;EP 2018072608 W,2017-08-23,A Wind Turbine Blade and a Method of Operating Such a Wind Turbine Blade,"This invention relates to an airfoil modifying device, a wind turbine blade and a method of modifying an airfoil profile of the wind turbine blade. The airfoil modifying device comprises a deformable element connected to a filler element, both configured to deform between a retracted position and an extended position. The airfoil modifying device is passively deformed by the local air pressure acting on the blade surface and thus the airfoil modifying device.",LM WIND POWER INT TECH II APS,ARCE CARLOS LEÓN;;MADSEN JESPER,LM WIND POWER INTERNATIONAL TECHNOLOGY II APS (2020-06-11),https://lens.org/076-632-473-930-367,Patent Application,yes,5,2,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06;;F03D3/06,,0,0,,,,ACTIVE
82,US,B2,US 11674497 B2,171-252-156-168-793,2023-06-13,2023,US 201816640291 A,2018-08-22,EP 17187522 A;;EP 2018072608 W,2017-08-23,Wind turbine blade and a method of operating such a wind turbine blade,"This invention relates to an airfoil modifying device, a wind turbine blade and a method of modifying an airfoil profile of the wind turbine blade. The airfoil modifying device comprises a deformable element connected to a filler element, both configured to deform between a retracted position and an extended position. The airfoil modifying device is passively deformed by the local air pressure acting on the blade surface and thus the airfoil modifying device.",LM WIND POWER INT TECH II APS,ARCE CARLOS LEÓN;;MADSEN JESPER,LM WIND POWER INTERNATIONAL TECHNOLOGY II APS (2020-06-11),https://lens.org/171-252-156-168-793,Granted Patent,yes,38,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06;;B29L31/08;;F03D3/06,,0,0,,,,ACTIVE
83,CA,A1,CA 3072004 A1,186-134-560-098-317,2019-02-28,2019,CA 3072004 A,2018-08-22,EP 17187522 A;;EP 2018072608 W,2017-08-23,A WIND TURBINE BLADE AND A METHOD OF OPERATING SUCH A WIND TURBINE BLADE,"This invention relates to an airfoil modifying device, a wind turbine blade and a method of modifying an airfoil profile of the wind turbine blade. The airfoil modifying device comprises a deformable element connected to a filler element, both configured to deform between a retracted position and an extended position. The airfoil modifying device is passively deformed by the local air pressure acting on the blade surface and thus the airfoil modifying device.",LM WIND POWER INT TECH II APS,ARCE CARLOS LEON;;MADSEN JESPER,,https://lens.org/186-134-560-098-317,Patent Application,no,0,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,PENDING
84,EP,A1,EP 3673171 A1,015-598-991-074-274,2020-07-01,2020,EP 18758613 A,2018-08-22,EP 17187522 A;;EP 2018072608 W,2017-08-23,A WIND TURBINE BLADE AND A METHOD OF OPERATING SUCH A WIND TURBINE BLADE,,LM WIND POWER INT TECH II APS,ARCE CARLOS LEÓN;;MADSEN JESPER,LM WIND POWER A/S (2022-03-23),https://lens.org/015-598-991-074-274,Patent Application,yes,0,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,ACTIVE
85,EP,B1,EP 3673171 B1,045-402-792-182-193,2022-05-11,2022,EP 18758613 A,2018-08-22,EP 17187522 A;;EP 2018072608 W,2017-08-23,A WIND TURBINE BLADE AND A METHOD OF OPERATING SUCH A WIND TURBINE BLADE,,LM WIND POWER AS,ARCE CARLOS LEÓN;;MADSEN JESPER,LM WIND POWER A/S (2022-03-23),https://lens.org/045-402-792-182-193,Granted Patent,yes,5,0,11,11,0,F05B2240/31;;F05B2240/311;;Y02E10/74;;Y02E10/72;;F03D1/0675;;B29L2031/085;;F03D3/061;;F05B2240/301;;F05B2240/311;;F05B2280/6003;;F03D1/0675,F03D1/06,,0,0,,,,ACTIVE
86,US,B2,US 11473555 B2,005-909-608-926-431,2022-10-18,2022,US 201816476951 A,2018-01-12,EP 17151172 A;;EP 2018050755 W,2017-01-12,Wind turbine blade comprising a trailing edge noise reducing device,"This invention relates to a noise reducing device, a wind turbine blade comprises such a noise reducing device, a method of retrofitted a noise reducing device, and a method of manufacturing such a noise reducing device. The noise reducing device comprises first noise reducing elements projecting from a base part having a third surface towards a second end. Second noise reducing elements are attached to the third surface and projects along the first noise reducing elements towards the second end. The first noise reducing elements are preferably serrations while the second noise reducing elements are bristles. The bristles projects at least into the gaps formed between adjacent serrations.",LM WIND POWER US TECH APS,ARCE CARLOS;;NIELSEN BJARKE;;BAEK PETER,LM WINDPOWER US TECHNOLOGY APS (2019-05-09),https://lens.org/005-909-608-926-431,Granted Patent,yes,28,0,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D1/06;;F03D7/02,,2,0,,,"Sun CN 106246478 English Machine Translation, Translated by ProQuest Aug. 18, 2021 (Year: 2016).;;Communication Pursuant to Article 94(3) EPC dated Jun. 27,2022 corresponding to application No. 17151172.8-1002.",ACTIVE
87,AU,B2,AU 2016/223496 B2,040-906-355-384-405,2021-09-09,2021,AU 2016/223496 A,2016-02-25,EP 15157661 A;;US 201562121131 P;;EP 15185191 A;;US 201562121113 P;;EP 2016053934 W,2015-02-26,Methods of treating infertility,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/040-906-355-384-405,Granted Patent,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08;;C12N5/073,,2,2,026-468-563-429-837;;004-932-628-671-99X,23394782;;10.1016/j.fertnstert.2012.12.048;;24341292;;10.1186/1477-7827-11-115;;pmc3878562,"ARCE J. ET AL, FERTILITY AND STERILITY, (2013), vol. 99, no. 6, page 1644;;AMER S. ET AL, REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, (2013), vol. 11, no. 1, page 115",ACTIVE
88,LT,T,LT 3261661 T,003-103-393-867-853,2024-01-25,2024,LT EP2016053934 T,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,MENOTROPIN FOR TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/003-103-393-867-853,Unknown,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/00;;A61P15/08;;C12N5/073,,0,0,,,,PENDING
89,WO,A1,WO 2012/131585 A1,053-949-629-307-098,2012-10-04,2012,IB 2012051467 W,2012-03-27,CO 11037516 A,2011-03-28,CERAMIC BIOCOMPOSITE FOR BONE REGENERATION,"The invention relates to a ceramic biocomposite for bone regeneration, having a pH range of between 6.5 and 8.5, with an initial plasticity that allows the biocomposite to be easily moulded in situ and to set after 7 minutes, meaning that it can remain at the indicated location during the healing process. In addition, the biocomposite has demonstrated an ability to stimulate bone formation in hard-to-heal wounds. The material can act alone or in combination with other types of bone graft such as autografts, homografts or xenografts which act as a vehicle, as a binding material for endosseous prostheses or as a covering for endosseous implants or prostheses.",UNIV AUTONOMA DE OCCIDENTE;;ARCE GUERRERO SANDRA;;VALENCIA CARLOS HUMBERTO,ARCE GUERRERO SANDRA;;VALENCIA CARLOS HUMBERTO,,https://lens.org/053-949-629-307-098,Patent Application,yes,3,0,6,6,0,A61K31/722;;A61K31/722;;A61K45/06;;A61L27/12;;A61L27/12;;A61L27/20;;A61L27/20;;A61L27/24;;A61L27/24;;A61L27/3608;;A61L27/3608;;A61L27/40;;A61L27/40;;A61L27/58;;A61L27/58;;A61L2430/02;;A61L2430/02;;C08K3/22;;C08K3/22;;C08K3/32;;C08K3/32;;C08K5/52;;C08K5/52;;C08K2003/2206;;C08K2003/2206;;C08K2003/2296;;C08K2003/2296,A61L27/20;;A61F2/28;;A61K6/898;;A61L27/12,,1,1,047-329-512-942-616,10.3233/bme-1994-4603;;7833787,"ITO, M. ET AL.: ""Experimental development of a chitosan-bonded beta-tricalcium phosphate bone filling paste"", BIO-MEDICAL MATERIALS AND ENGINEERING, vol. 4, no. 6, 1994, pages 439 - 449",PENDING
90,WO,A1,WO 2016/135221 A1,106-051-379-529-690,2016-09-01,2016,EP 2016053934 W,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A,2015-02-26,METHODS OF TREATING INFERTILITY,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/106-051-379-529-690,Patent Application,yes,3,3,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08;;C12N5/073,,17,14,004-932-628-671-99X;;026-468-563-429-837;;009-133-775-244-69X;;063-163-783-525-876;;063-163-783-525-876;;003-722-433-316-582;;033-476-358-244-714;;006-017-423-730-611;;002-136-306-690-370;;009-133-775-244-69X;;026-468-563-429-837;;030-462-143-792-530;;013-331-117-188-376;;000-959-141-421-280,24341292;;10.1186/1477-7827-11-115;;pmc3878562;;23394782;;10.1016/j.fertnstert.2012.12.048;;17640944;;10.1093/humrep/dem221;;10.1016/j.fertnstert.2011.12.016;;22244781;;10.1016/j.fertnstert.2011.12.016;;22244781;;24782016;;10.1007/978-1-4939-0659-8_14;;10.1016/j.fertnstert.2008.01.012;;18314124;;23136144;;10.1093/humrep/des389;;20627979;;10.1093/humrep/deq174;;17640944;;10.1093/humrep/dem221;;23394782;;10.1016/j.fertnstert.2012.12.048;;23953585;;10.1016/j.rbmo.2013.07.006;;23725804;;10.1016/j.fertnstert.2013.04.043;;22473395;;pmc3357198;;10.1093/humrep/des101,"SAAD A AMER ET AL: ""The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study"", REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, BIOMED CENTRAL LTD, GB, vol. 11, no. 1, 17 December 2013 (2013-12-17), pages 115, XP021171351, ISSN: 1477-7827, DOI: 10.1186/1477-7827-11-115;;ARCE JOAN-CARLES ET AL: ""Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients"", FERTILITY AND STERILITY, vol. 99, no. 6, 6 May 2013 (2013-05-06), pages 1644, XP028591395, ISSN: 0015-0282, DOI: 10.1016/J.FERTNSTERT.2012.12.048;;S. ZIEBE ET AL: ""Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF"", HUMAN REPRODUCTION, vol. 22, no. 9, 28 June 2007 (2007-06-28), pages 2404 - 2413, XP055208240, ISSN: 0268-1161, DOI: 10.1093/humrep/dem221;;DEVROEY PAUL ET AL: ""A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer"", FERTILITY AND STERILITY, vol. 97, no. 3, 3 March 2012 (2012-03-03), pages 561 - 571, XP028902191, ISSN: 0015-0282, DOI: 10.1016/J.FERTNSTERT.2011.12.016;;DEVROEY ET AL., FERTILITY AND STERILITY, vol. 97, 2012, pages 561 - 71;;HAMDINE ET AL.: ""Human Fertility: Methods and Protocols, Methods in Molecular Biology"", vol. 1154, 2014, SPRINGER SCIENCE+BUSINESS MEDIA, article ""Ovarian Stimulation for IVF: Mild Approaches"";;HAAF ET AL., FERTILITY AND STERILITY, vol. 91, no. 3, 2009, pages 733 - 38;;FATEMI ET AL., HUMAN REPRODUCTION, vol. 28, no. 2, 2013, pages 442 - 52;;RUBIO ET AL., HUMAN REPRODUCTION, vol. 25, no. 9, 2010, pages 2290 - 2010;;ZIEBE ET AL., HUMAN REPRODUCTION, vol. 22, no. 9, 2007, pages 2404 - 13;;LA MARCA ET AL., FERTILITY AND STERILITY, 2012, pages 0 - 169;;ARCE ET AL., FERTILITY AND STERILITY, vol. 99, 2013, pages 1644 - 53;;VAN DEN ABBEEL ET AL., REPRODUCTIVE BIOMED. ONLINE, vol. 27, 2013, pages 353 - 61;;FORMAN ET AL., FERTILITY AND STERILITY, vol. 100, 2013, pages 718 - 24;;ANCKAERT ET AL., HUMAN REPRODUCTION, vol. 27, 2012, pages 1829 - 39;;SCHOOLCRAFT: ""TOWARDS REPRODUCTIVE CERTAINTY: FERTILITY AND GENETICS BEYOND"", 1998, THE PARTHENON PUBLISHING GROUP, article ""In-vitro culture of human blastocysts"", pages: 378 - 88;;GARDNER DK; SCHOOLCRAFT WB: ""Towards reproductive certainty"", article ""In vitro culture of human blastocysts""",PENDING
91,CN,A,CN 110177935 A,010-952-446-520-563,2019-08-27,2019,CN 201880006639 A,2018-01-12,EP 17151172 A;;EP 2018050755 W,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,"This invention relates to a noise reducing device, a wind turbine blade comprises such a noise reducing device, a method of retrofitted a noise reducing device, and a method of manufacturing such a noise reducing device. The noise reducing device comprises first noise reducing elements projecting from a base part having a third surface towards a second end. Second noise reducing elements are attached to the third surface and projects along the first noise reducing elements towards the second end. The first noise reducing elements are preferably serrations while the second noise reducing elements are bristles. The bristles projects at least into the gaps formed between adjacent serrations.",LM WIND POWER INT TECH II APS,ARCE CARLOS;;NIELSEN BJARKE;;BAEK PETER,,https://lens.org/010-952-446-520-563,Patent Application,no,8,1,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
92,EP,B1,EP 3084209 B1,028-749-392-277-675,2019-09-25,2019,EP 14812758 A,2014-12-18,EP 13198952 A;;EP 2014078462 W;;EP 14812758 A,2013-12-20,A WIND TURBINE BLADE HAVING DEPLOYABLE AERODYNAMIC DEVICES,,LM WP PATENT HOLDING AS,ARCE CARLOS;;DAHL MARTIN;;MADSEN JESPER,,https://lens.org/028-749-392-277-675,Granted Patent,yes,4,0,9,9,0,F05B2240/311;;F03D1/0633;;F05B2240/2211;;Y02E10/72;;F05B2240/305;;F05B2240/3062;;F05B2240/122;;F05B2240/311;;Y02E10/72;;F03D1/0633;;F05B2240/2211,F03D1/06,,0,0,,,,ACTIVE
93,PH,A1,PH 12017501493 A1,043-777-740-211-86X,2018-01-29,2018,PH 12017501493 A,2017-08-17,US 201562121131 P;;EP 15157661 A;;US 201562121113 P;;EP 15185191 A;;EP 2016053934 W,2015-02-26,METHODS OF TREATING INFERTILITY,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/043-777-740-211-86X,Patent Application,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08;;C12N5/073,,0,0,,,,PENDING
94,MA,A,MA 41700 A,050-399-326-919-764,2018-11-28,2018,MA 41700 A,2017-05-22,MA 41700 A,2017-05-22,PALE DE TURBINE ÉOLIENNE COMPRENANT UN DISPOSITIF DE RÉDUCTION DE BRUIT,,LM WIND POWER INT TECH II APS,ARCE CARLOS;;BÆK PETER;;NIELSEN BJARKE,,https://lens.org/050-399-326-919-764,Unknown,no,0,0,1,1,0,Y02E10/72,F03D1/06,,0,0,,,,PENDING
95,EP,A3,EP 4289477 A3,189-390-938-833-961,2024-02-21,2024,EP 23195379 A,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 16709720 A;;EP 2016053934 W,2015-02-26,MENOTROPIN FOR TREATING INFERTILITY,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/189-390-938-833-961,Search Report,yes,3,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/00;;A61P15/08;;C12N5/073;;G01N33/50,,6,0,,,"SAAD A AMER ET AL: ""The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study"", REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, BIOMED CENTRAL LTD, GB, vol. 11, no. 1, 17 December 2013 (2013-12-17), pages 115, XP021171351, ISSN: 1477-7827, DOI: 10.1186/1477-7827-11-115;;ARCE JOAN-CARLES ET AL: ""Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients"", FERTILITY AND STERILITY, vol. 99, no. 6, 6 May 2013 (2013-05-06), pages 1644, XP028591395, ISSN: 0015-0282, DOI: 10.1016/J.FERTNSTERT.2012.12.048;;S. ZIEBE ET AL: ""Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF"", HUMAN REPRODUCTION, vol. 22, no. 9, 28 June 2007 (2007-06-28), pages 2404 - 2413, XP055208240, ISSN: 0268-1161, DOI: 10.1093/humrep/dem221;;DEVROEY PAUL ET AL: ""A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer"", FERTILITY AND STERILITY, vol. 97, no. 3, 3 March 2012 (2012-03-03), pages 561 - 571, XP028902191, ISSN: 0015-0282, DOI: 10.1016/J.FERTNSTERT.2011.12.016;;ELLEN ANCKAERT ET AL: ""The value of anti-Müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments"", HUMAN REPRODUCTION, OXFORD JOURNALS, GB, vol. 27, no. 6, 1 June 2012 (2012-06-01), pages 1829 - 1839, XP002686253, ISSN: 0268-1161, [retrieved on 20120403], DOI: 10.1093/HUMREP/DES101;;WITZ CRAIG A ET AL: ""Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection"", FERTILITY AND STERILITY, ELSEVIER, AMSTERDAM, NL, vol. 114, no. 2, 13 May 2020 (2020-05-13), pages 321 - 330, XP086235412, ISSN: 0015-0282, [retrieved on 20200513], DOI: 10.1016/J.FERTNSTERT.2020.03.029",PENDING
96,WO,A1,WO 2015/091797 A1,058-056-866-332-311,2015-06-25,2015,EP 2014078462 W,2014-12-18,EP 13198952 A,2013-12-20,A WIND TURBINE BLADE HAVING DEPLOYABLE AERODYNAMIC DEVICES,"A wind turbine blade is described, as well as a trailing edge plate for a wind turbine blade. A flexible flow modulation device, e.g. an acoustic flap or a plurality of serrations, is arranged at the trailing edge of a wind turbine blade, wherein the flexible device is coupled to at least one aerodynamic device, preferably vortex generators. As the flexible device is bent by action of flow over the wind turbine blade, the at least one aerodynamic device is deployed to provide for attached flow over the bent flexible device.",LM WP PATENT HOLDING AS,ARCE CARLOS;;DAHL MARTIN;;MADSEN JESPER,,https://lens.org/058-056-866-332-311,Patent Application,yes,4,6,9,9,0,F05B2240/311;;F03D1/0633;;F05B2240/2211;;Y02E10/72;;F05B2240/305;;F05B2240/3062;;F05B2240/122;;F05B2240/311;;Y02E10/72;;F03D1/0633;;F05B2240/2211,F03D1/06,,0,0,,,,PENDING
97,CA,A1,CA 3048747 A1,192-002-139-116-289,2018-07-19,2018,CA 3048747 A,2018-01-12,EP 17151172 A;;EP 2018050755 W,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,"This invention relates to a noise reducing device, a wind turbine blade comprises such a noise reducing device, a method of retrofitted a noise reducing device, and a method of manufacturing such a noise reducing device. The noise reducing device comprises first noise reducing elements projecting from a base part having a third surface towards a second end. Second noise reducing elements are attached to the third surface and projects along the first noise reducing elements towards the second end. The first noise reducing elements are preferably serrations while the second noise reducing elements are bristles. The bristles projects at least into the gaps formed between adjacent serrations.",LM WIND POWER INT TECH II APS,ARCE CARLOS;;NIELSEN BJARKE;;BAK PETER,,https://lens.org/192-002-139-116-289,Patent Application,no,0,0,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
98,EP,B1,EP 3261661 B1,081-765-968-782-992,2023-10-18,2023,EP 16709720 A,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,MENOTROPIN FOR TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/081-765-968-782-992,Granted Patent,yes,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/00;;A61P15/08;;C12N5/073,,1,1,000-959-141-421-280,22473395;;pmc3357198;;10.1093/humrep/des101,"ELLEN ANCKAERT ET AL: ""The value of anti-Müllerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments"", HUMAN REPRODUCTION, OXFORD JOURNALS, GB, vol. 27, no. 6, 1 June 2012 (2012-06-01), pages 1829 - 1839, XP002686253, ISSN: 0268-1161, [retrieved on 20120403], DOI: 10.1093/HUMREP/DES101",ACTIVE
99,CN,A,CN 103687632 A,113-887-907-208-975,2014-03-26,2014,CN 201280023434 A,2012-03-27,IB 2012051467 W;;CO 11037516 A,2011-03-28,Ceramic biocomposite for bone regeneration,"The invention relates to a ceramic biocomposite for bone regeneration, having a pH range of between 6.5 and 8.5, with an initial plasticity that allows the biocomposite to be easily moulded in situ and to set after 7 minutes, meaning that it can remain at the indicated location during the healing process. In addition, the biocomposite has demonstrated an ability to stimulate bone formation in hard-to-heal wounds. The material can act alone or in combination with other types of bone graft such as autografts, homografts or xenografts which act as a vehicle, as a binding material for endosseous prostheses or as a covering for endosseous implants or prostheses.",UNIV AUTONOMA DE OCCIDENTE,ARCE GUERRERO SANDRA;;VALENCIA CARLOS HUMBERTO,,https://lens.org/113-887-907-208-975,Patent Application,no,3,1,6,6,0,A61K31/722;;A61K31/722;;A61K45/06;;A61L27/12;;A61L27/12;;A61L27/20;;A61L27/20;;A61L27/24;;A61L27/24;;A61L27/3608;;A61L27/3608;;A61L27/40;;A61L27/40;;A61L27/58;;A61L27/58;;A61L2430/02;;A61L2430/02;;C08K3/22;;C08K3/22;;C08K3/32;;C08K3/32;;C08K5/52;;C08K5/52;;C08K2003/2206;;C08K2003/2206;;C08K2003/2296;;C08K2003/2296,A61L27/20;;A61F2/28;;A61K6/898;;A61L27/12,,4,1,058-607-046-832-036,11255183;;10.1002/1097-4636(20010605)55:3<304::aid-jbm1018>3.0.co;2-j,"MICHIO ITO ET AL.: ""EXPERIMENTAL DEVELOPMENT OF A CHITOSAN-BONDED β-TRICALCIUM PHOSPHATE BONE FILLING PASTE"", 《BIO-MEDICAL MATERIALS AND ENGINEERING》;;YONG ZHANG ET AL.: ""Synthesis and characterization of macroporous chitosan/calcium phosphate composite scaffolds for tissue engineering"", 《JOURNAL OF BIOMEDICAL MATERIALS RESEARCH》;;王磊等: ""甲壳素、壳聚糖在骨修复方面的研究进展"", 《口腔颌面外科杂》;;姚子昂等: ""壳聚糖在组织工程中应用的研究进展"", 《中国生物工程杂志》",ACTIVE
100,WO,A1,WO 2018/130651 A1,150-711-021-691-972,2018-07-19,2018,EP 2018050755 W,2018-01-12,EP 17151172 A,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,"This invention relates to a noise reducing device, a wind turbine blade comprises such a noise reducing device, a method of retrofitted a noise reducing device, and a method of manufacturing such a noise reducing device. The noise reducing device comprises first noise reducing elements projecting from a base part having a third surface towards a second end. Second noise reducing elements are attached to the third surface and projects along the first noise reducing elements towards the second end. The first noise reducing elements are preferably serrations while the second noise reducing elements are bristles. The bristles projects at least into the gaps formed between adjacent serrations.",LM WIND POWER INT TECH II APS;;LM WIND POWER US TECH APS,ARCE CARLOS;;NIELSEN BJARKE;;BÆK PETER,,https://lens.org/150-711-021-691-972,Patent Application,yes,9,0,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
101,CN,A,CN 105992870 A,157-496-387-284-381,2016-10-05,2016,CN 201480075966 A,2014-12-18,EP 13198952 A;;EP 2014078462 W,2013-12-20,A wind turbine blade having deployable aerodynamic devices,"A wind turbine blade is described, as well as a trailing edge plate for a wind turbine blade. A flexible flow modulation device, e.g. an acoustic flap or a plurality of serrations, is arranged at the trailing edge of a wind turbine blade, wherein the flexible device is coupled to at least one aerodynamic device, preferably vortex generators. As the flexible device is bent by action of flow over the wind turbine blade, the at least one aerodynamic device is deployed to provide for attached flow over the bent flexible device.",LM WP PATENT HOLDING AS,ARCE CARLOS;;DAHL MARTIN;;MADSEN JESPER,,https://lens.org/157-496-387-284-381,Patent Application,no,5,6,9,9,0,F05B2240/311;;F03D1/0633;;F05B2240/2211;;Y02E10/72;;F05B2240/305;;F05B2240/3062;;F05B2240/122;;F05B2240/311;;Y02E10/72;;F03D1/0633;;F05B2240/2211,F03D1/06,,0,0,,,,ACTIVE
102,JP,A,JP 2020203904 A,163-667-465-250-592,2020-12-24,2020,JP 2020139478 A,2020-08-20,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A,2015-02-26,METHOD OF TREATING INFERTILITY,"To provide a method for treating infertility by promoting the development of haploid blastocysts, the method being useful for women at risk of high ovarian response to regulated ovarian stimulation.SOLUTION: The present invention relates to a composition comprising menotropin (human menopausal gonadotropin or hMG) for use in the treatment of infertility by promoting the development of equiploid blastocysts, wherein the treatment includes: selecting a woman having a risk of high ovarian response to regulated ovarian stimulation which is identified, before stimulation, to have serum anti-Mullerian hormone (AMH) levels≥5.0±0.5ng/ml and total number of follicular follicles (AFC)≥10 in both ovaries; and giving the selected women a dose of 75-300 IU hMG or equivalent per day from day 1 to day 5 of treatment.SELECTED DRAWING: Figure 1",FERRING BV,JOAN CARLOS ARCE SAEZ;;JANE RUMAN,,https://lens.org/163-667-465-250-592,Patent Application,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61K35/54;;A61K45/00;;A61P15/00;;A61P15/08;;A61P43/00,,2,2,004-954-448-220-734;;068-909-517-967-890,10.3109/09513590.2014.892066;;24576226;;pmc4059219;;18182396;;10.1093/humrep/dem412,"ARCE JC ET AL.: ""The rate of high ovarian response in women identified at risk by a high serum AMH level is influence"", GYNECOLOGICAL ENDOCRINOLOGY, vol. 30, no. 6, JPN6019032431, 2014, pages 444 - 450, XP055784562, ISSN: 0004564947, DOI: 10.3109/09513590.2014.892066;;WEGHOFER A ET AL.: ""The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protoco"", HUMAN REPRODUCTION, vol. 23, no. 3, JPN7019002678, 2008, pages 499 - 503, ISSN: 0004564948",ACTIVE
103,CA,A1,CA 2976032 A1,126-063-954-600-056,2016-09-01,2016,CA 2976032 A,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,METHODS OF TREATING INFERTILITY,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/126-063-954-600-056,Patent Application,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08;;C12N5/073,,0,0,,,,PENDING
104,RU,C2,RU 2723098 C2,175-327-195-671-745,2020-06-08,2020,RU 2017131129 A,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,METHODS OF TREATING INFERTILITY,"FIELD: medicine; gynecology.SUBSTANCE: group of inventions can be used for treating infertility in a patient. In order to stimulate development of euploid blastocysts and for future blastocyst transfer, the method involves identification of a patient having serum level of anti-Mullerian hormone (AMN) greater than or equal to 4.7 ng/ml and the number of antral follicles (AFC) greater than or equal to 10 in both ovaries together before treatment/stimulation. Dose of 75 to 300 IU (international unit) or equivalent dose of hMG (human menopausal gonadotrophin) per day from day 1 to at least 5 days of treatment is administered. Group of inventions also refers to a method of treating infertility in a woman who does not have PCOS (polycystic ovaries syndrome) at risk of severe ovarian response to controlled ovarian stimulation.EFFECT: use of this group of inventions enables to perform assisted reproductive technology using highly purified menotropin (HP-hMG) for stimulating follicular development in controlled ovarian stimulation, especially in women at risk of severe ovarian response to controlled ovarian stimulation.14 cl, 2 dwg, 3 tbl, 2 ex",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/175-327-195-671-745,Granted Patent,no,1,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08,,2,2,004-932-628-671-99X;;009-133-775-244-69X,24341292;;10.1186/1477-7827-11-115;;pmc3878562;;17640944;;10.1093/humrep/dem221,"SAAD A AMER et al., The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study, Reproductive Biology and Endocrinology, 2013, N 11, c.115.;;SOREN ZIEBE et al., Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF, Human Reproduction, Volume 22, Issue 9, September 2007, c. 2404-2413.",ACTIVE
105,DK,T3,DK 3261661 T3,040-266-977-111-716,2024-01-15,2024,DK 16709720 T,2016-02-25,US 201562121131 P;;US 201562121113 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,MENOTROPIN TIL BEHANDLING AF INFERTILITET,,FERRING BV,RUMAN JANE;;ARCE SAEZ JOAN CARLOS,,https://lens.org/040-266-977-111-716,Granted Patent,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/00;;A61P15/08;;C12N5/073,,0,0,,,,ACTIVE
106,EP,A1,EP 3348825 A1,035-743-392-785-609,2018-07-18,2018,EP 17151172 A,2017-01-12,EP 17151172 A,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,"This invention relates to a noise reducing device, a wind turbine blade comprises such a noise reducing device, a method of retrofitted a noise reducing device, and a method of manufacturing such a noise reducing device. The noise reducing device comprises first noise reducing elements projecting from a base part having a third surface towards a second end. Second noise reducing elements are attached to the third surface and projects along the first noise reducing elements towards the second end. The first noise reducing elements are preferably serrations while the second noise reducing elements are bristles. The bristles projects at least into the gaps formed between adjacent serrations.
",LM WP PATENT HOLDING AS,ARCE CARLOS;;NIELSEN BJARKE;;BÆK PETER,LM WIND POWER A/S (2022-03-23),https://lens.org/035-743-392-785-609,Patent Application,yes,7,3,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
107,US,B2,US 9066969 B2,070-199-383-469-877,2015-06-30,2015,US 201214008176 A,2012-03-27,CO 11037516 A;;IB 2012051467 W,2011-03-28,Ceramic biocomposite for bone regeneration,"The invention relates to a ceramic biocomposite for bone regeneration, having a pH range of between 6.5 and 8.5, with an initial plasticity that allows the biocomposite to be easily moulded in situ and to set after 7 minutes, meaning that it can remain at the indicated location during the healing process. In addition, the biocomposite has demonstrated an ability to stimulate bone formation in hard-to-heal wounds. The material can act alone or in combination with other types of bone graft such as autografts, homografts or xenografts which act as a vehicle, as a binding material for endosseous prostheses or as a covering for endosseous implants or prostheses.",ARCE GUERPERO SANDRA;;VALENCIA CARLOS HUMBERTO;;UNIV AUTONOMA DE OCCIDENTE,ARCE GUERPERO SANDRA;;VALENCIA CARLOS HUMBERTO,UNIVERSIDAD AUTONOMA DE OCCIDENTE (2013-10-01),https://lens.org/070-199-383-469-877,Granted Patent,yes,9,0,6,6,0,A61K31/722;;A61K31/722;;A61K45/06;;A61L27/12;;A61L27/12;;A61L27/20;;A61L27/20;;A61L27/24;;A61L27/24;;A61L27/3608;;A61L27/3608;;A61L27/40;;A61L27/40;;A61L27/58;;A61L27/58;;A61L2430/02;;A61L2430/02;;C08K3/22;;C08K3/22;;C08K3/32;;C08K3/32;;C08K5/52;;C08K5/52;;C08K2003/2206;;C08K2003/2206;;C08K2003/2296;;C08K2003/2296,A61K35/32;;A61K6/898;;A61K31/722;;A61K45/06;;A61L27/12;;A61L27/20;;A61L27/24;;A61L27/36;;A61L27/40;;A61L27/58;;C08L5/08,,4,3,046-263-746-092-41X;;042-081-511-705-135;;047-329-512-942-616,8864877;;10.1002/(sici)1097-4636(199609)32:1<95::aid-jbm11>3.0.co;2-h;;10.1002/(sici)1097-4636(199609)32:1<95::aid-jbm11>3.3.co;2-l;;10.1016/j.msec.2006.05.018;;10.3233/bme-1994-4603;;7833787,"Fuentes G. et al. Influence of the Composition on Setting Time and Porosity in Hydroxyapatite Cements with Alginate and Chitosan. Latin American Applied Research 35(4)289-294, 2005.;;Ito, M. et al. In vitro Properties of a Chitosan Bonded Bone Filling Paste. J of Biomedical Materials Research 32(1)95-98, Sep. 1996.;;Kalita S. et al. Nanocrystalline Calcium Phosphate Ceramics in Biomedical Engineering. Materials Science & Engineering C. 27:441-449, 2007.;;Ito, M. et al.; Experimental Development of a Chitosan-bonded Beta-tricalcium Phosphate Bone Filling Paste; Bio-Medical Materials and Engineering, vol. 4, No. 6, pp. 439-449, 1994.",INACTIVE
108,DK,T3,DK 3084209 T3,150-998-881-041-620,2020-01-13,2020,DK 14812758 T,2014-12-18,EP 13198952 A;;EP 2014078462 W,2013-12-20,En vindmøllevinge med deployerbare aerodynamiske enheder,,LM WP PATENT HOLDING AS,DAHL MARTIN;;MADSEN JESPER;;ARCE CARLOS,,https://lens.org/150-998-881-041-620,Granted Patent,no,0,0,9,9,0,F05B2240/311;;F03D1/0633;;F05B2240/2211;;Y02E10/72;;F05B2240/305;;F05B2240/3062;;F05B2240/122;;F05B2240/311;;Y02E10/72;;F03D1/0633;;F05B2240/2211,F03D1/06,,0,0,,,,ACTIVE
109,US,B2,US 10731626 B2,147-740-462-017-101,2020-08-04,2020,US 201415105823 A,2014-12-18,EP 13198952 A;;EP 2014078462 W,2013-12-20,Wind turbine blade having deployable aerodynamic devices,"A wind turbine blade is described, as well as a trailing edge plate for a wind turbine blade. A flexible flow modulation device, e.g. an acoustic flap or a plurality of serrations, is arranged at the trailing edge of a wind turbine blade, wherein the flexible device is coupled to at least one aerodynamic device, preferably vortex generators. As the flexible device is bent by action of flow over the wind turbine blade, the at least one aerodynamic device is deployed to provide for attached flow over the bent flexible device.",LM WP PATENT HOLDING AS,ARCE CARLOS;;DAHL MARTIN;;MADSEN JESPER,LM WP PATENT HOLDING A/S (2016-09-16),https://lens.org/147-740-462-017-101,Granted Patent,yes,11,0,9,9,0,F05B2240/311;;F03D1/0633;;F05B2240/2211;;Y02E10/72;;F05B2240/305;;F05B2240/3062;;F05B2240/122;;F05B2240/311;;Y02E10/72;;F03D1/0633;;F05B2240/2211,F03D1/06,,0,0,,,,ACTIVE
110,MA,A,MA 41758 A,170-775-128-703-548,2018-01-03,2018,MA 41758 A,2016-02-25,EP 15157661 A;;EP 15185191 A;;US 201562121113 P;;US 201562121131 P,2015-02-26,PROCÉDÉS DE TRAITEMENT DE L'INFERTILITÉ,"La présente invention concerne une technologie de reproduction assistée améliorée utilisant de la ménotropine hautement purifiée (hp-hmg) pour stimuler le développement de follicules dans une stimulation ovarienne contrôlée, en particulier chez des femmes présentant un risque élevé de réponse ovarienne à une stimulation ovarienne contrôlée.",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/170-775-128-703-548,Unknown,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08,,0,0,,,,PENDING
111,MX,A,MX 2017010320 A,172-599-440-764-620,2018-01-23,2018,MX 2017010320 A,2016-02-25,US 201562121131 P;;US 201562121113 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,METHODS OF TREATING INFERTILITY.,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.",FERRING BV,JOAN CARLOS ARCE SAEZ;;JANE RUMAN,,https://lens.org/172-599-440-764-620,Patent Application,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08;;C12N5/073,,0,0,,,,PENDING
112,US,A1,US 2016/0312763 A1,000-754-563-483-618,2016-10-27,2016,US 201415105823 A,2014-12-18,EP 13198952 A;;EP 2014078462 W,2013-12-20,A Wind Turbine Blade Having Deployable Aerodynamic Devices,"A wind turbine blade is described, as well as a trailing edge plate for a wind turbine blade. A flexible flow modulation device, e.g. an acoustic flap or a plurality of serrations, is arranged at the trailing edge of a wind turbine blade, wherein the flexible device is coupled to at least one aerodynamic device, preferably vortex generators. As the flexible device is bent by action of flow over the wind turbine blade, the at least one aerodynamic device is deployed to provide for attached flow over the bent flexible device.",LM WP PATENT HOLDING AS,ARCE CARLOS;;DAHL MARTIN;;MADSEN JESPER,LM WP PATENT HOLDING A/S (2016-09-16),https://lens.org/000-754-563-483-618,Patent Application,yes,7,23,9,9,0,F05B2240/311;;F03D1/0633;;F05B2240/2211;;Y02E10/72;;F05B2240/305;;F05B2240/3062;;F05B2240/122;;F05B2240/311;;Y02E10/72;;F03D1/0633;;F05B2240/2211,F03D1/06,,0,0,,,,ACTIVE
113,ES,T3,ES 2763837 T3,041-035-399-594-602,2020-06-01,2020,ES 14812758 T,2014-12-18,EP 13198952 A;;EP 2014078462 W,2013-12-20,Una pala de aerogenerador que tiene dispositivos aerodinámicos desplegables,"Una pala de aerogenerador que tiene un perfil aerodinámico con un borde de ataque y un borde de salida y una cuerda que se extiende entre los mismos, la pala caracterizada por: al menos un miembro flexible (74) que sobresale aguas abajo desde el borde de salida de la pala, en donde dicho al menos un miembro flexible se dispone para flexionar bajo acción de flujo de aire sobre el miembro flexible (74), y en donde la flexión de dicho al menos un miembro flexible (74) actúa para desplegar al menos un dispositivo aerodinámico (76), en el borde de salida (20) de la pala de aerogenerador, para impedir la separación de flujo sobre dicho al menos un miembro flexible (74).",LM WP PATENT HOLDING AS,ARCE CARLOS;;DAHL MARTIN;;MADSEN JESPER,,https://lens.org/041-035-399-594-602,Granted Patent,no,0,0,9,9,0,F05B2240/311;;F03D1/0633;;F05B2240/2211;;Y02E10/72;;F05B2240/305;;F05B2240/3062;;F05B2240/122;;F05B2240/311;;Y02E10/72;;F03D1/0633;;F05B2240/2211,F03D1/06,,0,0,,,,ACTIVE
114,SG,A,SG 11201706693Q A,065-768-579-217-467,2017-09-28,2017,SG 11201706693Q A,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,METHODS OF TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/065-768-579-217-467,Unknown,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08;;C12N5/073,,0,0,,,,PENDING
115,US,A1,US 2014/0105876 A1,078-303-080-386-028,2014-04-17,2014,US 201214008176 A,2012-03-27,CO 11037516 A;;IB 2012051467 W,2011-03-28,CERAMIC BIOCOMPOSITE FOR BONE REGENERATION,"The invention relates to a ceramic biocomposite for bone regeneration, having a pH range of between 6.5 and 8.5, with an initial plasticity that allows the biocomposite to be easily moulded in situ and to set after 7 minutes, meaning that it can remain at the indicated location during the healing process. In addition, the biocomposite has demonstrated an ability to stimulate bone formation in hard-to-heal wounds. The material can act alone or in combination with other types of bone graft such as autografts, homografts or xenografts which act as a vehicle, as a binding material for endosseous prostheses or as a covering for endosseous implants or prostheses.",ARCE GUERRERO SANDRA;;VALENCIA CARLOS HUMBERTO;;UNIV AUTONOMA DE OCCIDENTE,ARCE GUERRERO SANDRA;;VALENCIA CARLOS HUMBERTO,UNIVERSIDAD AUTONOMA DE OCCIDENTE (2013-10-01),https://lens.org/078-303-080-386-028,Patent Application,yes,6,0,6,6,0,A61K31/722;;A61K31/722;;A61K45/06;;A61L27/12;;A61L27/12;;A61L27/20;;A61L27/20;;A61L27/24;;A61L27/24;;A61L27/3608;;A61L27/3608;;A61L27/40;;A61L27/40;;A61L27/58;;A61L27/58;;A61L2430/02;;A61L2430/02;;C08K3/22;;C08K3/22;;C08K3/32;;C08K3/32;;C08K5/52;;C08K5/52;;C08K2003/2206;;C08K2003/2206;;C08K2003/2296;;C08K2003/2296,A61K31/722;;A61K6/898;;A61K45/06,424/93.72;;514/55;;514/17.2;;424/549;;514/21.2,3,2,046-263-746-092-41X;;042-081-511-705-135,8864877;;10.1002/(sici)1097-4636(199609)32:1<95::aid-jbm11>3.0.co;2-h;;10.1002/(sici)1097-4636(199609)32:1<95::aid-jbm11>3.3.co;2-l;;10.1016/j.msec.2006.05.018,"Fuentes G. et al. Influence of the Composition on Setting Time and Porosity in Hydroxyapatite Cements with Alginate and Chitosan. Latin American Applied Research 35(4)289-294, 2005.;;Ito, M. et al. In vitro Properties of a Chitosan Bonded Bone Filling Paste. J of Biomedical Materials Research 32(1)95-98, Sept. 1996.;;Kalita S. et al. Nanocrystalline Calcium Phosphate Ceramics in Biomedical Engineering. Materials Science & Engineering C. 27:441-449, 2007.",INACTIVE
116,MA,A,MA 44704 A,107-219-932-808-808,2019-02-27,2019,MA 44704 A,2017-01-12,MA 44704 A,2017-01-12,PALE D' ÉOLIENNE COMPRENANT UN DISPOSITIF DE RÉDUCTION DE BRUIT DE BORD DE FUITE,,LM WP PATENT HOLDING AS,ARCE CARLOS;;BÆK PETER;;NIELSEN BJARKE,,https://lens.org/107-219-932-808-808,Unknown,no,0,0,1,1,0,Y02E10/72,F03D1/06;;F03D7/02,,0,0,,,,PENDING
117,AU,A1,AU 2016/223496 A1,129-575-937-929-114,2017-08-10,2017,AU 2016/223496 A,2016-02-25,EP 15157661 A;;US 201562121131 P;;EP 15185191 A;;US 201562121113 P;;EP 2016053934 W,2015-02-26,Methods of treating infertility,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/129-575-937-929-114,Patent Application,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08;;C12N5/073,,0,0,,,,ACTIVE
118,BR,B1,BR 112019014435 B1,169-059-405-878-571,2023-10-17,2023,BR 112019014435 A,2018-01-12,EP 2018050755 W;;EP 17151172 A,2017-01-12,Pá de turbina eólica que compreende um dispositivo de redução de ruído de bordo de fuga,"esta invenção se refere a um dispositivo de redução de ruído, uma pá de turbina eólica compreende tal dispositivo de redução de ruído, um método de retroencaixe de um dispositivo de redução de ruído, e um método de fabricação como um dispositivo de redução de ruído. o dispositivo de redução de ruído compreende primeiros elementos de redução de ruído que se projetam de uma parte de base com uma terceira superfície em direção a uma segunda extremidade. os segundos elementos redutores de ruído são ficados à terceira superfície e se projetam ao longo dos primeiros elementos de redução de ruído em direção à segunda extremidade. os primeiros elementos de redução de ruído são preferencialmente serrilhados, enquanto os segundos elementos de redução de ruído são cerdas. as cerdas se projetam pelo menos para os vãos formados entre serrilhados adjacentes.",LM WIND POWER INT TECH II APS,NIELSEN BJARKE;;ARCE CARLOS;;BAEK PETER,,https://lens.org/169-059-405-878-571,Granted Patent,no,0,0,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D1/06;;F03D7/02,,0,0,,,,ACTIVE
119,CO,A1,CO 6530149 A1,039-482-489-541-101,2012-09-28,2012,CO 11037516 A,2011-03-28,CO 11037516 A,2011-03-28,Biocompuesto ceramico para regeneracion osea,"Esta invención se encuentra dirigida a un biocompuesto cerámico para regeneración ósea que presenta un rango de pH de 6,5 a 8,5 con una plasticidad inicial que permite su fácil moldeo in situ y un endurecimiento después de 7 minutos, que hace posible que permanezca en el lugar indicado mientras ocurre el proceso de cicatrización. Adicionalmente, el biocompuesto muestra capacidad de estimular la formación ósea en defectos de difícil cicatrización.El material puede actuar solo o en combinación con otros tipos de injerto óseo ya sea autoinjertos, homoinjertos o xenoinjertos que actúan como vehículo, como material cementante de prótesis endo-óseas o como recubrimiento en prótesis o implantes endo-óseos.",SUR OCCIDENTAL DE ACEITES,ARCE GUERRERO SANDRA;;VALENCIA CARLOS HUMBERTO,,https://lens.org/039-482-489-541-101,Patent Application,no,0,0,6,6,0,A61K31/722;;A61K31/722;;A61K45/06;;A61L27/12;;A61L27/12;;A61L27/20;;A61L27/20;;A61L27/24;;A61L27/24;;A61L27/3608;;A61L27/3608;;A61L27/40;;A61L27/40;;A61L27/58;;A61L27/58;;A61L2430/02;;A61L2430/02;;C08K3/22;;C08K3/22;;C08K3/32;;C08K3/32;;C08K5/52;;C08K5/52;;C08K2003/2206;;C08K2003/2206;;C08K2003/2296;;C08K2003/2296,C04B35/71;;A61K6/898,,0,0,,,,PENDING
120,FI,T3,FI 3261661 T3,141-497-722-317-288,2024-01-15,2024,FI 16709720 T,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,MENOTROPIN FOR TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/141-497-722-317-288,Unknown,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/00;;A61P15/08;;C12N5/073,,0,0,,,,PENDING
121,EP,B1,EP 3348825 B1,089-319-063-977-673,2023-12-13,2023,EP 17151172 A,2017-01-12,EP 17151172 A,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE,,LM WIND POWER AS,ARCE CARLOS;;NIELSEN BJARKE;;BÆK PETER,LM WIND POWER A/S (2022-03-23),https://lens.org/089-319-063-977-673,Granted Patent,yes,1,0,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,ACTIVE
122,EP,A1,EP 3084209 A1,166-690-794-383-34X,2016-10-26,2016,EP 14812758 A,2014-12-18,EP 13198952 A;;EP 2014078462 W;;EP 14812758 A,2013-12-20,A WIND TURBINE BLADE HAVING DEPLOYABLE AERODYNAMIC DEVICES,,LM WP PATENT HOLDING AS,ARCE CARLOS;;DAHL MARTIN;;MADSEN JESPER,,https://lens.org/166-690-794-383-34X,Patent Application,yes,0,2,9,9,0,F05B2240/311;;F03D1/0633;;F05B2240/2211;;Y02E10/72;;F05B2240/305;;F05B2240/3062;;F05B2240/122;;F05B2240/311;;Y02E10/72;;F03D1/0633;;F05B2240/2211,F03D1/06,,0,0,,,,ACTIVE
123,MX,A,MX 2019008271 A,178-355-252-677-252,2019-09-09,2019,MX 2019008271 A,2018-01-12,EP 17151172 A;;EP 2018050755 W,2017-01-12,A WIND TURBINE BLADE COMPRISING A TRAILING EDGE NOISE REDUCING DEVICE.,"This invention relates to a noise reducing device, a wind turbine blade comprises such a noise reducing device, a method of retrofitted a noise reducing device, and a method of manufacturing such a noise reducing device. The noise reducing device comprises first noise reducing elements projecting from a base part having a third surface towards a second end. Second noise reducing elements are attached to the third surface and projects along the first noise reducing elements towards the second end. The first noise reducing elements are preferably serrations while the second noise reducing elements are bristles. The bristles projects at least into the gaps formed between adjacent serrations.",LM WIND POWER INT TECH II APS,CARLOS ARCE;;BJARKE NIELSEN;;PETER BAÆK,,https://lens.org/178-355-252-677-252,Patent Application,no,0,0,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D7/02;;F03D1/06,,0,0,,,,PENDING
124,CN,A,CN 113769069 A,117-385-949-125-540,2021-12-10,2021,CN 202111138328 A,2016-02-25,EP 15157661 A;;EP 15185191 A;;US 201562121113 P;;US 201562121131 P;;CN 201680011732 A,2015-02-26,METHODS OF TREATING INFERTILITY,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/117-385-949-125-540,Patent Application,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/073;;C12N5/075,,0,0,,,,PENDING
125,HK,A1,HK 1246655 A1,066-234-776-309-096,2018-09-14,2018,HK 18106172 A,2018-05-11,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,METHODS OF TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/066-234-776-309-096,Patent Application,no,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K/;;A61P/;;C12N/,,0,0,,,,PENDING
126,KR,A,KR 20170123321 A,182-062-952-556-131,2017-11-07,2017,KR 20177026095 A,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,불임 치료 방법,본 발명은 특히 과배란 유도에 대해 난소 고 반응성 위험군인 여성에서 과배란 유도시 난포 발생을 자극하기 위해 고도로 정제된 메노트로핀 (HP-hMG)을 이용한 개선된 보조생식술에 관한 것이다.,FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/182-062-952-556-131,Patent Application,no,0,1,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61K45/06;;C12N5/075;;G01N33/74,,1,0,,,"Joan-Carles Arce 등, Gynecol Endocrinol. 2014, 30(6) 444~450*",ACTIVE
127,EP,A1,EP 3261661 A1,094-095-963-185-138,2018-01-03,2018,EP 16709720 A,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 2016053934 W,2015-02-26,METHODS OF TREATING INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/094-095-963-185-138,Patent Application,yes,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08;;C12N5/073,,0,0,,,,ACTIVE
128,EP,A2,EP 4289477 A2,103-441-925-599-587,2023-12-13,2023,EP 23195379 A,2016-02-25,US 201562121113 P;;US 201562121131 P;;EP 15157661 A;;EP 15185191 A;;EP 16709720 A;;EP 2016053934 W,2015-02-26,MENOTROPIN FOR TREATING INFERTILITY,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.
",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/103-441-925-599-587,Patent Application,yes,0,0,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61P15/08,,9,7,063-163-783-525-876;;003-722-433-316-582;;033-476-358-244-714;;006-017-423-730-611;;002-136-306-690-370;;009-133-775-244-69X;;030-462-143-792-530,10.1016/j.fertnstert.2011.12.016;;22244781;;24782016;;10.1007/978-1-4939-0659-8_14;;10.1016/j.fertnstert.2008.01.012;;18314124;;23136144;;10.1093/humrep/des389;;20627979;;10.1093/humrep/deq174;;17640944;;10.1093/humrep/dem221;;23953585;;10.1016/j.rbmo.2013.07.006,"DEVROEY ET AL., FERTILITY AND STERILITY, vol. 97, 2012, pages 561 - 169;;HAMDINE ET AL.: ""Human Fertility: Methods and Protocols, Methods in Molecular Biology"", vol. 1154, 2014, SPRINGER SCIENCE+BUSINESS MEDIA, article ""Ovarian Stimulation for IVF: Mild Approaches"";;HAAF ET AL., FERTILITY AND STERILITY, vol. 91, no. 3, 2009, pages 733 - 38;;FATEMI ET AL., HUMAN REPRODUCTION, vol. 28, no. 2, 2013, pages 442 - 52;;RUBIO ET AL., HUMAN REPRODUCTION, vol. 25, no. 9, 2010, pages 2290 - 2010;;ZIEBE ET AL., HUMAN REPRODUCTION, vol. 22, no. 9, 2007, pages 2404 - 13;;FORMAN ET AL., FERTILITY AND STERILITY, vol. 100, 2013, pages 1644 - 24;;VAN DEN ABBEEL ET AL., REPRODUCTIVE BIOMED. ONLINE, vol. 27, 2013, pages 353 - 61;;GARDNER DKSCHOOLCRAFT WB: ""The plenary proceedings of the 11th world congress on in vitro fertilization and human reproductive genetics"", 1999, THE PARTHENON PUBLISHING GROUP, article ""In vitro culture of human blastocysts. In: Towards reproductive certainty"", pages: 378 - 88",PENDING
129,CN,A,CN 107257690 A,133-875-307-929-426,2017-10-17,2017,CN 201680011732 A,2016-02-25,EP 15157661 A;;EP 15185191 A;;US 201562121113 P;;US 201562121131 P;;EP 2016053934 W,2015-02-26,Methods of treating infertility,"The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.",FERRING BV,ARCE SAEZ JOAN CARLOS;;RUMAN JANE,,https://lens.org/133-875-307-929-426,Patent Application,no,1,2,34,35,0,A61K38/24;;A61K45/06;;A61P15/08;;C12N5/0604;;C12N5/0609;;A61K38/24;;A61P15/00;;A61P15/08;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74;;A61K38/24;;A61P15/08;;A61B17/425;;C12N5/0604;;A61K38/24;;A61K45/06;;C12N5/0609;;G01N33/74,A61K38/24;;A61P15/08,,2,2,026-468-563-429-837;;004-932-628-671-99X,23394782;;10.1016/j.fertnstert.2012.12.048;;24341292;;10.1186/1477-7827-11-115;;pmc3878562,"JOAN-CARLES ARCE,ET AL: ""Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients"", 《FERTILITY AND STERILITY》;;SAAD A AMER,ET AL: ""The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study"", 《REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY》",PENDING
130,US,A1,US 2019/0353141 A1,146-246-035-024-219,2019-11-21,2019,US 201816476951 A,2018-01-12,EP 17151172 A;;EP 2018050755 W,2017-01-12,A Wind Turbine Blade Comprising a Trailing Edge Noise Reducing Device,"This invention relates to a noise reducing device, a wind turbine blade comprises such a noise reducing device, a method of retrofitted a noise reducing device, and a method of manufacturing such a noise reducing device. The noise reducing device comprises first noise reducing elements projecting from a base part having a third surface towards a second end. Second noise reducing elements are attached to the third surface and projects along the first noise reducing elements towards the second end. The first noise reducing elements are preferably serrations while the second noise reducing elements are bristles. The bristles projects at least into the gaps formed between adjacent serrations.",LM WIND POWER US TECH APS,ARCE CARLOS;;NIELSEN BJARKE;;BAEK PETER,LM WINDPOWER US TECHNOLOGY APS (2019-05-09),https://lens.org/146-246-035-024-219,Patent Application,yes,0,0,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D1/06;;F03D7/02,,0,0,,,,ACTIVE
131,EP,A1,EP 3406892 A1,196-274-893-633-08X,2018-11-28,2018,EP 17172212 A,2017-05-22,EP 17172212 A,2017-05-22,A WIND TURBINE BLADE COMPRISING A NOISE REDUCING DEVICE,"This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises noise reducing elements projecting from a base part towards a second end. Airflow modifying elements projects further from the base part towards a first end. The noise reducing elements and airflow modifying elements are arranged on opposite sides of the base part and preferably have different dimensions and/or shapes.
",LM WIND POWER INT TECH II APS,ARCE CARLOS;;BÆK PETER;;NIELSEN BJARKE,LM WIND POWER A/S (2022-03-23),https://lens.org/196-274-893-633-08X,Patent Application,yes,8,0,8,8,0,F03D1/0675;;F05B2230/60;;F05B2240/30;;F05B2260/96;;F05B2240/3042;;F05B2240/3062;;F03D1/0675;;F05B2240/30;;F05B2240/3042;;F05B2260/96;;F05B2240/3062,F03D1/06,,0,0,,,,PENDING
132,BR,A2,BR 112019014435 A2,197-628-450-501-442,2020-04-14,2020,BR 112019014435 A,2018-01-12,EP 2018050755 W;;EP 17151172 A,2017-01-12,pá de turbina eólica que compreende um dispositivo de redução de ruído de bordo de fuga,"esta invenção se refere a um dispositivo de redução de ruído, uma pá de turbina eólica compreende tal dispositivo de redução de ruído, um método de retroencaixe de um dispositivo de redução de ruído, e um método de fabricação como um dispositivo de redução de ruído. o dispositivo de redução de ruído compreende primeiros elementos de redução de ruído que se projetam de uma parte de base com uma terceira superfície em direção a uma segunda extremidade. os segundos elementos redutores de ruído são ficados à terceira superfície e se projetam ao longo dos primeiros elementos de redução de ruído em direção à segunda extremidade. os primeiros elementos de redução de ruído são preferencialmente serrilhados, enquanto os segundos elementos de redução de ruído são cerdas. as cerdas se projetam pelo menos para os vãos formados entre serrilhados adjacentes.",LM WIND POWER INT TECH II APS,BJARKE NIELSEN;;CARLOS ARCE;;PETER BAEK,,https://lens.org/197-628-450-501-442,Patent Application,no,0,0,10,10,0,F03D7/0296;;F03D1/0633;;F03D1/0641;;F05B2260/96;;Y02E10/72;;Y02P70/50;;F03D1/0641;;F03D7/0296;;F05B2250/182;;F05B2260/96,F03D1/06;;F03D7/02,,0,0,,,,ACTIVE
133,WO,A1,WO 2018/215461 A1,195-141-863-311-519,2018-11-29,2018,EP 2018063379 W,2018-05-22,EP 17172212 A,2017-05-22,A WIND TURBINE BLADE COMPRISING A NOISE REDUCING DEVICE,This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises noise reducing elements projecting from a base part towards a second end. Airflow modifying elements projects further from the base part towards a first end. The noise reducing elements and airflow modifying elements are arranged on opposite sides of the base part and preferably have different dimensions and/or shapes.,LM WIND POWER INT TECH II APS;;LM WIND POWER US TECH APS,ARCE CARLOS;;BÆK PETER;;VAN MALKENHORST BJARKE,,https://lens.org/195-141-863-311-519,Patent Application,yes,10,0,8,8,0,F03D1/0675;;F05B2230/60;;F05B2240/30;;F05B2260/96;;F05B2240/3042;;F05B2240/3062;;F03D1/0675;;F05B2240/30;;F05B2240/3042;;F05B2260/96;;F05B2240/3062,F03D1/06,,0,0,,,,PENDING
134,EP,B1,EP 3631197 B1,182-708-431-499-143,2023-10-25,2023,EP 18724294 A,2018-05-22,EP 17172212 A;;EP 2018063379 W,2017-05-22,A WIND TURBINE BLADE COMPRISING A NOISE REDUCING DEVICE,,LM WIND POWER AS,ARCE CARLOS;;BAEK PETER;;VAN MALKENHORST BJARKE,LM WIND POWER A/S (2022-03-23),https://lens.org/182-708-431-499-143,Granted Patent,yes,5,0,8,8,0,F03D1/0675;;F05B2230/60;;F05B2240/30;;F05B2260/96;;F05B2240/3042;;F05B2240/3062;;F03D1/0675;;F05B2240/30;;F05B2240/3042;;F05B2260/96;;F05B2240/3062,F03D1/06,,0,0,,,,ACTIVE
135,EP,A1,EP 3631197 A1,020-225-207-270-247,2020-04-08,2020,EP 18724294 A,2018-05-22,EP 17172212 A;;EP 2018063379 W,2017-05-22,A WIND TURBINE BLADE COMPRISING A NOISE REDUCING DEVICE,,LM WIND POWER INT TECH II APS,ARCE CARLOS;;BAEK PETER;;VAN MALKENHORST BJARKE,LM WIND POWER A/S (2022-03-23),https://lens.org/020-225-207-270-247,Patent Application,yes,0,0,8,8,0,F03D1/0675;;F05B2230/60;;F05B2240/30;;F05B2260/96;;F05B2240/3042;;F05B2240/3062;;F03D1/0675;;F05B2240/30;;F05B2240/3042;;F05B2260/96;;F05B2240/3062,F03D1/06,,0,0,,,,ACTIVE
136,MA,A,MA 48932 A,110-922-877-759-371,2020-04-08,2020,MA 48932 A,2018-05-22,EP 17172212 A,2017-05-22,PALE D'ÉOLIENNE DOTÉE D'UN DISPOSITIF DE RÉDUCTION DE BRUIT,,LM WIND POWER INT TECH II APS,ARCE CARLOS;;BAEK PETER;;VAN MALKENHORST BJARKE,,https://lens.org/110-922-877-759-371,Unknown,no,0,0,8,8,0,F03D1/0675;;F05B2230/60;;F05B2240/30;;F05B2260/96;;F05B2240/3042;;F05B2240/3062;;F03D1/0675;;F05B2240/30;;F05B2240/3042;;F05B2260/96;;F05B2240/3062,F03D1/06,,0,0,,,,PENDING
137,DK,T3,DK 3631197 T3,040-993-502-326-570,2023-12-11,2023,DK 18724294 T,2018-05-22,EP 17172212 A;;EP 2018063379 W,2017-05-22,VINDMØLLEVINGE OMFATTENDE EN STØJREDUCERENDE ANORDNING,,LM WIND POWER AS,ARCE CARLOS;;BAEK PETER;;VAN MALKENHORST BJARKE,,https://lens.org/040-993-502-326-570,Granted Patent,no,0,0,8,8,0,F03D1/0675;;F05B2230/60;;F05B2240/30;;F05B2260/96;;F05B2240/3042;;F05B2240/3062;;F03D1/0675;;F05B2240/30;;F05B2240/3042;;F05B2260/96;;F05B2240/3062,F03D1/06,,0,0,,,,ACTIVE
138,CO,A1,CO 2017012483 A1,114-013-591-903-187,2018-01-05,2018,CO 2017012483 A,2017-12-03,CO 2017012483 A,2017-12-03,"Sistema, método y dispositivo contador de mosquitos","La presente invención proporciona un sistema, método y dispositivo contador de mosquitos. El sistema tiene un mecanismo de agitación que golpea el contenedor que contiene los mosquitos, luego se frena el mecanismo de agitación y se procede a adquirir las señales acústicas por medio de un sensor acústico o micrófono, luego los datos son enviados a un programa de computador el cual consta de una interfaz gráfica, donde el programa de computador analiza la grabación y filtra los datos y mediante un algoritmo de análisis de la onda acústica que calcula el resultado de la cantidad de mosquitos contenidos en el contenedor.",UNIV ICESI,ARCE LOPERA CARLOS ALBERTO;;GARCÍA LÓPEZ FELIPE,,https://lens.org/114-013-591-903-187,Patent Application,no,0,0,1,1,0,,A01M23/02,,0,0,,,,PENDING
139,US,A1,US 2020/0149507 A1,032-551-327-305-263,2020-05-14,2020,US 201816614633 A,2018-05-22,EP 17172212 A;;EP 2018063379 W,2017-05-22,A Wind Turbine Blade Comprising A Noise Reducing Device,This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises noise reducing elements projecting from a base part towards a second end. Airflow modifying elements projects further from the base part towards a first end. The noise reducing elements and airflow modifying elements are arranged on opposite sides of the base part and preferably have different dimensions and/or shapes.,LM WIND POWER US TECH APS,ARCE CARLOS;;BAEK PETER;;VAN MALKENHORST BJARKE,,https://lens.org/032-551-327-305-263,Patent Application,yes,3,2,8,8,0,F03D1/0675;;F05B2230/60;;F05B2240/30;;F05B2260/96;;F05B2240/3042;;F05B2240/3062;;F03D1/0675;;F05B2240/30;;F05B2240/3042;;F05B2260/96;;F05B2240/3062,F03D1/06,,0,0,,,,ACTIVE
140,US,B2,US 11448183 B2,019-579-972-225-008,2022-09-20,2022,US 201816614633 A,2018-05-22,EP 17172212 A;;EP 2018063379 W,2017-05-22,Wind turbine blade comprising a noise reducing device,This invention relates to a noise reducing device and a wind turbine blade comprises such a noise reducing device. The noise reducing device comprises noise reducing elements projecting from a base part towards a second end. Airflow modifying elements projects further from the base part towards a first end. The noise reducing elements and airflow modifying elements are arranged on opposite sides of the base part and preferably have different dimensions and/or shapes.,LM WIND POWER US TECH APS,ARCE CARLOS;;BAEK PETER;;VAN MALKENHORST BJARKE,LM WIND POWER US TECHNOLOGY APS (2019-11-21),https://lens.org/019-579-972-225-008,Granted Patent,yes,21,2,8,8,0,F03D1/0675;;F05B2230/60;;F05B2240/30;;F05B2260/96;;F05B2240/3042;;F05B2240/3062;;F03D1/0675;;F05B2240/30;;F05B2240/3042;;F05B2260/96;;F05B2240/3062,F03D1/06,,1,0,,,"Extended European Search Report dated Nov. 22, 2017 corresponding to application No. 17172212.7-1607.",ACTIVE
141,MX,A,MX 2007008369 A,010-981-440-463-513,2009-02-19,2009,MX 2007008369 A,2007-07-10,MX 2007008369 A,2007-07-10,METHOD FOR THE MANUFACTURE OF PARTIALLY MODIFIED SURFACE ZEOLITES USEFUL FOR SEQUESTERING WIDE SPECTRUM MYCOTOXINS.,"The present invention concerns a method for manufacturing a partially modified surface zeolite resulting from the reaction between a zeolitic material and an ammonium quaternary salt acting as a wide spectrum mycotoxin sequestering agent useful in domestic and farm animals feed. The process for manufacturing the present invention does not require filtrating steps or sophisticated equipment such as high speed mixers, thus turning the process into a cost effective process.",BENITEZ CARLOS RICARDO CASTRO,BENITEZ CARLOS RICARDO CASTRO;;GARCIA LUIS FELIPE ARCE,,https://lens.org/010-981-440-463-513,Patent Application,no,0,4,1,1,0,,B01J29/04,,0,0,,,,ACTIVE
142,ES,T3,ES 2349657 T3,187-560-602-493-461,2011-01-10,2011,ES 06744549 T,2006-04-24,US 67616505 P,2005-04-29,TRATAMIENTO O PREVENCION DEL SINDROME DE HIPERESTIMULACION OVARICA (SHO) USANDO UN AGONISTA DE DOMAMINA.,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL;;ARCE JOAN-CARLOS;;PELLICER-MARTINEZ ANTONIO,,https://lens.org/187-560-602-493-461,Granted Patent,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,0,0,,,,ACTIVE
143,CA,A1,CA 2605972 A1,131-221-704-606-975,2006-11-09,2006,CA 2605972 A,2006-04-24,US 67616505 P;;IB 2006000989 W,2005-04-29,TREATMENT OR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) USING A DOPAMINE AGONIST,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;GOMEZ-GALLEGO RAUL;;SIMON-VALLES CARLOS;;ARCE JOAN-CARLOS,,https://lens.org/131-221-704-606-975,Patent Application,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,0,0,,,,INACTIVE
144,DE,D1,DE 602006015796 D1,161-341-041-654-590,2010-09-09,2010,DE 602006015796 T,2006-04-24,US 67616505 P;;IB 2006000989 W,2005-04-29,BEHANDLUNG ODER VORBEUGUNG DES OVARIELLEN ÜBERSTIMULATIONSSYNDROMS (OHSS) MIT EINEM DOPAMINAGONISTEN,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,"FERRING INTERNATIONAL CENTER S.A., SAINT-PREX, CH (2010-10-14)",https://lens.org/161-341-041-654-590,Granted Patent,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,0,0,,,,ACTIVE
145,PT,E,PT 1874313 E,138-248-583-491-52X,2010-10-21,2010,PT 06744549 T,2006-04-24,US 67616505 P,2005-04-29,TREATMENT OR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) USING A DOPAMINE AGONIST,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,,https://lens.org/138-248-583-491-52X,Granted Patent,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,0,0,,,,ACTIVE
146,CA,C,CA 2605972 C,002-613-645-553-847,2011-08-02,2011,CA 2605972 A,2006-04-24,US 67616505 P;;IB 2006000989 W,2005-04-29,TREATMENT OR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) USING A DOPAMINE AGONIST,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,,https://lens.org/002-613-645-553-847,Granted Patent,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,0,0,,,,INACTIVE
147,PL,T3,PL 1874313 T3,197-892-437-622-736,2011-03-31,2011,PL 06744549 T,2006-04-24,US 67616505 P;;EP 06744549 A;;IB 2006000989 W,2005-04-29,TREATMENT OR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) USING A DOPAMINE AGONIST,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CENTER SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,,https://lens.org/197-892-437-622-736,Patent Application,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,0,0,,,,PENDING
148,EP,B1,EP 1874313 B1,022-769-869-963-69X,2010-07-28,2010,EP 06744549 A,2006-04-24,IB 2006000989 W;;US 67616505 P,2005-04-29,TREATMENT OR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) USING A DOPAMINE AGONIST,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,FERRING INTERNATIONAL CENTER S.A. (2011-03-31),https://lens.org/022-769-869-963-69X,Granted Patent,yes,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,4,0,,,"PAPALEO ENRICO ET AL: ""Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome"" HUMAN REPRODUCTION (OXFORD), vol. 16, no. 11, November 2001 (2001-11), pages 2263-2266, XP002393408 ISSN: 0268-1161;;GOMEZ RAUL ET AL: ""Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist Bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS."" FERTILITY AND STERILITY, vol. 80, no. Suppl. 3, September 2003 (2003-09), pages S43-S44, XP009070619 & 59TH ANNUAL MEETING OF THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE; SAN ANTONIO, TEXAS, USA; OCTOBER 11-15, 2003 ISSN: 0015-0282;;MORRIS RANDY S ET AL: ""Conservative management of ovarian hyperstimulation syndrome"" JOURNAL OF REPRODUCTIVE MEDICINE, vol. 40, no. 10, 1995, pages 711-714, XP009070629 ISSN: 0024-7758;;MANNO ET AL: ""Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?"" EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, EXCERPTA MEDICA, AMSTERDAM,, NL, vol. 122, no. 1, 1 September 2005 (2005-09-01), pages 127-128, XP005067200 ISSN: 0301-2115",ACTIVE
149,EP,B8,EP 1874313 B8,056-330-397-824-466,2010-09-01,2010,EP 06744549 A,2006-04-24,IB 2006000989 W;;US 67616505 P,2005-04-29,TREATMENT OR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) USING A DOPAMINE AGONIST,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,FERRING INTERNATIONAL CENTER S.A. (2011-03-31),https://lens.org/056-330-397-824-466,Amended Patent,yes,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,4,0,,,"PAPALEO ENRICO ET AL: ""Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome"" HUMAN REPRODUCTION (OXFORD), vol. 16, no. 11, November 2001 (2001-11), pages 2263-2266, XP002393408 ISSN: 0268-1161;;GOMEZ RAUL ET AL: ""Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist Bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS."" FERTILITY AND STERILITY, vol. 80, no. Suppl. 3, September 2003 (2003-09), pages S43-S44, XP009070619 & 59TH ANNUAL MEETING OF THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE; SAN ANTONIO, TEXAS, USA; OCTOBER 11-15, 2003 ISSN: 0015-0282;;MORRIS RANDY S ET AL: ""Conservative management of ovarian hyperstimulation syndrome"" JOURNAL OF REPRODUCTIVE MEDICINE, vol. 40, no. 10, 1995, pages 711-714, XP009070629 ISSN: 0024-7758;;MANNO ET AL: ""Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?"" EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, EXCERPTA MEDICA, AMSTERDAM,, NL, vol. 122, no. 1, 1 September 2005 (2005-09-01), pages 127-128, XP005067200 ISSN: 0301-2115",ACTIVE
150,AT,T1,AT E475420 T1,126-902-429-319-658,2010-08-15,2010,AT 06744549 T,2006-04-24,US 67616505 P;;IB 2006000989 W,2005-04-29,BEHANDLUNG ODER VORBEUGUNG DES OVARIELLEN ÜBERSTIMULATIONSSYNDROMS (OHSS) MIT EINEM DOPAMINAGONISTEN,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,,https://lens.org/126-902-429-319-658,Granted Patent,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,,,0,0,,,,ACTIVE
151,EP,A1,EP 1874313 A1,159-481-859-332-996,2008-01-09,2008,EP 06744549 A,2006-04-24,IB 2006000989 W;;US 67616505 P,2005-04-29,TREATMENT OR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) USING A DOPAMINE AGONIST,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,FERRING INTERNATIONAL CENTER S.A. (2011-03-31),https://lens.org/159-481-859-332-996,Patent Application,yes,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,0,0,,,,ACTIVE
152,WO,A1,WO 2006/117608 A1,134-953-732-777-774,2006-11-09,2006,IB 2006000989 W,2006-04-24,US 67616505 P,2005-04-29,TREATMENT OR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) USING A DOPAMINE AGONIST,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA;;PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,,https://lens.org/134-953-732-777-774,Patent Application,yes,0,6,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,4,4,012-412-187-643-176;;012-403-826-382-925;;000-745-843-255-48X;;002-788-112-576-426,10.1093/humrep/16.11.2263;;11679501;;10.1016/s0015-0282(03)01918-6;;8551473;;10.1016/j.ejogrb.2005.01.009;;16154051,"PAPALEO ENRICO ET AL: ""Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome"", HUMAN REPRODUCTION (OXFORD), vol. 16, no. 11, November 2001 (2001-11-01), pages 2263 - 2266, XP002393408, ISSN: 0268-1161;;GOMEZ RAUL ET AL: ""Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist Bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS."", FERTILITY AND STERILITY, vol. 80, no. Suppl. 3, September 2003 (2003-09-01), & 59TH ANNUAL MEETING OF THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE; SAN ANTONIO, TEXAS, USA; OCTOBER 11-15, 2003, pages S43 - S44, XP009070619, ISSN: 0015-0282;;MORRIS RANDY S ET AL: ""Conservative management of ovarian hyperstimulation syndrome"", JOURNAL OF REPRODUCTIVE MEDICINE, vol. 40, no. 10, 1995, pages 711 - 714, XP009070629, ISSN: 0024-7758;;MANNO ET AL: ""Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?"", EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, EXCERPTA MEDICA, AMSTERDAM,, NL, vol. 122, no. 1, 1 September 2005 (2005-09-01), pages 127 - 128, XP005067200, ISSN: 0301-2115",PENDING
153,DK,T3,DK 1874313 T3,181-765-764-031-527,2010-11-15,2010,DK 06744549 T,2006-04-24,US 67616505 P;;IB 2006000989 W,2005-04-29,Behandling eller forebyggelse af ovarielt hyperstimulationssyndrom (OHSS) ved anvendelse af en dopaminagonist,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLOS;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,,https://lens.org/181-765-764-031-527,Granted Patent,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/00;;A61K31/498;;A61P15/00,,0,0,,,,ACTIVE
154,TW,B,TW I749255 B,043-513-714-956-797,2021-12-11,2021,TW 107130683 A,2018-08-31,EP 17189119 A,2017-09-01,Composition for controlled ovarian stimulation,,FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/043-513-714-956-797,Granted Patent,no,2,0,42,42,0,A61K38/24;;G01N33/6893;;A61K38/24;;A61K38/24;;A61K38/22;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/24;;A61P15/08;;A61K38/24;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/22,,,0,0,,,,ACTIVE
155,CN,A,CN 107405385 A,027-337-768-161-834,2017-11-28,2017,CN 201680015085 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,Composition for treatment of infertility,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility are disclosed.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/027-337-768-161-834,Patent Application,no,1,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P15/08,,3,0,,,"A. WUNSCH等: ""polymorphism of the FISH receptor and ovarian response to FSH"", 《ANNALS OF ENDOCRINOLOGY》;;M PEREZ MAYORGA等: ""Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype"", 《J CLIN ENDOCRINOL METAB》;;DIMITRIS LOUTRADIS等: ""FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs"", 《JOURNAL OF ASSISTED REPRODUCTION AND GENETICS》",PENDING
156,WO,A1,WO 2017/220594 A1,165-492-015-776-029,2017-12-28,2017,EP 2017065113 W,2017-06-20,EP 16175186 A,2016-06-20,WIND TURBINE BLADE WITH TIP END SERRATIONS,"The present invention relates to a wind turbine blade (10) comprising two or more serrations (100a, 100b, 100c) provided along a section (S) of the trailing edge (20). The section (S) extends spanwise from the tip end (14) towards the root end (16) for up to 5% of the total blade length (L). The serration (100a) closest to the tip end has a height (H) and/or width (W) greater than the respective height (H) and/or width (W) of at least one other serration (100b, 100c) in said section. The present invention also relates to a wind turbine (2) comprising at least one wind turbine blade (10) of the present invention and to a serrated panel (66).",LM WIND POWER INT TECH II APS;;LM WIND POWER US TECH APS,ARCE CARLOS;;MADSEN JESPER;;HERTEL NILSSON VAN KALKEN JORDY,,https://lens.org/165-492-015-776-029,Patent Application,yes,10,2,7,7,0,F03D1/0675;;F05B2230/80;;F05B2240/301;;F05B2250/183;;F05B2260/96;;F03D1/0633;;Y02E10/72;;Y02P70/50;;F05B2230/80;;F05B2240/301;;F05B2250/183;;F05B2260/96;;F03D1/0675;;Y02E10/72;;Y02P70/50;;F03D1/0633,F03D1/06,,0,0,,,,PENDING
157,CA,A1,CA 2975444 A1,191-043-796-314-976,2016-10-20,2016,CA 2975444 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,COMPOSITION FOR TREATMENT OF INFERTILITY,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/191-043-796-314-976,Patent Application,no,0,0,37,37,16,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,PENDING
158,ES,T3,ES 2784625 T3,181-376-326-744-093,2020-09-29,2020,ES 16719315 T,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,FSH para el tratamiento de la infertilidad,"Una composición para su uso en el tratamiento de la infertilidad, comprendiendo la composición de > 12 a 24 μg de hormona estimuladora del folículo (FSH), donde la composición es para la administración a un paciente que se identifica que tiene Ser/Ser variante en la posición 680 del receptor de FSH antes del tratamiento y se identifica que tiene un nivel de AMH en suero < 15 pmol/L antes del tratamiento.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/181-376-326-744-093,Granted Patent,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,ACTIVE
159,TW,A,TW 201919687 A,007-815-857-140-03X,2019-06-01,2019,TW 107130683 A,2018-08-31,EP 17189119 A,2017-09-01,Composition for controlled ovarian stimulation,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility in patients having high AMH and low bodyweight.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/007-815-857-140-03X,Patent of Addition,no,0,0,42,42,0,A61K38/24;;G01N33/6893;;A61K38/24;;A61K38/24;;A61K38/22;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/24;;A61P15/08;;A61K38/24;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/22,A61K38/24;;A61P5/30;;A61P15/08,,0,0,,,,ACTIVE
160,CN,A,CN 111050787 A,038-192-389-067-72X,2020-04-21,2020,CN 201880055934 A,2018-08-31,EP 17189119 A;;EP 2018073442 W,2017-09-01,COMPOSITION FOR CONTROLLED OVARIAN STIMULATION,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility in patients having high AMH and low bodyweight.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/038-192-389-067-72X,Patent Application,no,0,0,42,42,0,A61K38/24;;G01N33/6893;;A61K38/24;;A61K38/24;;A61K38/22;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/24;;A61P15/08;;A61K38/24;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/22,A61K38/24;;A61P15/08,,0,0,,,,PENDING
161,AU,B2,AU 2016/247498 B2,122-912-418-387-069,2021-06-03,2021,AU 2016/247498 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,Composition for treatment of infertility,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/122-912-418-387-069,Granted Patent,no,1,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,4,4,137-816-192-028-198;;012-550-897-743-185;;060-915-679-172-724;;034-219-789-803-855,pmc3454958;;10.1007/s10815-005-9015-z;;16758348;;10.1111/j.0001-6349.2005.00736.x;;10.1080/j.0001-6349.2005.00736.x;;16026410;;10.1093/humupd/8.5.413;;12398222;;17544358;;10.1016/j.ando.2007.04.006,"DIMITRIS LOUTRADIS ET AL, JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, (2006-05-19), vol. 23, no. 4, doi:10.1007/S10815-005-9015-Z, ISSN 1573-7330, pages 177 - 184;;FALCONER HENRIK ET AL, ""Follicle-stimulating hormone receptor polymorphisms in a population of infertile women."", ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA AUG 2005, (2005-08), vol. 84, no. 8, ISSN 0001-6349, pages 806 - 811;;M. SIMONI ET AL, HUMAN REPRODUCTION UPDATE, (2002-09-01), vol. 8, no. 5, doi:10.1093/humupd/8.5.413, ISSN 1355-4786, pages 413 - 421;;A. WUNSCH ET AL, ""Polymorphism of the FSH receptor and ovarian response to FSH"", ANNALES D'ENDOCRINOLOGIE, (2007-06-01), vol. 68, no. 2-3, doi:10.1016/j.ando.2007.04.006, ISSN 0003-4266, pages 160 - 166",ACTIVE
162,US,B2,US 11028823 B2,147-265-144-789-78X,2021-06-08,2021,US 201716311505 A,2017-06-20,EP 16175186 A;;EP 2017065113 W,2016-06-20,Wind turbine blade with tip end serrations,"The present invention relates to a wind turbine blade ( 10 ) comprising two or more serrations ( 100 a, 100 b, 100 c ) provided along a section (S) of the trailing edge ( 20 ). The section (S) extends spanwise from the tip end ( 14 ) towards the root end ( 16 ) for up to 5% of the total blade length (L), The serration ( 100 a ) closest to the tip end has a height (H) and/or width (W) greater than the respective height (H) and/or width (W) of at least one other serration ( 100 b, 100 c ) in said section. The present invention also relates to a wind turbine ( 2 ) comprising at least one wind turbine blade ( 10 ) of the present invention and to a serrated panel ( 66 ).",LM WIND POWER US TECH APS,ARCE CARLOS;;MADSEN JESPER;;HERTEL NILSSON VAN KALKEN JORDY,LM WIND POWER US TECHNOLOGY APS (2018-12-04),https://lens.org/147-265-144-789-78X,Granted Patent,yes,8,0,7,7,0,F03D1/0633;;F03D1/0633;;F03D1/0675;;F03D1/0675;;F05B2230/80;;F05B2230/80;;F05B2240/301;;F05B2240/301;;F05B2250/183;;F05B2250/183;;F05B2260/96;;F05B2260/96;;Y02E10/72;;Y02E10/72;;Y02P70/50;;Y02P70/50,F03D1/06,,1,0,,,"International Search Report dated Nov. 9, 2017 issued in corresponding International Application No. PCT/EP2017/065113.",ACTIVE
163,HU,T2,HU E048757 T2,152-941-983-718-490,2020-08-28,2020,HU E16719315 A,2016-04-15,EP 15164043 A,2015-04-17,FSH FOR TREATMENT OF INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/152-941-983-718-490,Amended Patent,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,PENDING
164,AR,A1,AR 112541 A1,019-646-480-843-640,2019-11-06,2019,AR P180102492 A,2018-08-31,EP 17189119 A,2017-09-01,COMPOSICIÓN PARA ESTIMULACIÓN OVÁRICA CONTROLADA CON HEF RECOMBINANTE,"Preparaciones que incluyen HEF, por ejemplo HEF recombinante, para uso en el tratamiento de la infertilidad en pacientes que tienen HAM alta y bajo peso corporal. Reivindicación 12: Una composición para uso conforme a cualquier reivindicación precedente donde la HEF recombinante incluye sialilación a2,3 y a2,6.",FERRING BV,KLEIN BJARKE MIRNER;;HELMGAARD LISBETH;;ARCE SAEZ JOAN CARLOS,,https://lens.org/019-646-480-843-640,Patent Application,no,0,0,42,42,0,A61K38/24;;G01N33/6893;;A61K38/24;;A61K38/24;;A61K38/22;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/24;;A61P15/08;;A61K38/24;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/22,A61K38/24;;A61K31/7012;;A61P15/08,,0,0,,,,PENDING
165,MA,B1,MA 46548 B1,028-306-079-578-065,2020-03-31,2020,MA 46548 A,2016-04-15,EP 15164043 A;;EP 2016058358 W;;EP 16719315 A,2015-04-17,Fsh pour le traitement de l'infertilité,"La présente invention concerne des préparations contenant de la fsh, par exemple de la fsh recombinante, pouvant être utilisées dans le traitement de l'infertilité.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/028-306-079-578-065,Granted Patent,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61P5/24;;A61K38/24,,0,0,,,,ACTIVE
166,US,A1,US 2019/0234373 A1,014-668-654-102-152,2019-08-01,2019,US 201716311505 A,2017-06-20,EP 16175186 A;;EP 2017065113 W,2016-06-20,WIND TURBINE BLADE WITH TIP END SERRATIONS,"The present invention relates to a wind turbine blade ( 10 ) comprising two or more serrations ( 100 a, 100 b, 100 c ) provided along a section (S) of the trailing edge ( 20 ). The section (S) extends spanwise from the tip end ( 14 ) towards the root end ( 16 ) for up to 5% of the total blade length (L), The serration ( 100 a ) closest to the tip end has a height (H) and/or width (W) greater than the respective height (H) and/or width (W) of at least one other serration ( 100 b, 100 c ) in said section. The present invention also relates to a wind turbine ( 2 ) comprising at least one wind turbine blade ( 10 ) of the present invention and to a serrated panel ( 66 ).",LM WIND POWER US TECH APS,ARCE CARLOS;;MADSEN JESPER;;HERTEL NILSSON VAN KALKEN JORDY,LM WIND POWER US TECHNOLOGY APS (2018-12-04),https://lens.org/014-668-654-102-152,Patent Application,yes,0,1,7,7,0,F03D1/0633;;F03D1/0633;;F03D1/0675;;F03D1/0675;;F05B2230/80;;F05B2230/80;;F05B2240/301;;F05B2240/301;;F05B2250/183;;F05B2250/183;;F05B2260/96;;F05B2260/96;;Y02E10/72;;Y02E10/72;;Y02P70/50;;Y02P70/50,F03D1/06,,0,0,,,,ACTIVE
167,US,A1,US 2018/0125942 A1,187-454-464-869-838,2018-05-10,2018,US 201615566657 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,COMPOSITION FOR TREATMENT OF INFERTILITY,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,FERRING B.V (2017-11-13),https://lens.org/187-454-464-869-838,Patent Application,yes,1,1,37,37,16,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,3,3,036-570-967-846-796;;019-300-954-165-290;;010-652-046-166-011,18972201;;pmc2593769;;10.1007/s10815-008-9266-6;;19136673;;10.1093/humrep/den480;;10.1007/bf02215667;;22358666,"Lekamge et al., J Assist Reprod Genet. 2008; 25: 515-521 (Year: 2008);;Nelson et al., Human Reproduction, 2009; 24: 867-875 (Year: 2009);;Chin et al., Cytotechnology, 1996; 21: 171-182 (Year: 1996)",ACTIVE
168,SI,T1,SI 3283097 T1,187-881-880-661-848,2020-06-30,2020,SI 201630710 T,2016-04-15,EP 15164043 A;;EP 2016058358 W;;EP 16719315 A,2015-04-17,FSH FOR TREATMENT OF INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/187-881-880-661-848,Granted Patent,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/00;;A61P5/00,,0,0,,,,ACTIVE
169,CN,A,CN 109563804 A,101-608-104-383-42X,2019-04-02,2019,CN 201780038185 A,2017-06-20,EP 16175186 A;;EP 2017065113 W,2016-06-20,WIND TURBINE BLADE WITH TIP END SERRATIONS,"The present invention relates to a wind turbine blade (10) comprising two or more serrations (100a, 100b, 100c) provided along a section (S) of the trailing edge (20). The section (S) extends spanwisefrom the tip end (14) towards the root end (16) for up to 5% of the total blade length (L). The serration (100a) closest to the tip end has a height (H) and/or width (W) greater than the respective height (H) and/or width (W) of at least one other serration (100b, 100c) in said section. The present invention also relates to a wind turbine (2) comprising at least one wind turbine blade (10) of thepresent invention and to a serrated panel (66).",LM WIND POWER INT TECH II APS,ARCE CARLOS;;MADSEN JESPER;;HERTEL NILSSON VAN KALKEN JORDY,,https://lens.org/101-608-104-383-42X,Patent Application,no,5,0,7,7,0,F03D1/0633;;F03D1/0633;;F03D1/0675;;F03D1/0675;;F05B2230/80;;F05B2230/80;;F05B2240/301;;F05B2240/301;;F05B2250/183;;F05B2250/183;;F05B2260/96;;F05B2260/96;;Y02E10/72;;Y02E10/72;;Y02P70/50;;Y02P70/50,F03D1/06,,0,0,,,,ACTIVE
170,KR,A,KR 20170137041 A,095-752-280-106-481,2017-12-12,2017,KR 20177022439 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,불임 치료용 조성물,"불임 치료에 사용하기 위한, FSH, 예를 들어, 재조합 FSH를 포함하는 조제물.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/095-752-280-106-481,Patent Application,no,0,0,37,37,32,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24,,0,0,,,,DISCONTINUED
171,JP,A,JP 2021020915 A,169-990-329-693-581,2021-02-18,2021,JP 2020170254 A,2020-10-08,EP 15164043 A,2015-04-17,COMPOSITION FOR TREATMENT OF INFERTILITY,"To provide a composition and a pharmaceutical product for treatment of infertility.SOLUTION: A composition for use in treatment of infertility comprises follicle stimulating hormone (FSH), where the treatment comprises the steps of: prior to treatment, identifying a patient having variant Ser/Ser at position 680 of the FSH receptor; and administering FSH at a dose of or equivalent to more than 12 μg to 24 μg to the patient (identified as) having variant Ser/Ser at position 680 of the FSH receptor.SELECTED DRAWING: None",FERRING BV,JOAN CARLOS ARCE SAEZ;;LISBETH HELMGAARD;;BJARKE MIRNER KLEIN,,https://lens.org/169-990-329-693-581,Patent Application,no,1,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61K47/61;;A61P5/06;;A61P15/08,,2,0,,,"MAYORGA, M.P. ET AL., THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol. 85, no. 9, JPN7019004131, 2000, pages 3365 - 3369, ISSN: 0004716590;;LOUTRADIS, D. ET AL., JOURNAL OF ASSISTED REPRODUCTION AND GENETICSS, vol. 23, no. 4, JPN5018001973, 19 May 2006 (2006-05-19), pages 177 - 184, ISSN: 0004887924",ACTIVE
172,AU,A1,AU 2016/247498 A1,051-226-395-208-81X,2017-08-17,2017,AU 2016/247498 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,Composition for treatment of infertility,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/051-226-395-208-81X,Patent Application,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,ACTIVE
173,EP,B1,EP 3472456 B1,103-441-186-453-890,2020-12-09,2020,EP 17734267 A,2017-06-20,EP 16175186 A;;EP 2017065113 W,2016-06-20,WIND TURBINE BLADE WITH TIP END SERRATIONS,,LM WIND POWER INT TECH II APS,ARCE CARLOS;;MADSEN JESPER;;HERTEL NILSSON VAN KALKEN JORDY,,https://lens.org/103-441-186-453-890,Granted Patent,yes,5,0,7,7,0,F03D1/0675;;F05B2230/80;;F05B2240/301;;F05B2250/183;;F05B2260/96;;F03D1/0633;;Y02E10/72;;Y02P70/50;;F05B2230/80;;F05B2240/301;;F05B2250/183;;F05B2260/96;;F03D1/0675;;Y02E10/72;;Y02P70/50;;F03D1/0633,F03D1/06,,0,0,,,,ACTIVE
174,MX,A,MX 2017010883 A,155-576-392-875-562,2017-12-07,2017,MX 2017010883 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,COMPOSITION FOR TREATMENT OF INFERTILITY.,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.",FERRING BV,JOAN CARLOS ARCE SAEZ;;LISBETH HELMGAARD;;BJARKE MIRNER KLEIN,,https://lens.org/155-576-392-875-562,Patent Application,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,PENDING
175,WO,A1,WO 2019/043143 A1,040-898-197-634-175,2019-03-07,2019,EP 2018073442 W,2018-08-31,EP 17189119 A,2017-09-01,COMPOSITION FOR CONTROLLED OVARIAN STIMULATION,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility in patients having high AMH and low bodyweight.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/040-898-197-634-175,Patent Application,yes,4,1,42,42,0,A61K38/24;;G01N33/6893;;A61K38/24;;A61K38/24;;A61K38/22;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/24;;A61P15/08;;A61K38/24;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/22,A61K38/24;;A61P15/08,,50,49,129-500-742-101-740;;041-327-727-454-807;;016-235-942-312-380;;088-059-895-197-771;;029-834-139-467-849;;063-254-282-888-365;;030-807-032-264-437;;159-630-588-959-960;;062-317-486-021-543;;013-401-553-350-430;;094-929-255-173-353;;022-076-022-203-060;;050-848-882-593-727;;060-288-499-498-719;;087-140-187-570-098;;022-308-183-921-098;;078-818-985-402-46X;;019-687-053-768-421;;068-253-174-589-074;;058-631-516-586-141;;005-351-449-709-527;;035-832-687-342-308;;050-320-015-840-544;;071-537-162-600-312;;025-993-967-171-704;;044-221-649-600-04X;;057-376-434-666-250;;023-987-574-645-709;;066-994-769-117-67X;;107-153-363-226-445;;120-461-399-032-955;;020-068-864-813-33X;;082-263-414-562-935;;104-582-473-306-346;;082-904-722-775-403;;035-666-481-329-836;;197-153-227-692-200;;039-099-345-749-040;;051-302-910-142-926;;075-887-453-140-761;;029-442-002-458-156;;000-434-440-710-208;;031-740-249-590-092;;001-409-868-676-882;;128-673-843-001-449;;051-159-909-455-90X;;133-864-576-784-399;;026-802-336-550-70X;;086-309-984-693-01X,10.1007/s10815-015-0538-7;;pmc4595398;;26194744;;10.1213/00000539-194101000-00064;;15333258;;10.1016/s1472-6483(10)62135-9;;10.1210/me.11.5.517;;10.1210/mend.11.5.9928;;9139796;;10.1016/0304-4157(88)90012-3;;3130893;;10.1016/s1472-6483(10)60937-6;;15823219;;10.1677/jme.0.0230153;;10514553;;10.1093/humrep/14.5.1160;;10325254;;10.1021/bi060435k;;16834341;;10.1021/bi060435k.s001;;11750726;;10.1016/s0188-4409(01)00333-2;;10.1038/281351a0;;481597;;10.1210/jc.79.3.756;;8077357;;10.1210/jcem.79.3.8077357;;10.1210/me.15.3.378;;11222739;;10.1210/mend.15.3.0603;;10.1111/j.1432-1033.1995.718zz.x;;10.1111/j.1432-1033.1995.tb20866.x;;7588709;;3121612;;10.1016/s0021-9258(19)57351-3;;3121609;;2408023;;pmc333489;;10.1093/nar/18.3.667;;9079412;;10.1093/humupd/2.2.172;;3182859;;10.1016/s0021-9258(19)77864-8;;2494176;;10.1016/s0021-9258(18)83656-0;;10.1016/s0021-9258(17)42271-x;;8288606;;2668274;;10.1016/s0021-9258(18)80078-3;;10.1093/molehr/2.5.361;;9238704;;14907713;;10.1016/s0021-9258(19)52451-6;;pmc1436109;;10.1136/jcp.s1-7.1.16;;22557;;19192339;;10.1016/s1472-6483(10)60256-8;;6267989;;0006267989;;10.1146/annurev.bi.50.070181.002341;;4327329;;10.1016/s0021-9258(18)62010-1;;1158880;;10.1016/s0021-9258(19)40994-0;;10.1016/0304-4165(78)90196-4;;78729;;17072008;;10.1385/1-59745-167-3:125;;2442804;;10.1016/b978-0-12-571143-2.50016-2;;1249074;;10.1016/s0021-9258(17)33791-2;;10.1210/endo-53-6-604;;13116950;;6244303;;10.1016/s0021-9258(19)85843-x;;2249992;;10.1016/s0021-9258(17)45295-1;;10.1016/s0021-9258(18)68975-6;;3346214;;10.1159/000054310;;10810283;;10.1677/joe.0.1650193;;3134393;;10.1093/oxfordjournals.humrep.a136734;;10.1093/oxfordjournals.humrep.a137550;;1551953;;10.1210/er.16.6.765;;10.1210/edrv-16-6-765;;8747835;;11750727;;10.1016/s0188-4409(01)00319-8;;12700183;;10.1095/biolreprod.103.016915;;10.1016/s0021-9258(19)45034-5;;4402937;;10.1210/jcem-70-1-271;;2104625;;10.1210/jc.76.4.885;;8473400;;10.1210/jcem.76.4.8473400;;17711919;;10.1210/jc.2007-1342;;10451219;;10.1385/endo:10:2:113;;10.1016/s0304-4165(98)00095-6;;9838208,"MOY VICKY ET AL: ""Obesity adversely affects serum anti-müllerian hormone (AMH) levels in Caucasian women"", JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, PLENUM PUBLISHING, US, vol. 32, no. 9, 21 July 2015 (2015-07-21), pages 1305 - 1311, XP035553234, ISSN: 1058-0468, [retrieved on 20150721], DOI: 10.1007/S10815-015-0538-7;;GOODMAN; GILMAN'S: ""THE PHARMACOLOGICAL BASIS FOR THERAPEUTICES"";;REMINGTON: ""THE SCIENCE AND PRACTICE OF PHARMACY"", pages: 780 - 820;;ANDERSEN CY; WESTERGAARD LG; VAN WELY M.: ""FSH isoform composition of commercial gonadotrophin preparations: a neglected aspect?"", REPROD BIOMED ONLINE, vol. 9, no. 2, 2004, pages 231 - 236, XP027053197;;AREY BJ; STEVIS PE; DEECHER DC; SHEN ES; FRAIL DE; NEGRO-VILAR A; LOPEZ FJ.: ""Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms"", MOL ENDOCRINOL., vol. 11, no. 5, 1997, pages 517 - 526;;BAENZIGER JU; GREEN ED.: ""Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin"", BIOCHIM BIOPHYS ACTA, vol. 947, no. 2, 1988, pages 287 - 306, XP023580274, DOI: doi:10.1016/0304-4157(88)90012-3;;BASSETT RM; DRIEBERGEN R.: ""Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH"", REPROD BIOMED ONLINE, vol. 10, no. 2, 2005, pages 169 - 177, XP009155002;;DAMIAN-MATSUMURA P; ZAGA V; MALDONADO A; SANCHEZ-HERNANDEZ C; TIMOSSI C; ULLOA-AGUIRRE A.: ""Oestrogens regulate pituitary alpha2,3-sialyltransferase messenger ribonucleic acid levels in the female rat"", J MOL ENDOCRINOL., vol. 23, no. 2, 1999, pages 153 - 165;;D'ANTONIO M.; BORRELLI F.; DATOLA A.; BUCCI R.; MASCIA M.; POLLETTA P.; PISCITELLI D.; PAPOIAN R.: ""Biological characterization of recombinant human follicle stimulating hormone isoforms"", HUMAN REPRODUCTION, vol. 14, 1999, pages 1160 - 1167, XP003017497, DOI: doi:10.1093/humrep/14.5.1160;;DALPATHADO DS; IRUNGU J; GO EP; BUTNEV VY; NORTON K; BOUSFIELD GR; DESAIRE H.: ""Comparative glycomics of the glycoprotein follicle stimulating hormone: glycopeptide analysis of isolates from two mammalian species"", BIOCHEMISTRY, vol. 45, no. 28, 2006, pages 8665 - 8673, XP002494718, DOI: doi:10.1021/bi060435k;;DIAS JA; VAN ROEY P.: ""Structural biology of human follitropin and its receptor"", ARCH MED RES., vol. 32, no. 6, 2001, pages 510 - 519, XP002538747;;FIDDES, J. C.; GOODMAN, H. M.: ""Isolation, cloning and sequence analysis of the cDNA for the alpha-subunit of human chorionic gonadotropin"", NATURE, vol. 281, 1979, pages 351 - 356, XP003001628, DOI: doi:10.1038/281351a0;;FLACK, M.R.; BENNET, A.P.; FROEHLICH, J.; ANASTI, JN; NISULA, B.: ""Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line"", J. CLIN. ENDOCRINOL. METAB., vol. 79, 1994, pages 756 - 760, XP002494715, DOI: doi:10.1210/jc.79.3.756;;FOX KM; DIAS JA; VAN ROEY P.: ""Three-dimensional structure of human follicle-stimulating hormone"", MOL ENDOCRINOL., vol. 15, no. 3, 2001, pages 378 - 89, XP002533091, DOI: doi:10.1210/me.15.3.378;;GRABENHORST E; HOFFMANN A; NIMTZ M; ZETTLMEISSL G; CONRADT HS.: ""Construction of stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(beta 1-4 )GlcNAc-R alpha 2,6-sialyltransferase alpha 2,6-linked NeuAc is preferentially attached to the Gal(beta 1-4 )GIcNAc(beta 1-2 )Man(alpha 1-3 )-branch of diantennary oligosaccharides from secreted rec"", EUR J BIOCHEM., vol. 232, no. 3, 1995, pages 718 - 25;;GREEN ED; BAENZIGER JU.: ""Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. II. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones"", J BIOL CHEM., vol. 263, no. 1, 1988, pages 36 - 44;;GRUNDMANN,U.; NERLICH,C.; REIN,T.; ZETTLMEISSL, G.: ""Complete cDNA sequence encoding human beta-galactoside alpha-2,6-sialyltransferase"", G NUCLEIC ACIDS RES., vol. 18, no. 3, 1990, pages 667;;HOWLES, C.M.: ""Genetic engineering of human FSH (Gonal-F"", HUM REPROD. UPDATE, vol. 2, 1996, pages 172 - 191, XP003022809, DOI: doi:10.1093/humupd/2.2.172;;KAGAWA Y; TAKASAKI S; UTSUMI J; HOSOI K; SHIMIZU H; KOCHIBE N; KOBATA A.: ""Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells"", J BIOL CHEM., vol. 263, no. 33, 1988, pages 17508 - 17515;;KEENE, J.L.; MATZUK, M.M.; OTANI, T.; FAUSER, B,C,J,M.; GALWAY, A.B.; HSUEH, A.J.W.; BOIME, I.: ""Expression of Biologically active Human Follitropin in Chinese Hamster Ovary Cells"", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 264, no. 9, 1989, pages 4769 - 4775;;KITAGAWA,H.; PAULSON,J.C: ""Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups"", J. BIOL. CHEM., vol. 269, no. 2, 1994, pages 1394 - 1401;;LEE EU; ROTH J; PAULSON JC: ""Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase"", J BIOL CHEM., vol. 264, no. 23, 1989, pages 13848 - 13855, XP002476861;;DE LEEUW, R.; MULDERS, J.; VOORTMAN, G.; ROMBOUT, F.; DAMM, J.; KLOOSTERBOER, L.: ""Structure-function relationship of recombinant follicle stimulating hormone (Puregon"", MOL. HUM. REPROD., vol. 2, 1996, pages 361 - 369, XP055039633, DOI: doi:10.1093/molehr/2.5.361;;LOWRY OH; ROSEBROUGH NJ; FARR AL; RANDALL RJ.: ""Protein measurement with the Folin phenol reagent"", J BIOL CHEM., vol. 193, no. 1, 1951, pages 265 - 75, XP000196391;;LOWRY, PJ; MCLEAN, C; JONES RL; SATGUNASINGAM N.: ""Purification of anterior pituitary and hypothalamic hormones"", CLIN PATHOL SUPPL (ASSOC CLIN PATHOL, vol. 7, 1976, pages 16 - 21;;OLIVENNES F; HOWIES CM; BORINI A; GERMOND M; TREW G; WIKLAND M; ZEGERS-HOCHSCHILD F; SAUNDERS H: ""Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study"", REPROD BIOMED ONLINE, vol. 18, no. 2, February 2009 (2009-02-01), pages 195 - 204;;PIERCE JG; PARSONS TF: ""Glycoprotein hormones: structure and function"", ANNU REV BIOCHEM., vol. 50, 1981, pages 465 - 495, XP000618487, DOI: doi:10.1146/annurev.bi.50.070181.002341;;PRICER WE JR; ASHWELL G.: ""The binding of desialylated glycoproteins by plasma membranes of rat liver"", J BIOL CHEM., vol. 246, no. 15, 1971, pages 4825 - 33;;RATHNAM P; SAXENA BB.: ""Primary amino acid sequence of follicle-stimulating hormone from human pituitary glands. I. alpha subunit"", J BIOL CHEM., vol. 250, no. 17, 1975, pages 6735 - 6746;;REGOECZI E; DEBANNE MT; HATTON MC; KOJ A.: ""Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism"", BIOCHIM BIOPHYS ACTA, vol. 541, no. 3, 1978, pages 372 - 84, XP025788194, DOI: doi:10.1016/0304-4165(78)90196-4;;ROYLE L; RADCLIFFE CM; DWEK RA; RUDD PM: ""Methods in Molecular Biology"", vol. 347, 2006, HUMANA PRESS, article ""Glycobiology protocols"", pages: 125 - 144;;RYAN RJ; KEUTMANN HT; CHARLESWORTH MC; MCCORMICK DJ; MILIUS RP; CALVO FO; VUTYAVANICH T.: ""Structure-function relationships of gonadotropins"", RECENT PROG HORM RES., vol. 43, 1987, pages 383 - 429;;SAXENA BB; RATHNAM P.: ""Amino acid sequence of the beta subunit of follicle-stimulating hormone from human pituitary glands"", J BIOL CHEM., vol. 251, no. 4, 1976, pages 993 - 1005;;STEELMAN SL; POHLEY FM.: ""Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin"", ENDOCRINOLOGY, vol. 53, no. 6, 1953, pages 604 - 616, XP001007244;;STEER CJ; ASHWELL G.: ""Studies on a mammalian hepatic binding protein specific for asialoglycoproteins. Evidence for receptor recycling in isolated rat hepatocytes"", J BIOL CHEM., vol. 255, no. 7, 1980, pages 3008 - 13;;SVENSSON EC; SOREGHAN B; PAULSON JC.: ""Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation"", J BIOL CHEM., vol. 265, no. 34, 1990, pages 20863 - 20868;;TAKEUCHI M; TAKASAKI S; MIYAZAKI H; KATO T; HOSHI S; KOCHIBE N; KOBATA A: ""Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells"", J BIOL CHEM., vol. 263, no. 8, 1988, pages 3657 - 3663, XP003000621;;TIMOSSI CM; BARRIOS DE TOMASI J; ZAMBRANO E; GONZALEZ R; ULLOA-AGUIRRE A.: ""A naturally occurring basically charged human follicle-stimulating hormone (FSH) variant inhibits FSH-induced androgen aromatization and tissue-type plasminogen activator enzyme activity in vitro"", NEUROENDOCRINOLOGY, vol. 67, no. 3, 1998, pages 153 - 163;;TIMOSSI CM; BARRIOS-DE-TOMASI J; GONZALEZ-SUAREZ R; ARRANZ MC; PADMANABHAN V; CONN PM; ULLOA-AGUIRRE A.: ""Differential effects of the charge variants of human follicle-stimulating hormone"", J ENDOCRINOL., vol. 165, no. 2, 2000, pages 193 - 205, XP002356575, DOI: doi:10.1677/joe.0.1650193;;ULLOA-AGUIRRE, A.; ESPINOZA, R.; DAMIAN-MATSUMURA, P.; CHAPPEL, S.C.: ""Immunological and biological potencies of the different molecular species of gonadotrophins"", HUM. REPROD., vol. 3, 1988, pages 491 - 501;;ULLOA-AGUIRRE, A.; CRAVIOTO, A.; DAMIAN-MATSUMURA, P.; JIMENEZ, M; ZAMBRANO, E; DIAZ-SANCHEZ, V.: ""Biological characterization of the naturally occurring analogues of intrapituitary human follicle stimulating hormone"", HUM. REPROD., vol. 7, 1992, pages 23 - 30;;ULLOA-AGUIRRE A; MIDGLEY AR JR; BEITINS IZ; PADMANABHAN V.: ""Follicle-stimulating isohormones: characterization and physiological relevance"", ENDOCR REV., vol. 16, no. 6, 1995, pages 765 - 787;;ULLOA-AGUIRRE A; MALDONADO A; DAMIAN-MATSUMURA P; TIMOSSI C: ""Endocrine regulation of gonadotropin glycosylation"", ARCH MED RES., vol. 32, no. 6, 2001, pages 520 - 532, XP003010058, DOI: doi:10.1016/S0188-4409(01)00319-8;;ULLOA-AGUIRRE A; TIMOSSI C; BARRIOS-DE-TOMASI J; MALDONADO A; NAYUDU P.: ""Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone: studies derived from in vitro and in vivo models"", BIOL REPROD., vol. 69, no. 2, 2003, pages 379 - 389, XP055039629, DOI: doi:10.1095/biolreprod.103.016915;;VAN LENTEN L; ASHWELL G.: ""The binding of desialylated glycoproteins by plasma membranes of rat liver. Development of a quantitative inhibition assay"", J BIOL CHEM., vol. 247, no. 14, 1972, pages 4633 - 40;;WIDE, L.; ALBERTSSON-WIKLAND, K.: ""Change in electrophoretic mobility of human follicle-stimulating hormone in serum after administration of gonadotropin-releasing hormone"", J. CLIN. ENDOCRINOL. METAB., vol. 70, 1990, pages 271 - 276;;WIDE, L.; BAKOS, O.: ""More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase"", J. CLIN. ENDOCRINOL. METAB., vol. 76, 1993, pages 885 - 889;;WIDE L; NAESSEN T; SUNDSTROM-POROMAA I; ERIKSSON K: ""Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men"", J CLIN ENDOCRINOL METAB., vol. 92, no. 11, 2007, pages 4410 - 4417;;ZAMBRANO E; ZARINAN T; OLIVARES A; BARRIOS-DE-TOMASI J; ULLOA-AGUIRRE A: ""Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implications for the structure-function relationship of the FSH variants"", ENDOCRINE, vol. 10, no. 2, 1999, pages 113 - 121, XP002554816, DOI: doi:10.1385/ENDO:10:2:113;;ZHANG X; LOK SH; KON OL: ""Stable expression of human alpha-2,6-sialyltransferase in Chinese hamster ovary cells: functional consequences for human erythropoietin expression and bioactivity"", BIOCHIM BIOPHYS ACTA, vol. 1425, no. 3, 1998, pages 441 - 452, XP004276231, DOI: doi:10.1016/S0304-4165(98)00095-6",PENDING
176,PL,T3,PL 3283097 T3,053-961-909-519-476,2020-10-19,2020,PL 16719315 T,2016-04-15,EP 15164043 A;;EP 16719315 A;;EP 2016058358 W,2015-04-17,FSH FOR TREATMENT OF INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/053-961-909-519-476,Patent Application,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,PENDING
177,EP,B1,EP 3283097 B1,022-588-420-057-715,2020-02-12,2020,EP 16719315 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,FSH FOR TREATMENT OF INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,FERRING B.V. (2019-09-25),https://lens.org/022-588-420-057-715,Granted Patent,yes,1,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,6,0,,,"DIMITRIS LOUTRADIS ET AL: ""FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs"", JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 23, no. 4, 19 May 2006 (2006-05-19), pages 177-184, XP019398419, ISSN: 1573-7330, DOI: 10.1007/S10815-005-9015-Z;;SIMONI M ET AL: ""MUTATIONAL ANALYSIS OF THE FOLLICLE-STIMULATING HORMONE (FSH) RECEPTOR IN NORMAL AND INFERTILE MEN: IDENTIFICATION AND CHARACTERIZATION OF TWO DISCRETE FSH RECEPTOR ISOFORMS"", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, vol. 84, no. 2, 1 February 1999 (1999-02-01), pages 751-755, XP000920695, ISSN: 0021-972X, DOI: 10.1210/JC.84.2.751;;FALCONER HENRIK ET AL: ""Follicle-stimulating hormone receptor polymorphisms in a population of infertile women."", ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA AUG 2005, vol. 84, no. 8, August 2005 (2005-08), pages 806-811, XP002744921, ISSN: 0001-6349;;M. SIMONI ET AL: ""Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction"", HUMAN REPRODUCTION UPDATE, vol. 8, no. 5, 1 September 2002 (2002-09-01), pages 413-421, XP055214996, ISSN: 1355-4786, DOI: 10.1093/humupd/8.5.413;;A. WUNSCH ET AL: ""Polymorphism of the FSH receptor and ovarian response to FSH"", ANNALES D'ENDOCRINOLOGIE, vol. 68, no. 2-3, 1 June 2007 (2007-06-01) , pages 160-166, XP055214997, ISSN: 0003-4266, DOI: 10.1016/j.ando.2007.04.006;;S. KALLIO ET AL: ""Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries"", HUMAN REPRODUCTION, vol. 27, no. 3, 1 March 2012 (2012-03-01), pages 854-860, XP055215631, ISSN: 0268-1161, DOI: 10.1093/humrep/der473",ACTIVE
178,EP,A1,EP 3472456 A1,064-112-734-281-496,2019-04-24,2019,EP 17734267 A,2017-06-20,EP 16175186 A;;EP 2017065113 W,2016-06-20,WIND TURBINE BLADE WITH TIP END SERRATIONS,,LM WIND POWER INT TECH II APS,ARCE CARLOS;;MADSEN JESPER;;HERTEL NILSSON VAN KALKEN JORDY,,https://lens.org/064-112-734-281-496,Patent Application,yes,0,0,7,7,0,F03D1/0633;;F03D1/0633;;F03D1/0675;;F03D1/0675;;F05B2230/80;;F05B2230/80;;F05B2240/301;;F05B2240/301;;F05B2250/183;;F05B2250/183;;F05B2260/96;;F05B2260/96;;Y02E10/72;;Y02E10/72;;Y02P70/50;;Y02P70/50,F03D1/06,,1,0,,,See references of WO 2017220594A1,ACTIVE
179,MA,A,MA 46548 A,102-740-731-961-991,2018-02-21,2018,MA 46548 A,2016-04-15,EP 15164043 A;;EP 2016058358 W;;EP 16719315 A,2015-04-17,FSH POUR LE TRAITEMENT DE L'INFERTILITÉ,"La présente invention concerne des préparations contenant de la fsh, par exemple de la fsh recombinante, pouvant être utilisées dans le traitement de l'infertilité.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/102-740-731-961-991,Unknown,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,ACTIVE
180,WO,A1,WO 2016/166288 A1,033-430-489-568-897,2016-10-20,2016,EP 2016058358 W,2016-04-15,EP 15164043 A,2015-04-17,COMPOSITION FOR TREATMENT OF INFERTILITY,"Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/033-430-489-568-897,Patent Application,yes,2,8,37,37,16,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,61,58,137-816-192-028-198;;050-458-135-309-688;;012-550-897-743-185;;060-915-679-172-724;;034-219-789-803-855;;029-202-384-502-657;;050-458-135-309-688;;012-550-897-743-185;;137-816-192-028-198;;009-463-243-858-043;;058-070-182-330-658;;016-235-942-312-380;;088-059-895-197-771;;029-834-139-467-849;;063-254-282-888-365;;030-807-032-264-437;;159-630-588-959-960;;062-317-486-021-543;;013-401-553-350-430;;094-929-255-173-353;;022-076-022-203-060;;050-848-882-593-727;;060-288-499-498-719;;087-140-187-570-098;;022-308-183-921-098;;078-818-985-402-46X;;019-687-053-768-421;;068-253-174-589-074;;058-631-516-586-141;;005-351-449-709-527;;035-832-687-342-308;;050-320-015-840-544;;071-537-162-600-312;;025-993-967-171-704;;044-221-649-600-04X;;057-376-434-666-250;;023-987-574-645-709;;066-994-769-117-67X;;107-153-363-226-445;;120-461-399-032-955;;020-068-864-813-33X;;082-263-414-562-935;;104-582-473-306-346;;082-904-722-775-403;;035-666-481-329-836;;197-153-227-692-200;;039-099-345-749-040;;051-302-910-142-926;;075-887-453-140-761;;029-442-002-458-156;;000-434-440-710-208;;031-740-249-590-092;;001-409-868-676-882;;128-673-843-001-449;;051-159-909-455-90X;;133-864-576-784-399;;026-802-336-550-70X;;086-309-984-693-01X,pmc3454958;;10.1007/s10815-005-9015-z;;16758348;;10022448;;10.1210/jcem.84.2.5500;;10.1210/jc.84.2.751;;10.1111/j.0001-6349.2005.00736.x;;10.1080/j.0001-6349.2005.00736.x;;16026410;;10.1093/humupd/8.5.413;;12398222;;17544358;;10.1016/j.ando.2007.04.006;;22258659;;10.1093/humrep/der473;;10022448;;10.1210/jcem.84.2.5500;;10.1210/jc.84.2.751;;10.1111/j.0001-6349.2005.00736.x;;10.1080/j.0001-6349.2005.00736.x;;16026410;;pmc3454958;;10.1007/s10815-005-9015-z;;16758348;;10764609;;10.1006/meth.2000.0977;;10.1016/s0015-0282(97)81391-x;;9130884;;15333258;;10.1016/s1472-6483(10)62135-9;;10.1210/me.11.5.517;;10.1210/mend.11.5.9928;;9139796;;10.1016/0304-4157(88)90012-3;;3130893;;10.1016/s1472-6483(10)60937-6;;15823219;;10.1677/jme.0.0230153;;10514553;;10.1093/humrep/14.5.1160;;10325254;;10.1021/bi060435k;;16834341;;10.1021/bi060435k.s001;;11750726;;10.1016/s0188-4409(01)00333-2;;10.1038/281351a0;;481597;;10.1210/jc.79.3.756;;8077357;;10.1210/jcem.79.3.8077357;;10.1210/me.15.3.378;;11222739;;10.1210/mend.15.3.0603;;10.1111/j.1432-1033.1995.718zz.x;;10.1111/j.1432-1033.1995.tb20866.x;;7588709;;3121612;;10.1016/s0021-9258(19)57351-3;;3121609;;2408023;;pmc333489;;10.1093/nar/18.3.667;;9079412;;10.1093/humupd/2.2.172;;3182859;;10.1016/s0021-9258(19)77864-8;;2494176;;10.1016/s0021-9258(18)83656-0;;10.1016/s0021-9258(17)42271-x;;8288606;;2668274;;10.1016/s0021-9258(18)80078-3;;10.1093/molehr/2.5.361;;9238704;;14907713;;10.1016/s0021-9258(19)52451-6;;pmc1436109;;10.1136/jcp.s1-7.1.16;;22557;;19192339;;10.1016/s1472-6483(10)60256-8;;6267989;;0006267989;;10.1146/annurev.bi.50.070181.002341;;4327329;;10.1016/s0021-9258(18)62010-1;;1158880;;10.1016/s0021-9258(19)40994-0;;10.1016/0304-4165(78)90196-4;;78729;;17072008;;10.1385/1-59745-167-3:125;;2442804;;10.1016/b978-0-12-571143-2.50016-2;;1249074;;10.1016/s0021-9258(17)33791-2;;10.1210/endo-53-6-604;;13116950;;6244303;;10.1016/s0021-9258(19)85843-x;;2249992;;10.1016/s0021-9258(17)45295-1;;10.1016/s0021-9258(18)68975-6;;3346214;;10.1159/000054310;;10810283;;10.1677/joe.0.1650193;;3134393;;10.1093/oxfordjournals.humrep.a136734;;10.1093/oxfordjournals.humrep.a137550;;1551953;;10.1210/er.16.6.765;;10.1210/edrv-16-6-765;;8747835;;11750727;;10.1016/s0188-4409(01)00319-8;;12700183;;10.1095/biolreprod.103.016915;;10.1016/s0021-9258(19)45034-5;;4402937;;10.1210/jcem-70-1-271;;2104625;;10.1210/jc.76.4.885;;8473400;;10.1210/jcem.76.4.8473400;;17711919;;10.1210/jc.2007-1342;;10451219;;10.1385/endo:10:2:113;;10.1016/s0304-4165(98)00095-6;;9838208,"DIMITRIS LOUTRADIS ET AL: ""FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs"", JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 23, no. 4, 19 May 2006 (2006-05-19), pages 177 - 184, XP019398419, ISSN: 1573-7330, DOI: 10.1007/S10815-005-9015-Z;;SIMONI M ET AL: ""MUTATIONAL ANALYSIS OF THE FOLLICLE-STIMULATING HORMONE (FSH) RECEPTOR IN NORMAL AND INFERTILE MEN: IDENTIFICATION AND CHARACTERIZATION OF TWO DISCRETE FSH RECEPTOR ISOFORMS"", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, vol. 84, no. 2, 1 February 1999 (1999-02-01), pages 751 - 755, XP000920695, ISSN: 0021-972X, DOI: 10.1210/JC.84.2.751;;FALCONER HENRIK ET AL: ""Follicle-stimulating hormone receptor polymorphisms in a population of infertile women."", ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA AUG 2005, vol. 84, no. 8, August 2005 (2005-08-01), pages 806 - 811, XP002744921, ISSN: 0001-6349;;M. SIMONI ET AL: ""Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction"", HUMAN REPRODUCTION UPDATE, vol. 8, no. 5, 1 September 2002 (2002-09-01), pages 413 - 421, XP055214996, ISSN: 1355-4786, DOI: 10.1093/humupd/8.5.413;;A. WUNSCH ET AL: ""Polymorphism of the FSH receptor and ovarian response to FSH"", ANNALES D'ENDOCRINOLOGIE, vol. 68, no. 2-3, 1 June 2007 (2007-06-01), pages 160 - 166, XP055214997, ISSN: 0003-4266, DOI: 10.1016/j.ando.2007.04.006;;S. KALLIO ET AL: ""Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries"", HUMAN REPRODUCTION, vol. 27, no. 3, 1 March 2012 (2012-03-01), pages 854 - 860, XP055215631, ISSN: 0268-1161, DOI: 10.1093/humrep/der473;;SIMONI ET AL., JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 84, no. 2, 1999, pages 751 - 755;;FALCONER ET AL., ACTA OBSTET GYNECOL SCAND 2005, vol. 84, 2005, pages 806 - 811;;LOUTRADIS ET AL., JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, vol. 23, no. 4, April 2006 (2006-04-01);;GROMOLL ET AL., METHODS, vol. 21, 2000, pages 83 - 97;;FERTIL STERIL, vol. 67, 1997, pages 817 - 821;;""Remington's Pharmaceutical Sciences, 15th ed."", 1975, MATT PUBLISHING COMPANY, article ""pages 1405 to 1412 and 1461 - 1487"", pages: 1405 - 1487;;GOODMAN; GILMAN'S: ""THE PHARMACOLOGICAL BASIS FOR THERAPEUTICES, 7th ed."", .;;""REMINGTON; THE SCIENCE AND PRACTICE OF PHARMACY"", pages: 780 - 820;;ANDERSEN CY; WESTERGAARD LG; VAN WELY M: ""FSH isoform composition of commercial gonadotrophin preparations: a neglected aspect?"", REPROD BIOMED ONLINE, vol. 9, no. 2, 2004, pages 231 - 236, XP027053197;;AREY BJ; STEVIS PE; DEECHER DC; SHEN ES; FRAIL DE; NEGRO-VILAR A; LOPEZ FJ: ""Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms"", MOL ENDOCRINOL., vol. 11, no. 5, 1997, pages 517 - 526;;BAENZIGER JU; GREEN ED: ""Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin"", BIOCHIM BIOPHYS ACTA, vol. 941, no. 2, 1988, pages 287 - 306, XP023580274, DOI: doi:10.1016/0304-4157(88)90012-3;;BASSETT RM; DRIEBERGEN R: ""Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH"", REPROD BIOMED ONLINE, vol. 10, no. 2, 2005, pages 169 - 177, XP009155002;;DAMIAN-MATSUMURA P; ZAGA V; MALDONADO A; SANCHEZ-HERNANDEZ C; TIMOSSI C; ULLOA-AGUIRRE A: ""Oestrogens regulate pituitary alpha2,3-sialyltransferase messenger ribonucleic acid levels in the female rat"", J MOL ENDOCRINOL., vol. 23, no. 2, 1999, pages 153 - 165;;D'ANTONIO M.; BORRELLI F.; DATOLA A.; BUCCI R.; MASCIA M.; POLLETTA P.; PISCITELLI D.; PAPOIAN R.: ""Biological characterization of recombinant human follicle stimulating hormone isoforms"", HUMAN REPRODUCTION, vol. 14, 1999, pages 1160 - 1167, XP003017497, DOI: doi:10.1093/humrep/14.5.1160;;DALPATHADO DS; IRUNGU J; GO EP; BUTNEV VY; NORTON K; BOUSFIELD GR; DESAIRE H: ""Comparative glycomics of the glycoprotein follicle stimulating hormone: glycopeptide analysis of isolates from two mammalian species"", BIOCHEMISTRY, vol. 45, no. 28, 2006, pages 8665 - 8673, XP002494718, DOI: doi:10.1021/bi060435k;;DIAS JA; VAN ROEY P: ""Structural biology of human follitropin and its receptor"", ARCH MED RES., vol. 32, no. 6, 2001, pages 510 - 519, XP002538747;;FIDDES, J. C.; GOODMAN, H. M.: ""Isolation, cloning and sequence analysis of the cDNA for the alpha-subunit of human chorionic gonadotropin"", NATURE, vol. 281, 1979, pages 351 - 356, XP003001628, DOI: doi:10.1038/281351a0;;FLACK, M.R.; BENNET, A.P.; FROEHLICH, J.; ANASTI, JN; NISULA, B.: ""Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line"", J. CLIN. ENDOCRINOL. METAB., vol. 79, 1994, pages 756 - 760, XP002494715, DOI: doi:10.1210/jc.79.3.756;;FOX KM; DIAS JA; VAN ROEY P: ""Three-dimensional structure of human follicle-stimulating hormone"", MOL ENDOCRINOL., vol. 15, no. 3, 2001, pages 378 - 89, XP002533091, DOI: doi:10.1210/me.15.3.378;;GRABENHORST E; HOFFMANN A; NIMTZ M; ZETTLMEISSL G; CONRADT HS: ""Construction of stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(beta 1-4 )GIcNAc-R alpha 2,6-sialyltransferase alpha 2,6-linked NeuAc is preferentially attached to the Gal(beta 1-4 )GIcNAc(beta 1-2 )Man(alpha 1-3 )-branch of diantennary oligosaccharides from secreted rec"", EUR J BIOCHEM., vol. 232, no. 3, 1995, pages 718 - 25;;GREEN ED; BAENZIGER JU: ""Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. II. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones"", J BIOL CHEM., vol. 263, no. 1, 1988, pages 36 - 44;;GRUNDMANN,U.; NERLICH,C.; REIN,T.; ZETTLMEISSL, G.: ""Complete cDNA sequence encoding human beta-galactoside alpha-2,6-sialyltransferase"", G NUCLEIC ACIDS RES., vol. 18, no. 3, 1990, pages 667;;HOWLES, C.M.: ""Genetic engineering of human FSH (Gonal-F"", HUM REPROD. UPDATE, vol. 2, 1996, pages 172 - 191, XP003022809, DOI: doi:10.1093/humupd/2.2.172;;KAGAWA Y; TAKASAKI S; UTSUMI J; HOSOI K; SHIMIZU H; KOCHIBE N; KOBATA A: ""Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells"", J BIOL CHEM., vol. 263, no. 33, 1988, pages 17508 - 17515;;KEENE, J.L.; MATZUK, M.M.; OTANI, T.; FAUSER, B,C,J,M.; GALWAY, A.B.; HSUEH, A.J.W.; BOIME, I.: ""Expression of Biologically active Human Follitropin in Chinese Hamster Ovary Cells"", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 264, no. 9, 1989, pages 4769 - 4775;;KITAGAWA,H.; PAULSON,J.C: ""Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups"", J. BIOL. CHEM., vol. 269, no. 2, 1994, pages 1394 - 1401;;LEE EU; ROTH J; PAULSON JC: ""Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase"", J BIOL CHEM., vol. 264, no. 23, 1989, pages 13848 - 13855, XP002476861;;DE LEEUW, R.; MULDERS, J.; VOORTMAN, G.; ROMBOUT, F.; DAMM, J.; KLOOSTERBOER, L.: ""Structure-function relationship of recombinant follicle stimulating hormone (Puregon"", MOL. HUM. REPROD., vol. 2, 1996, pages 361 - 369, XP055039633, DOI: doi:10.1093/molehr/2.5.361;;LOWRY OH; ROSEBROUGH NJ; FARR AL; RANDALL RJ: ""Protein measurement with the Folin phenol reagent"", J BIOL CHEM., vol. 193, no. 1, 1951, pages 265 - 75, XP000196391;;LOWRY, PJ; MCLEAN, C; JONES RL; SATGUNASINGAM N: ""Purification of anterior pituitary and hypothalamic hormones"", CLIN PATHOL SUPPL (ASSOC CLIN PATHOL, vol. 7, 1976, pages 16 - 21;;OLIVENNES F; HOWLES CM; BORINI A; GERMOND M; TREW G; WIKLAND M; ZEGERS-HOCHSCHILD F, SAUNDERS H: ""Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study"", REPROD BIOMED ONLINE, vol. 18, no. 2, February 2009 (2009-02-01), pages 195 - 204;;PIERCE JG; PARSONS TF: ""Glycoprotein hormones: structure and function"", ANNU REV BIOCHEM., vol. 50, 1981, pages 465 - 495, XP000618487, DOI: doi:10.1146/annurev.bi.50.070181.002341;;PRICER WE JR; ASHWELL G: ""The binding of desialylated glycoproteins by plasma membranes of rat liver"", J BIOL CHEM., vol. 246, no. 15, 1971, pages 4825 - 33;;RATHNAM P; SAXENA BB: ""Primary amino acid sequence of follicle-stimulating hormone from human pituitary glands. I. alpha subunit"", J BIOL CHEM., vol. 250, no. 17, 1975, pages 6735 - 6746;;REGOECZI E; DEBANNE MT; HATTON MC; KOJ A: ""Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism"", BIOCHIM BIOPHYS ACTA, vol. 541, no. 3, 1978, pages 372 - 84, XP025788194, DOI: doi:10.1016/0304-4165(78)90196-4;;ROYLE L; RADCLIFFE CM; DWEK RA; RUDD PM: ""347: Glycobiology protocols"", 2006, HUMANA PRESS, article ""Methods in Molecular Biology"", pages: 125 - 144;;RYAN RJ; KEUTMANN HT; CHARLESWORTH MC; MCCORMICK DJ; MILIUS RP; CALVO FO; VUTYAVANICH T: ""Structure-function relationships of gonadotropins"", RECENT PROG HORM RES., vol. 43, 1987, pages 383 - 429;;SAXENA BB; RATHNAM P: ""Amino acid sequence of the beta subunit of follicle-stimulating hormone from human pituitary glands"", J BIOL CHEM., vol. 251, no. 4, 1976, pages 993 - 1005;;STEELMAN SL; POHLEY FM: ""Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin"", ENDOCRINOLOGY, vol. 53, no. 6, 1953, pages 604 - 616, XP001007244;;STEER CJ; ASHWELL G: ""Studies on a mammalian hepatic binding protein specific for asialoglycoproteins. Evidence for receptor recycling in isolated rat hepatocytes"", J BIOL CHEM., vol. 255, no. 7, 1980, pages 3008 - 13;;SVENSSON EC; SOREGHAN B; PAULSON JC: ""Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation"", J BIOL CHEM., vol. 265, no. 34, 1990, pages 20863 - 20868;;TAKEUCHI M; TAKASAKI S; MIYAZAKI H; KATO T; HOSHI S; KOCHIBE N; KOBATA A: ""Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells"", J BIOL CHEM., vol. 263, no. 8, 1988, pages 3657 - 3663, XP003000621;;TIMOSSI CM; BARRIOS DE TOMASI J; ZAMBRANO E; GONZALEZ R; ULLOA-AGUIRRE A: ""A naturally occurring basically charged human follicle-stimulating hormone (FSH) variant inhibits FSH-induced androgen aromatization and tissue-type plasminogen activator enzyme activity in vitro"", NEUROENDOCRINOLOGY, vol. 67, no. 3, 1998, pages 153 - 163;;TIMOSSI CM; BARRIOS-DE-TOMASI J; GONZALEZ-SUAREZ R; ARRANZ MC; PADMANABHAN V; CONN PM; ULLOA-AGUIRRE A: ""Differential effects of the charge variants of human follicle-stimulating hormone"", J ENDOCRINOL., vol. 165, no. 2, 2000, pages 193 - 205, XP002356575, DOI: doi:10.1677/joe.0.1650193;;ULLOA-AGUIRRE, A.; ESPINOZA, R.; DAMIAN-MATSUMURA, P.; CHAPPEL, S.C.: ""Immunological and biological potencies of the different molecular species of gonadotrophins"", HUM. REPROD., vol. 3, 1988, pages 491 - 501;;ULLOA-AGUIRRE, A.; CRAVIOTO, A.; DAMIAN-MATSUMURA, P.; JIMENEZ, M; ZAMBRANO, E; DIAZ-SANCHEZ, V.: ""Biological characterization of the naturally occurring analogues of intrapituitary human follicle stimulating hormone"", HUM. REPROD., vol. 7, 1992, pages 23 - 30;;ULLOA-AGUIRRE A; MIDGLEY AR JR; BEITINS IZ; PADMANABHAN V: ""Follicle-stimulating isohormones: characterization and physiological relevance"", ENDOCR REV., vol. 16, no. 6, 1995, pages 765 - 787;;ULLOA-AGUIRRE A; MALDONADO A; DAMIAN-MATSUMURA P; TIMOSSI C: ""Endocrine regulation of gonadotropin glycosylation"", ARCH MED RES., vol. 32, no. 6, 2001, pages 520 - 532, XP003010058, DOI: doi:10.1016/S0188-4409(01)00319-8;;ULLOA-AGUIRRE A; TIMOSSI C; BARRIOS-DE-TOMASI J; MALDONADO A; NAYUDU P: ""Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone: studies derived from in vitro and in vivo models"", BIOL REPROD., vol. 69, no. 2, 2003, pages 379 - 389, XP055039629, DOI: doi:10.1095/biolreprod.103.016915;;VAN LENTEN L; ASHWELL G: ""The binding of desialylated glycoproteins by plasma membranes of rat liver. Development of a quantitative inhibition assay"", J BIOL CHEM., vol. 247, no. 14, 1972, pages 4633 - 40;;WIDE, L.; ALBERTSSON-WIKLAND, K: ""Change in electrophoretic mobility of human follicle-stimulating hormone in serum after administration of gonadotropin-releasing hormone"", J. CLIN. ENDOCRINOL. METAB., vol. 70, 1990, pages 271 - 276;;WIDE, L.; BAKOS, O: ""More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase"", J. CLIN. ENDOCRINOL. METAB., vol. 76, 1993, pages 885 - 889;;WIDE L; NAESSEN T; SUNDSTROM-POROMAA I; ERIKSSON K: ""Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men"", J CLIN ENDOCRINOL METAB., vol. 92, no. 11, 2007, pages 4410 - 4417;;ZAMBRANO E; ZARINAN T; OLIVARES A; BARRIOS-DE-TOMASI J; ULLOA-AGUIRRE A: ""Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implications for the structure-function relationship of the FSH variants"", ENDOCRINE, vol. 10, no. 2, 1999, pages 113 - 121, XP002554816, DOI: doi:10.1385/ENDO:10:2:113;;ZHANG X; LOK SH; KON OL: ""Stable expression of human alpha-2,6-sialyltransferase in Chinese hamster ovary cells: functional consequences for human erythropoietin expression and bioactivity"", BIOCHIM BIOPHYS ACTA, vol. 1425, no. 3, 1998, pages 441 - 452, XP004276231, DOI: doi:10.1016/S0304-4165(98)00095-6",PENDING
181,EP,A1,EP 3662925 A1,104-301-224-058-915,2020-06-10,2020,EP 20150379 A,2016-04-15,EP 15164043 A;;EP 16719315 A;;EP 2016058358 W,2015-04-17,COMPOSITION COMPRISING FSH FOR TREATMENT OF INFERTILITY,"A composition for use in the treatment of infertility, the composition comprising 9 to 24 pg follicle stimulating hormone (FSH), wherein the composition is for administration to a patient identified as having variant Ser/Ser at position 680 of the FSH receptor.
",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/104-301-224-058-915,Patent Application,yes,3,0,37,37,16,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,57,57,137-816-192-028-198;;050-458-135-309-688;;012-550-897-743-185;;060-915-679-172-724;;034-219-789-803-855;;029-202-384-502-657;;050-458-135-309-688;;012-550-897-743-185;;137-816-192-028-198;;009-463-243-858-043;;023-987-574-645-709;;016-235-942-312-380;;088-059-895-197-771;;029-834-139-467-849;;063-254-282-888-365;;030-807-032-264-437;;159-630-588-959-960;;062-317-486-021-543;;013-401-553-350-430;;094-929-255-173-353;;022-076-022-203-060;;050-848-882-593-727;;060-288-499-498-719;;087-140-187-570-098;;022-308-183-921-098;;078-818-985-402-46X;;019-687-053-768-421;;068-253-174-589-074;;058-631-516-586-141;;005-351-449-709-527;;035-832-687-342-308;;050-320-015-840-544;;071-537-162-600-312;;025-993-967-171-704;;044-221-649-600-04X;;057-376-434-666-250;;066-994-769-117-67X;;107-153-363-226-445;;120-461-399-032-955;;020-068-864-813-33X;;082-263-414-562-935;;104-582-473-306-346;;082-904-722-775-403;;035-666-481-329-836;;197-153-227-692-200;;039-099-345-749-040;;051-302-910-142-926;;075-887-453-140-761;;029-442-002-458-156;;000-434-440-710-208;;031-740-249-590-092;;001-409-868-676-882;;128-673-843-001-449;;051-159-909-455-90X;;133-864-576-784-399;;026-802-336-550-70X;;086-309-984-693-01X,pmc3454958;;10.1007/s10815-005-9015-z;;16758348;;10022448;;10.1210/jcem.84.2.5500;;10.1210/jc.84.2.751;;10.1111/j.0001-6349.2005.00736.x;;10.1080/j.0001-6349.2005.00736.x;;16026410;;10.1093/humupd/8.5.413;;12398222;;17544358;;10.1016/j.ando.2007.04.006;;22258659;;10.1093/humrep/der473;;10022448;;10.1210/jcem.84.2.5500;;10.1210/jc.84.2.751;;10.1111/j.0001-6349.2005.00736.x;;10.1080/j.0001-6349.2005.00736.x;;16026410;;pmc3454958;;10.1007/s10815-005-9015-z;;16758348;;10764609;;10.1006/meth.2000.0977;;1158880;;10.1016/s0021-9258(19)40994-0;;15333258;;10.1016/s1472-6483(10)62135-9;;10.1210/me.11.5.517;;10.1210/mend.11.5.9928;;9139796;;10.1016/0304-4157(88)90012-3;;3130893;;10.1016/s1472-6483(10)60937-6;;15823219;;10.1677/jme.0.0230153;;10514553;;10.1093/humrep/14.5.1160;;10325254;;10.1021/bi060435k;;16834341;;10.1021/bi060435k.s001;;11750726;;10.1016/s0188-4409(01)00333-2;;10.1038/281351a0;;481597;;10.1210/jc.79.3.756;;8077357;;10.1210/jcem.79.3.8077357;;10.1210/me.15.3.378;;11222739;;10.1210/mend.15.3.0603;;10.1111/j.1432-1033.1995.718zz.x;;10.1111/j.1432-1033.1995.tb20866.x;;7588709;;3121612;;10.1016/s0021-9258(19)57351-3;;3121609;;2408023;;pmc333489;;10.1093/nar/18.3.667;;9079412;;10.1093/humupd/2.2.172;;3182859;;10.1016/s0021-9258(19)77864-8;;2494176;;10.1016/s0021-9258(18)83656-0;;10.1016/s0021-9258(17)42271-x;;8288606;;2668274;;10.1016/s0021-9258(18)80078-3;;10.1093/molehr/2.5.361;;9238704;;14907713;;10.1016/s0021-9258(19)52451-6;;pmc1436109;;10.1136/jcp.s1-7.1.16;;22557;;19192339;;10.1016/s1472-6483(10)60256-8;;6267989;;0006267989;;10.1146/annurev.bi.50.070181.002341;;4327329;;10.1016/s0021-9258(18)62010-1;;10.1016/0304-4165(78)90196-4;;78729;;17072008;;10.1385/1-59745-167-3:125;;2442804;;10.1016/b978-0-12-571143-2.50016-2;;1249074;;10.1016/s0021-9258(17)33791-2;;10.1210/endo-53-6-604;;13116950;;6244303;;10.1016/s0021-9258(19)85843-x;;2249992;;10.1016/s0021-9258(17)45295-1;;10.1016/s0021-9258(18)68975-6;;3346214;;10.1159/000054310;;10810283;;10.1677/joe.0.1650193;;3134393;;10.1093/oxfordjournals.humrep.a136734;;10.1093/oxfordjournals.humrep.a137550;;1551953;;10.1210/er.16.6.765;;10.1210/edrv-16-6-765;;8747835;;11750727;;10.1016/s0188-4409(01)00319-8;;12700183;;10.1095/biolreprod.103.016915;;10.1016/s0021-9258(19)45034-5;;4402937;;10.1210/jcem-70-1-271;;2104625;;10.1210/jc.76.4.885;;8473400;;10.1210/jcem.76.4.8473400;;17711919;;10.1210/jc.2007-1342;;10451219;;10.1385/endo:10:2:113;;10.1016/s0304-4165(98)00095-6;;9838208,"DIMITRIS LOUTRADIS ET AL: ""FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs"", JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 23, no. 4, 19 May 2006 (2006-05-19), pages 177 - 184, XP019398419, ISSN: 1573-7330, DOI: 10.1007/S10815-005-9015-Z;;SIMONI M ET AL: ""MUTATIONAL ANALYSIS OF THE FOLLICLE-STIMULATING HORMONE (FSH) RECEPTOR IN NORMAL AND INFERTILE MEN: IDENTIFICATION AND CHARACTERIZATION OF TWO DISCRETE FSH RECEPTOR ISOFORMS"", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, THE ENDOCRINE SOCIETY, US, vol. 84, no. 2, 1 February 1999 (1999-02-01), pages 751 - 755, XP000920695, ISSN: 0021-972X, DOI: 10.1210/JC.84.2.751;;FALCONER HENRIK ET AL: ""Follicle-stimulating hormone receptor polymorphisms in a population of infertile women."", ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA AUG 2005, vol. 84, no. 8, August 2005 (2005-08-01), pages 806 - 811, XP002744921, ISSN: 0001-6349;;M. SIMONI ET AL: ""Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction"", HUMAN REPRODUCTION UPDATE, vol. 8, no. 5, 1 September 2002 (2002-09-01), pages 413 - 421, XP055214996, ISSN: 1355-4786, DOI: 10.1093/humupd/8.5.413;;A. WUNSCH ET AL: ""Polymorphism of the FSH receptor and ovarian response to FSH"", ANNALES D'ENDOCRINOLOGIE, vol. 68, no. 2-3, 1 June 2007 (2007-06-01), pages 160 - 166, XP055214997, ISSN: 0003-4266, DOI: 10.1016/j.ando.2007.04.006;;S. KALLIO ET AL: ""Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries"", HUMAN REPRODUCTION, vol. 27, no. 3, 1 March 2012 (2012-03-01), pages 854 - 860, XP055215631, ISSN: 0268-1161, DOI: 10.1093/humrep/der473;;SIMONI ET AL., JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 84, no. 2, 1999, pages 751 - 755;;FALCONER ET AL., ACTA OBSTET GYNECOL SCAND, vol. 84, 2005, pages 806 - 811;;LOUTRADIS ET AL., JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, vol. 23, no. 4, April 2006 (2006-04-01);;GROMOLL ET AL., METHODS, vol. 21, 2000, pages 83 - 97;;RATHNAM PSAXENA BB: ""Primary amino acid sequence of follicle-stimulating hormone from human pituitary glands. I. alpha subunit"", J BIOL CHEM., vol. 250, no. 17, 1975, pages 6735 - 1412,1461-87;;ANDERSEN CYWESTERGAARD LGVAN WELY M.: ""FSH isoform composition of commercial gonadotrophin preparations: a neglected aspect?"", REPROD BIOMED ONLINE, vol. 9, no. 2, 2004, pages 231 - 236, XP027053197;;AREY BJSTEVIS PEDEECHER DCSHEN ESFRAIL DENEGRO-VILAR ALOPEZ FJ: ""Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms"", MOL ENDOCRINOL, vol. 11151, 1997, pages 517 - 526;;BAENZIGER JUGREEN ED: ""Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin"", BIOCHIM BIOPHYS ACTA, vol. 947, no. 2, 1988, pages 287 - 306, XP023580274, DOI: 10.1016/0304-4157(88)90012-3;;BASSETT RMDRIEBERGEN R: ""Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH"", REPROD BIOMED ONLINE, vol. 10, no. 2, 2005, pages 169 - 177, XP009155002;;DAMIAN-MATSUMURA PZAGA VMALDONADO ASANCHEZ-HERNANDEZ CTIMOSSI CULLOA-AGUIRRE A: ""Oestrogens regulate pituitary alpha2,3-sialyltransferase messenger ribonucleic acid levels in the female rat"", J MOL ENDOCRINOL, vol. 23, no. 2, 1999, pages 153 - 165;;D'ANTONIO M.BORRELLI F.DATOLA A.BUCCI R.MASCIA M.POLLETTA P.PISCITELLI D.PAPOIAN R.: ""Biological characterization of recombinant human follicle stimulating hormone isoforms"", HUMAN REPRODUCTION, vol. 14, 1999, pages 1160 - 1167, XP003017497, DOI: 10.1093/humrep/14.5.1160;;DALPATHADO DSIRUNGU JGO EPBUTNEV VYNORTON KBOUSFIELD GRDESAIRE H: ""Comparative glycomics of the glycoprotein follicle stimulating hormone: glycopeptide analysis of isolates from two mammalian species"", BIOCHEMISTRY, vol. 45, no. 28, 2006, pages 8665 - 8673, XP002494718, DOI: 10.1021/bi060435k;;DIAS JAVAN ROEY P: ""Structural biology of human follitropin and its receptor"", ARCH MED RES, vol. 32, no. 6, 2001, pages 510 - 519, XP002538747;;FIDDES, J. C.GOODMAN, H. M.: ""Isolation, cloning and sequence analysis of the cDNA for the alpha-subunit of human chorionic gonadotropin"", NATURE, vol. 281, 1979, pages 351 - 356, XP003001628, DOI: 10.1038/281351a0;;FLACK, M.R.BENNET, A.P.FROEHLICH, J.ANASTI, JNNISULA, B.: ""Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line"", J. CLIN. ENDOCRINOL. METAB., vol. 79, 1994, pages 756 - 760, XP002494715, DOI: 10.1210/jc.79.3.756;;FOX KMDIAS JAVAN ROEY P.: ""Three-dimensional structure of human follicle-stimulating hormone"", MOL ENDOCRINOL, vol. 15, no. 3, 2001, pages 378 - 89, XP002533091, DOI: 10.1210/me.15.3.378;;GRABENHORST EHOFFMANN ANIMTZ MZETTLMEISSL GCONRADT HS: ""Construction of stable BHK-21 cells coexpressing human secretory glycoproteins and human Gal(beta 1-4)GlcNAc-R"", EUR J BIOCHEM., vol. 232, no. 3, 1995, pages 718 - 25, XP001121694, DOI: 10.1111/j.1432-1033.1995.718zz.x;;GREEN EDBAENZIGER JU: ""Asparagine-linked oligosaccharides on lutropin, follitropin, and thyrotropin. II. Distributions of sulfated and sialylated oligosaccharides on bovine, ovine, and human pituitary glycoprotein hormones"", J BIOL CHEM., vol. 263, no. 1, 1988, pages 36 - 44;;GRUNDMANN,U.NERLICH,C.REIN,T.ZETTLMEISSL, G.: ""Complete cDNA sequence encoding human beta-galactoside alpha-2,6-sialyltransferase"", G NUCLEIC ACIDS RES., vol. 18, no. 3, 1990, pages 667;;HOWLES, C.M.: ""Genetic engineering of human FSH (Gonal-F"", HUM REPROD. UPDATE, vol. 2, 1996, pages 172 - 191, XP003022809, DOI: 10.1093/humupd/2.2.172;;KAGAWA YTAKASAKI SUTSUMI JHOSOI KSHIMIZU HKOCHIBE NKOBATA A: ""Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells"", J BIOL CHEM., vol. 263, no. 33, 1988, pages 17508 - 17515;;KEENE, J.L.MATZUK, M.M.OTANI, T.FAUSER, B,C,J,M.GALWAY, A.B.HSUEH, A.J.W.BOIME, I.: ""Expression of Biologically active Human Follitropin in Chinese Hamster Ovary Cells"", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 264, no. 9, 1989, pages 4769 - 4775;;KITAGAWA,H.PAULSON,J.C: ""Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups"", J. BIOL. CHEM., vol. 269, no. 2, 1994, pages 1394 - 1401;;LEE EUROTH JPAULSON JC: ""Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2,6-sialyltransferase"", J BIOL CHEM., vol. 264, no. 23, 1989, pages 13848 - 13855, XP002476861;;DE LEEUW, R.MULDERS, J.VOORTMAN, G.ROMBOUT, F.DAMM, J.KLOOSTERBOER, L.: ""Structure-function relationship of recombinant follicle stimulating hormone (Puregon"", MOL. HUM. REPROD., vol. 2, 1996, pages 361 - 369, XP055039633, DOI: 10.1093/molehr/2.5.361;;LOWRY OHROSEBROUGH NJFARR ALRANDALL RJ: ""Protein measurement with the Folin phenol reagent"", J BIOL CHEM., vol. 193, no. 1, 1951, pages 265 - 75, XP000196391;;LOWRY, PJMCLEAN, CJONES RLSATGUNASINGAM N: ""Purification of anterior pituitary and hypothalamic hormones"", CLIN PATHOL SUPPL (ASSOC CLIN PATHOL, vol. 7, 1976, pages 16 - 21;;OLIVENNES FHOWLES CMBORINI AGERMOND MTREW GWIKLAND MZEGERS-HOCHSCHILD FSAUNDERS H: ""Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study"", REPROD BIOMED ONLINE, vol. 18, no. 2, February 2009 (2009-02-01), pages 195 - 204;;PIERCE JGPARSONS TF: ""Glycoprotein hormones: structure and function"", ANNU REV BIOCHEM., vol. 50, 1981, pages 465 - 495, XP000618487, DOI: 10.1146/annurev.bi.50.070181.002341;;PRICERWE JRASHWELL G.: ""The binding of desialylated glycoproteins by plasma membranes of rat liver"", J BIOL CHEM., vol. 246, no. 15, 1971, pages 4825 - 33;;REGOECZI EDEBANNE MTHATTON MCKOJ A: ""Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism"", BIOCHIM BIOPHYS ACTA, vol. 541, no. 3, 1978, pages 372 - 84, XP025788194, DOI: 10.1016/0304-4165(78)90196-4;;ROYLE LRADCLIFFE CMDWEK RARUDD PM: ""Methods in Molecular Biology"", vol. 347, 2006, HUMANA PRESS, pages: 125 - 144;;RYAN RJKEUTMANN HTCHARLESWORTH MCMCCORMICK DJMILIUS RPCALVO FOVUTYAVANICH T: ""Structure-function relationships of gonadotropins"", RECENT PROG HORM RES., vol. 43, 1987, pages 383 - 429;;SAXENA BBRATHNAM P: ""Amino acid sequence of the beta subunit of follicle-stimulating hormone from human pituitary glands"", J BIOL CHEM., vol. 251, no. 4, 1976, pages 993 - 1005;;STEELMAN SLPOHLEY FM: ""Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin"", ENDOCRINOLOGY, vol. 53, no. 6, 1953, pages 604 - 616, XP001007244;;STEER CJASHWELL G: ""Studies on a mammalian hepatic binding protein specific for asialoglycoproteins. Evidence for receptor recycling in isolated rat hepatocytes"", J BIOL CHEM., vol. 255, no. 7, 1980, pages 3008 - 13;;SVENSSON ECSOREGHAN BPAULSON JC: ""Organization of the beta-galactoside alpha 2,6-sialyltransferase gene. Evidence for the transcriptional regulation of terminal glycosylation"", J BIOL CHEM., vol. 265, no. 34, 1990, pages 20863 - 20868;;TAKEUCHI MTAKASAKI SMIYAZAKI HKATO THOSHI SKOCHIBE NKOBATA A: ""Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells"", J BIOL CHEM., vol. 263, no. 8, 1988, pages 3657 - 3663, XP003000621;;TIMOSSI CMBARRIOS DE TOMASI JZAMBRANO EGONZALEZ RULLOA-AGUIRRE A: ""A naturally occurring basically charged human follicle-stimulating hormone (FSH) variant inhibits FSH-induced androgen aromatization and tissue-type plasminogen activator enzyme activity in vitro"", NEUROENDOCRINOLOGY, vol. 67, no. 3, 1998, pages 153 - 163;;TIMOSSI CMBARRIOS-DE-TOMASI JGONZALEZ-SUAREZ RARRANZ MCPADMANABHAN VCONN PMULLOA-AGUIRRE A: ""Differential effects of the charge variants of human follicle-stimulating hormone"", J ENDOCRINOL, vol. 165, no. 2, 2000, pages 193 - 205, XP002356575, DOI: 10.1677/joe.0.1650193;;ULLOA-AGUIRRE, A.ESPINOZA, R.DAMIAN-MATSUMURA, P.CHAPPEL, S.C.: ""Immunological and biological potencies of the different molecular species of gonadotrophins"", HUM. REPROD., vol. 3, 1988, pages 491 - 501;;ULLOA-AGUIRRE, A.CRAVIOTO, A.DAMIAN-MATSUMURA, P.JIMENEZ, MZAMBRANO, EDIAZ-SANCHEZ, V.: ""Biological characterization of the naturally occurring analogues of intrapituitary human follicle stimulating hormone"", HUM. REPROD., vol. 7, 1992, pages 23 - 30;;ULLOA-AGUIRRE AMIDGLEY AR JRBEITINS IZPADMANABHAN V.: ""Follicle-stimulating isohormones: characterization and physiological relevance"", ENDOCR REV, vol. 16, no. 6, 1995, pages 765 - 787;;ULLOA-AGUIRRE AMALDONADO ADAMIAN-MATSUMURA PTIMOSSI C: ""Endocrine regulation of gonadotropin glycosylation"", ARCH MED RES, vol. 32, no. 6, 2001, pages 520 - 532, XP003010058, DOI: 10.1016/S0188-4409(01)00319-8;;ULLOA-AGUIRRE ATIMOSSI CBARRIOS-DE-TOMASI JMALDONADO ANAYUDU P: ""Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone: studies derived from in vitro and in vivo models"", BIOL REPROD, vol. 69, no. 2, 2003, pages 379 - 389, XP055039629, DOI: 10.1095/biolreprod.103.016915;;VAN LENTEN LASHWELL G: ""The binding of desialylated glycoproteins by plasma membranes of rat liver. Development of a quantitative inhibition assay"", J BIOL CHEM., vol. 247, no. 14, 1972, pages 4633 - 40;;WIDE, L.ALBERTSSON-WIKLAND, K.: ""Change in electrophoretic mobility of human follicle-stimulating hormone in serum after administration of gonadotropin-releasing hormone"", J. CLIN. ENDOCRINOL. METAB., vol. 70, 1990, pages 271 - 276;;WIDE, L.BAKOS, O.: ""More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase"", J. CLIN. ENDOCRINOL. METAB., vol. 76, 1993, pages 885 - 889;;WIDE LNAESSEN TSUNDSTROM-POROMAA IERIKSSON K: ""Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men"", J CLIN ENDOCRINOL METAB., vol. 92, no. 11, 2007, pages 4410 - 4417;;ZAMBRANO EZARINAN TOLIVARES ABARRIOS-DE-TOMASI JULLOA-AGUIRRE A: ""Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implications for the structure-function relationship of the FSH variants"", ENDOCRINE, vol. 10, no. 2, 1999, pages 113 - 121, XP002554816, DOI: 10.1385/ENDO:10:2:113;;ZHANG XLOK SHKON OL: ""Stable expression of human alpha-2,6-sialyltransferase in Chinese hamster ovary cells: functional consequences for human erythropoietin expression and bioactivity"", BIOCHIM BIOPHYS ACTA, vol. 1425, no. 3, 1998, pages 441 - 452, XP004276231, DOI: 10.1016/S0304-4165(98)00095-6",ACTIVE
182,EP,A1,EP 3283097 A1,100-593-142-307-721,2018-02-21,2018,EP 16719315 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,FSH FOR TREATMENT OF INFERTILITY,,FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,FERRING B.V. (2019-09-25),https://lens.org/100-593-142-307-721,Patent Application,yes,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,ACTIVE
183,DK,T3,DK 3283097 T3,081-706-095-879-305,2020-04-20,2020,DK 16719315 T,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,FSH TIL BEHANDLING AF INFERTILITET,,FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER,,https://lens.org/081-706-095-879-305,Granted Patent,no,0,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,0,0,,,,ACTIVE
184,JP,A,JP 2021046398 A,107-317-418-288-132,2021-03-25,2021,JP 2020182295 A,2020-10-30,JP 2020512546 A;;EP 17189119 A,2017-09-01,COMPOSITION FOR CONTROLLED OVARIAN STIMULATION,"To provide a composition for treatment of infertility in patients having high AMH and low bodyweight.SOLUTION: Human derived recombinant FSH products which have a mixture of both α2,3 and α2,6-linked sialic acid may be utilized in individualized controlled ovarian stimulation (COS) protocols.SELECTED DRAWING: Figure 1",FERRING BV,JOAN CARLOS ARCE SAEZ;;LISBETH HELMGAARD;;BJARKE MIRNER KLEIN,,https://lens.org/107-317-418-288-132,Patent Application,no,1,0,42,42,0,A61K38/24;;G01N33/6893;;A61K38/24;;A61K38/24;;A61K38/22;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/24;;A61P15/08;;A61K38/24;;G01N33/6893;;A61P15/08;;C07K16/26;;A61K38/22,A61K38/24;;A61P5/06;;A61P15/08;;G01N33/68,,4,0,,,"""REKOVELLE(R) dosing chart for the first treatment cycle"", [ONLINE], JPN6020025360, March 2017 (2017-03-01), ISSN: 0004786955;;FERTIL. STERIL. (FEB 2017) VOL.107,NO.2, P.387-396, SUPPLEMENTAL TABLES, JPN6022021062, ISSN: 0004786956;;ABSTRACT OF THE 33RD ANNUAL MEETING OF ESHRE, (JUL-2017) P.I444(P-673), JPN6022021061, ISSN: 0004786957;;ABSTRACT OF THE 30TH ANNUAL MEETING OF ESHRE, (2014) P.I323(P-493), JPN6022021060, ISSN: 0004786958",ACTIVE
185,RU,C2,RU 2704252 C2,154-302-390-484-870,2019-10-25,2019,RU 2017128296 A,2016-04-15,EP 15164043 A;;EP 2016058358 W,2015-04-17,COMPOSITION FOR TREATING INFERTILITY,"FIELD: medicine.SUBSTANCE: group of inventions refers to infertility treatment. Disclosed is a method of treating infertility in a patient, wherein the infertility treatment involves: (a) identification of said patient as having serum level of antimueller hormone (AMH) less than 15 pmol/l before treatment; (b) identifying said patient as having a variant Ser/Ser at position 680 of a follicle-stimulating hormone receptor (FSH) prior to treatment; and (c) administering a dose of more than 12 to 24 mcg of recombinant follicle-stimulating hormone (FSH) a day or an equivalent dose to said patient. Also disclosed is another version of infertility treatment.EFFECT: group of inventions provides more effective treatment of infertility in certain patients.2 cl, 7 dwg, 3 tbl, 9 ex",FERRING BV,KLEIN BJARKE MIRNER;;HELMGAARD LISBETH;;ARCE SAEZ JOAN CARLOS,,https://lens.org/154-302-390-484-870,Granted Patent,no,2,0,37,37,0,A61K38/24;;A61K38/24;;A61P5/24;;A61K38/24;;A61K38/24;;A61P5/24;;A61P5/06;;A61K38/24;;A61P5/24,A61K38/24;;A61P5/24,,1,1,137-816-192-028-198,pmc3454958;;10.1007/s10815-005-9015-z;;16758348,"LOUTRADIS D ET AL. FSH RECEPTOR GENE POLYMORPHISMS HAVE A ROLE FOR DIFFERENT OVARIAN RESPONSE TO STIMULATION IN PATIENTS ENTERING IVF/ICSI-ET PROGRAMS/ Journal of Assisted Reproduction and Genetics, Vol. 23, No. 4, 2006.",ACTIVE
186,CA,A1,CA 2765997 A1,144-725-417-664-25X,2010-12-29,2010,CA 2765997 A,2010-06-25,EP 09251652 A;;IB 2010001687 W,2009-06-26,TREATMENT OF ENDOMETRIOSIS,A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.,FERRING BV,PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLOS,,https://lens.org/144-725-417-664-25X,Patent Application,no,0,0,10,10,0,A61K31/473;;A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P25/04;;A61P29/00;;A61P35/00,A61K31/473;;A61P15/00;;A61P35/00,,0,0,,,,DISCONTINUED
187,WO,A2,WO 2010/150098 A2,027-403-972-802-291,2010-12-29,2010,IB 2010001687 W,2010-06-25,EP 09251652 A,2009-06-26,TREATMENT OF ENDOMETRIOSIS,A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.,FERRING INT CT SA;;PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLOS,PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLOS,,https://lens.org/027-403-972-802-291,Patent Application,yes,0,9,10,10,0,A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P25/04;;A61P29/00;;A61P35/00;;A61K31/473,A61K31/473,,0,0,,,,PENDING
188,WO,A3,WO 2010/150098 A3,097-380-379-343-055,2011-05-12,2011,IB 2010001687 W,2010-06-25,EP 09251652 A,2009-06-26,"USE OF QUINGOLIDE IN THE TREATMENT OF ENDOMETRIOSIS, PAIN AND CANCER",A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.,FERRING INT CT SA;;PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLOS,PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLOS,,https://lens.org/097-380-379-343-055,Search Report,yes,1,0,10,10,0,A61K31/473;;A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P25/04;;A61P29/00;;A61P35/00,A61K31/473;;A61P15/00;;A61P35/00,,0,0,,,,PENDING
189,US,A1,US 2012/0157489 A1,030-501-896-499-477,2012-06-21,2012,US 201013380098 A,2010-06-25,EP 09251652 A;;IB 2010001687 W,2009-06-26,TREATMENT OF ENDOMETRIOSIS,A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.,PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLOS,PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLOS,FERRING B.V (2012-01-04),https://lens.org/030-501-896-499-477,Patent Application,yes,0,9,10,10,0,A61K31/473;;A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P25/04;;A61P29/00;;A61P35/00,A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P29/00;;A61P35/00,514/290,0,0,,,,DISCONTINUED
190,EP,A2,EP 2445501 A2,055-216-579-759-305,2012-05-02,2012,EP 10740269 A,2010-06-25,IB 2010001687 W;;EP 09251652 A;;EP 10740269 A,2009-06-26,"USE OF QUINGOLIDE IN THE TREATMENT OF ENDOMETRIOSIS, PAIN AND CANCER",,FERRING BV,PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLOS,,https://lens.org/055-216-579-759-305,Patent Application,yes,0,0,10,10,0,A61K31/473;;A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P25/04;;A61P29/00;;A61P35/00,A61K31/473;;A61P15/00;;A61P35/00,,1,0,,,See references of WO 2010150098A2,DISCONTINUED
191,ES,A1,ES 2454415 A1,031-451-937-404-707,2014-04-10,2014,ES 201231557 A,2012-10-10,ES 201231557 A,2012-10-10,"Integrated process for the recovery of zinc and other metals from steel dust or similar (Machine-translation by Google Translate, not legally binding)","Process for the continuous recovery of zinc, and in the case of other metals, from raw materials that contain zinc to be extracted by means of a treatment integrated by a hydro-pyrometallurgical cycle of concentration of the oxide and a hydrometallurgical cycle of zinc dissolution and purification of the solution, distinguishing the following stages: washing and hydraulic classification; waelz process; neutral collective leaching; sludge treatment; cementation; extraction with organic solvents; and recovery of ammonia. (Machine-translation by Google Translate, not legally binding)",ROS MORENO ANTONIO;;ARCE SANCHEZ JOSÉ CARLOS;;MARTINEZ CAPARROS ALFONSO,ROS MORENO ANTONIO;;ARCE SANCHEZ JOSÉ CARLOS;;MARTINEZ CAPARROS ALFONSO,,https://lens.org/031-451-937-404-707,Patent Application,no,8,0,2,2,0,C22B19/30;;C01G9/02;;C22B7/02;;Y02P10/20;;Y02P20/10,C22B19/30;;C01G9/02;;C22B7/02,,3,0,,,"Delalio, A., et al. Charecterization and pre-treatment of steelmaking dusts in order to recover valuable products, [en linea], 1998. Recuperado de internet 26/02/2014:  http://repositorium.sdum.uminho.pt/bitstream/1822/1542/1/Quo%20Vadis%20I.pdf. Páginas 5 y 6.;;B.O.C. y L. Nº130. 10/07/2009, página 21599.;;GORDON A R et al. Improved leaching technologies in the electrolytic zinc industry. Metallurgical Transactions B. Marzo 1975,  Vol. 6, Nº: 1, Páginas 43 - 53. The Jarosite process.",ACTIVE
192,ES,B1,ES 2454415 B1,040-750-923-382-216,2015-01-26,2015,ES 201231557 A,2012-10-10,ES 201231557 A,2012-10-10,Procedimiento integrado para la recuperación de zinc y otros metales a partir de polvo de acería o similares,,ROS MORENO ANTONIO;;ARCE SANCHEZ JOSÉ CARLOS;;MARTINEZ CAPARROS ALFONSO,ROS MORENO ANTONIO;;ARCE SANCHEZ JOSÉ CARLOS;;MARTINEZ CAPARROS ALFONSO,,https://lens.org/040-750-923-382-216,Granted Patent,no,0,2,2,2,0,C22B19/30;;C01G9/02;;C22B7/02;;Y02P10/20;;Y02P20/10,C22B19/30;;C01G9/02;;C22B7/02,,0,0,,,,ACTIVE
193,AR,A1,AR 116734 A1,091-691-550-463-234,2021-06-09,2021,AR P190102947 A,2019-10-17,US 201862746812 P,2018-10-17,COMPOSICIONES Y MÉTODOS PARA ESTIMULACIÓN OVÁRICA CONTROLADA,"Se describen los métodos de uso y las composiciones que incluyen FSH para su uso en el tratamiento de la infertilidad, en el que la dosis se selecciona en función de la edad de la paciente para optimizar la eficiencia acumulativa y/o reducir el riesgo de SHO.",FERRING BV,HEISER PATRICK;;KLEIN BJARKE MIRNER;;HELMAGAARD LISBETH;;ARCE SAEZ JOAN CARLOS,,https://lens.org/091-691-550-463-234,Patent Application,no,0,0,1,21,0,,A61K38/24;;A61P15/08,,0,0,,,,PENDING
194,IL,A,IL 280750 A,017-166-327-604-12X,2021-04-29,2021,IL 28075021 A,2021-02-09,US 201862746812 P;;EP 18203167 A;;EP 2019078170 W,2018-10-17,Compositions and methods for controlled ovarian stimulation,,FERRING BV;;HELMGAARD LISBETH;;ARCE SAEZ JOAN CARLOS;;KLEIN BJARKE MIRNER;;HEISER PATRICK,HELMGAARD LISBETH;;ARCE SAEZ JOAN CARLOS;;KLEIN BJARKE MIRNER;;HEISER PATRICK,,https://lens.org/017-166-327-604-12X,Patent Application,no,0,0,19,21,0,A61K38/24;;A61P15/08;;A61K38/24;;A61P15/08;;A61K38/24;;A61P15/08;;A61P15/08;;A61K38/24,,,0,0,,,,PENDING
195,TW,A,TW 202027780 A,067-738-389-117-954,2020-08-01,2020,TW 108137295 A,2019-10-16,US 201862746812 P;;EP 18203167 A,2018-10-17,Compositions and methods for controlled ovarian stimulation,"Methods using and compositions including FSH for use in the treatment of infertility are described, wherein the dose is selected based on the patient's age to optimise cumulative efficiency and/or reduce OHSS risk.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER;;HEISER PATRICK,,https://lens.org/067-738-389-117-954,Patent of Addition,no,0,0,19,21,0,A61K38/24;;A61P15/08;;A61K38/24;;A61P15/08;;A61K38/24;;A61P15/08;;A61P15/08;;A61K38/24,A61K38/24;;A61P15/08,,0,0,,,,PENDING
196,CN,A,CN 112789053 A,106-246-187-558-091,2021-05-11,2021,CN 201980064065 A,2019-10-17,EP 18203167 A;;US 201862746812 P;;EP 2019078170 W,2018-10-17,COMPOSITIONS AND METHODS FOR CONTROLLED OVARIAN STIMULATION,"Methods using and compositions including FSH for use in the treatment of infertility are described, wherein the dose is selected based on the patient's age to optimise cumulative efficiency and/or reduce OHSS risk.",FERRING BV,ARCE SAEZ JOAN CARLOS;;HELMGAARD LISBETH;;KLEIN BJARKE MIRNER;;HEISER PATRICK,,https://lens.org/106-246-187-558-091,Patent Application,no,0,0,19,21,0,A61K38/24;;A61P15/08;;A61K38/24;;A61P15/08;;A61K38/24;;A61P15/08;;A61P15/08;;A61K38/24,A61K38/24;;A61P15/08,,0,0,,,,PENDING
197,TW,A,TW 201102066 A,029-851-410-629-492,2011-01-16,2011,TW 99120796 A,2010-06-25,EP 09251652 A,2009-06-26,Treatment of endometriosis,A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE JOAN-CARLES,,https://lens.org/029-851-410-629-492,Patent of Addition,no,0,1,10,10,0,A61K31/473;;A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P25/04;;A61P29/00;;A61P35/00,A61K31/473;;A61P15/00;;C07D221/08,,0,0,,,,PENDING
198,US,A1,US 2008/0293693 A1,121-101-673-657-956,2008-11-27,2008,US 91245606 A,2006-04-24,US 91245606 A;;US 67616505 P;;IB 2006000989 W,2005-04-29,Treatment or Prevention of Ovarian Hyperstimulation Syndrome (Ohss) Using a Dopamine Agonist,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLES;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,FERRING INTERNATIONAL CENTER S.A (2005-06-09),https://lens.org/121-101-673-657-956,Patent Application,yes,2,11,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/55;;A61K31/403;;A61K31/428;;A61K31/473;;A61K31/495;;A61P5/00,514/215;;514/284;;514/367;;514/418;;514/250;;514/290;;514/285,1,1,022-517-521-768-93X,12758098;;10.1016/s1521-6934(02)00127-x,"Al-Shawaf et. al., Best Practice and Research Clinical Obstetrics and Gynaecology, 2003, Elsevier, vol. 17, no. 2, pp. 249-261",INACTIVE
199,ES,A1,ES 2400144 A1,039-657-137-443-307,2013-04-05,2013,ES 201131266 A,2011-07-22,ES 201131266 A,2011-07-22,"Procedure for obtaining information from a product during its traceability. (Machine-translation by Google Translate, not legally binding)","Procedure for obtaining information on a product during its traceability. The method of the invention is characterized in that it comprises the following steps: - coding with a first identification at least one unit of product; - coding with a second identification at least one product box that integrates several product units, this second identification containing information, part of which includes the first identification; - coding with a third identification a batch of product composed of several boxes of product supported by at least one pallet, this third identification containing information, part of which includes the first and second identifications; - associate the first, second and third identifications by means of an algorithm to relate the product units, boxes and pallets. (Machine-translation by Google Translate, not legally binding)",BODEGA MATARROMERA S L,ARCE SANTOLAYA RUBEN;;PINTO SOLANO JULIO;;GUADARRAMA RODRIGUEZ ALBERTO;;MORO GONZALEZ CARLOS,,https://lens.org/039-657-137-443-307,Patent Application,no,3,0,2,2,0,G06K19/00,G06K19/00,,0,0,,,,INACTIVE
200,US,B2,US 8334298 B2,128-982-948-443-71X,2012-12-18,2012,US 91245606 A,2006-04-24,US 91245606 A;;US 67616505 P;;IB 2006000989 W,2005-04-29,Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLES;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL;;FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;ARCE JOAN-CARLES;;SIMON-VALLES CARLOS;;GOMEZ-GALLEGO RAUL,FERRING INTERNATIONAL CENTER S.A (2005-06-09),https://lens.org/128-982-948-443-71X,Granted Patent,yes,5,3,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A01N43/42;;A61K31/44;;C07D221/06,514/290;;546/110,25,21,036-707-805-761-68X;;025-189-906-448-83X;;022-517-521-768-93X;;012-412-187-643-176;;012-403-826-382-925;;000-745-843-255-48X;;002-788-112-576-426;;053-746-415-889-07X;;026-250-643-029-751;;018-802-652-320-500;;052-612-700-612-31X;;137-879-422-055-924;;019-259-873-025-788;;042-240-723-509-780;;021-534-916-874-647;;143-217-438-157-559;;084-087-013-309-421;;001-757-241-478-445;;064-591-674-723-07X;;008-541-074-850-108;;032-760-997-357-901,10.1023/a:1012884214668;;11788012;;12859048;;10.1093/humupd/dmg018;;12758098;;10.1016/s1521-6934(02)00127-x;;10.1093/humrep/16.11.2263;;11679501;;10.1016/s0015-0282(03)01918-6;;8551473;;10.1016/j.ejogrb.2005.01.009;;16154051;;10.1080/00325481.1988.11700222;;3128777;;10.2165/00002018-199411060-00003;;7727051;;12399430;;10.1210/en.2002-220204;;12727942;;10.1210/jc.2002-021820;;10.1210/jcem.86.8.7766;;11502789;;10.1210/jc.86.8.3635;;10.1056/nejmoa030064;;12930928;;12605348;;10.1055/s-2003-37498;;11329058;;10.1038/87895;;10.1152/ajpheart.00272.2004;;15371263;;10.1080/gye.17.4.281.286;;14503971;;10.1080/713603291;;2794732;;10.1007/bf01130780;;10.1093/oxfordjournals.humrep.a136913;;2745669;;6434577;;10.1210/jcem-59-4-727;;3342895;;10.1016/s0015-0282(16)59769-6,"Schultz et. al., Pituitary, 2000, Kluwer Academic Press, vol. 3, pp. 239-249.;;Aboulghar et. al., Human Reproduction Update, 2003, European Society for Human Reproduction and Embryology, vol. 9, No. 3, pp. 275-289.;;McElhinney et. al., Bailliere's Clinical Obstetrics and Gynecology, 2000, Harcourt Publishers, vol. 14, No. 1, pp. 103-122.;;Al-Shawaf et. al., Best Practice and Research Clinical Obstetrics and Gynaecology, 2003, Elsevier, vol. 17, No. 2, pp. 249-261.;;Papaleo et al., ""Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome,"" Human Reproduction 16(11):2263-6 (Nov. 2001).;;Gomez et al., ""Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS,"" Fertility and Sterility, (Sep. 2003) vol. 80, No. Sppl. 3, pp. S43-S44. print. Meeting Info: 59th Annual Meeting of the American Society for Reproductive Medicine, San Antonio, Texas, U.S.A., (Oct. 11-15, 2003) (""Gomez"").;;Morris et al., ""Conservative management of ovarian hyperstimulation syndrome,"" J. Reprod. Med. 40(10):711-714 (Oct. 1995) (""Morris""); and.;;Manno et al., ""Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?"" Eur. J. Obstet. Gynecol. Reprod. Biol. 122(1):127-8 (Sep. 1, 2005) (""Manno"").;;Blankstein et al., ""The Anovulatory Patient. An Orderly approact to evaluation and treatment"" Infertility. 1988; 83: 97-102.;;Derman et al., ""Adverse Effects of Fertility Drugs"" Drug Safety, (1994) 11/6 (408-421).;;Gomez et al., ""Vascular Endothelial Growth Factor Receptor-2 Activation Induces Vascular Permeability in Hyperstimulated Rats, and this Effect Is Prevented by Receptor Blockade"" Endocrinology. 2002; 143, 4339-4348.;;Murata et al., ""Successful Pregnancy after Bromocriptine Therapy in an Anovulatory Women Complicated with Ovarian Hyperstimulation Caused by Follicle-Stimulating Hormone-Producing Plurihormonal Pituitary Microadenoma"" The Journal of Clinical Endocrinology and Metabolism, 2003; 88(5): 1988-93.;;Shimon et al., "" Ovarian Hyperstimulation without Elevated Serum Estradiol Associated with Pure Follicle-Stimulating Hormone-Secreting Pituitary Adenoma"" The Journal of Clinical Endocrinology and Metabolism, 2001; 86(8): 3635-40.;;Smits et al., ""Ovarian Hyperstimulation Syndrome Due to a Mutation in the Follicle-Stimulating Hormone Receptor"" The New England Journal of Medicine, 2003, vol. 349:760-766.;;Welter et al., ""Regulation of the VEGF-System in the Endometrium during Steroid-Replacement and Early Pregnancy of Pigs"" Exp Clin Endocrinol Diabetes. 2003; 111 (1): 33-40.;;Basu et al., ""The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor"" Nature Medicine May 2001; 7 (5): 569-74.;;Sarkar et al., ""Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells"" Am J Physiol Heart Circ Physiol. 2004; 287: H1554-60.;;Tsunoda et al., ""Treatment for ovarian hyperstimulation syndrome using an oral dopamine prodrug, docarpamine"" Gynecol Endocrinol. 2003; 17: 281-286.;;Gonen et al., ""The Influence of Transient Hyperprolactinemia on Hormonal Parameters, Oocyte Recovery, and Fertilization Rates in in Vitro Fertilization"" Journal of in vitro fertilization and embryo transfer: IVF, (Jun. 1989) 6 (3) 155-9.;;Seppala et. al., ""Suppression of prolactin secretion during ovarian hyperstimulation is followed by elevated serum levels of endometrial protein PP14 in the late luteal phase"" Human reproduction (Oxford, England), (May 1989) 4 (4) 389-91.;;Collins et al., ""Human menopausal gonadotropin/human chorionic gonadotropin-induced ovarian hyperstimulation with transient hyperprolactinemia: steroidogenesis enhanced during bromocriptine therapy in monkeys"" Journal of clinical endocrinology and metabolism, (Oct. 1984) 59 (4).;;Aono, T., ""Progress in Ovulation Induction"" Asian Medical Journal (1997), 40 (7), 354-360.;;Kauppila et al., ""Hypoprolactinemia and ovarian function"" Fertility and sterility, (Mar. 1988) 49 (3) 437-41.;;Kamilova D.P. et al, Case of Severe Ovarian Hyperstimulation Syndrome, 1999 (D4) with English language translation of the relevant extracts.;;Patent Office of The Russian Federation, Office Action (Inquiry) of the State Examination Dated Oct. 22, 2010 in English.",INACTIVE
201,JO,B1,JO 2658 B1,076-246-100-459-079,2012-06-17,2012,JO P20060122 A,2006-04-27,US 67616505 P,2005-04-29,Treatment or prevention of Ovarian Hyperstimulation Syndrome (OHSS) using a Dopamine Agonist,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier,FERRING INT CT SA,ANTONIO PELLICER-MARTINEZ;;RAUL GOMEZ-GALLEGO;;JOAN-CARLES ARCE;;CARLOS SIMON-VALLES,,https://lens.org/076-246-100-459-079,Granted Patent,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,,,0,0,,,,ACTIVE
202,ES,B1,ES 2400144 B1,107-117-047-639-397,2014-03-05,2014,ES 201131266 A,2011-07-22,ES 201131266 A,2011-07-22,PROCEDIMIENTO PARA OBTENCION DE INFORMACION DE UN PRODUCTO DURANTE SU TRAZABILIDAD.,,BODEGA MATARROMERA S L,ARCE SANTOLAYA RUBEN;;PINTO SOLANO JULIO;;GUADARRAMA RODRIGUEZ ALBERTO;;MORO GONZALEZ CARLOS,,https://lens.org/107-117-047-639-397,Granted Patent,no,0,0,2,2,0,G06K19/00,G06K19/00,,0,0,,,,INACTIVE
203,TW,B,TW I315668 B,022-449-663-379-049,2009-10-11,2009,TW 95115300 A,2006-04-28,US 67616505 P,2005-04-29,Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;GOMEZ-GALLEGO RAUL;;SIMON-VALLES CARLOS;;ARCE JOAN-CARLES,,https://lens.org/022-449-663-379-049,Granted Patent,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,,,0,0,,,,INACTIVE
204,TW,A,TW 200724141 A,177-231-603-906-344,2007-07-01,2007,TW 95115300 A,2006-04-28,US 67616505 P,2005-04-29,Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist,Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also disclosed herein is a method for treating ovarian hyperstimulation syndrome by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier.,FERRING INT CT SA,PELLICER-MARTINEZ ANTONIO;;GOMEZ-GALLEGO RAUL;;SIMON-VALLES CARLOS;;ARCE JOAN-CARLES,,https://lens.org/177-231-603-906-344,Patent of Addition,no,0,0,19,19,0,A61K31/00;;A61K31/48;;A61K31/498;;A61P15/00;;A61P5/00;;A61P5/08;;A61P5/24;;A61K31/00;;A61K31/498;;A61K31/48,A61K31/48;;A61K31/498;;A61P15/00,,0,0,,,,INACTIVE
205,US,A1,US 2014/0194460 A1,084-008-805-039-310,2014-07-10,2014,US 201313961027 A,2013-08-07,US 201313961027 A;;EP 09251652 A;;US 201213380098 A;;IB 2010001687 W,2009-06-26,TREATMENT OF ENDOMETRIOSIS,A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.,FERRING BV,PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE;;ARCE SAEZ JOAN CARLES,,https://lens.org/084-008-805-039-310,Patent Application,yes,0,0,10,10,0,A61K31/473;;A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P25/04;;A61P29/00;;A61P35/00,A61K31/473,514/290,0,0,,,,DISCONTINUED
206,AR,A1,AR 080541 A1,163-697-951-807-525,2012-04-18,2012,AR P100102257 A,2010-06-25,EP 09251652 A,2009-06-26,TRATAMIENTO PARA LA ENDOMETRIOSIS,"Reivindicacion 1: Una composicion farmacéutica que comprende quinagolida para el tratamiento y/o la prevencion de la endometriosis, en donde la composicion es para administracion en una dosis de 15 a 39 microgramos de quinagolida/día durante 10 a 20 días; seguida de administracion en una dosis 40 a 64 microgramos de quinagolida/día durante otros 10 a 20 días; seguida de la administracion en una dosis de 65 a 85 microgramos de quinagolida/día durante por lo menos 2 meses. Reivindicacion 4: Una composicion para uso de acuerdo con cualquier reivindicacion precedente para el tratamiento o la prevencion de la endometriosis en un sujeto que tiene, o que tiene tendencia a la, hiperprolactinemia. Reivindicacion 15: Una composicion farmacéutica que comprende quinagolida para el tratamiento y/o la prevencion del cáncer reproductivo. Reivindicacion 17: Una composicion farmacéutica que comprende quinagolida para el tratamiento de la infertilidad en un paciente que tiene endometriosis.",FERRING INT CT SA,ARCE SAEZ JOAN CARLES;;PELLICER-MARTINEZ ANTONIO;;SIMON-VALLES CARLOS;;NOVELLA-MAESTRE EDURNE,,https://lens.org/163-697-951-807-525,Patent Application,no,0,0,10,10,0,A61K31/473;;A61K31/473;;A61P15/00;;A61P15/08;;A61P15/18;;A61P25/04;;A61P29/00;;A61P35/00,,,0,0,,,,PENDING
207,BR,A2,BR 102021013683 A2,068-397-007-130-461,2021-08-24,2021,BR 102021013683 A,2021-07-12,BR 102021013683 A,2021-07-12,tabela periódica universal inclusiva e interativa,"tabela periódica universal inclusiva e interativa. a tabela periódica universal inclusiva e interativa. é um produto desenvolvido por meio dos conceitos do universal design for learning (udl) para o ensino e a aprendizagem da química. composto por uma maleta com duas tampas (1a, 1b), uma base central (2), um sistema de trava (3), duas plataformas (89a, 89b) e um sistema eletrônico (90a, 90b) dotado de alto-falantes (48) e uma tela sensível ao toque (151), o produto permite que estudantes sem deficiência, da educação especial ou com necessidades específicas tenham acesso, simultaneamente, a uma série de informações referentes aos elementos químicos ou substâncias, seja pela narração de áudios específicos, pela transcrição em linguagem libras ou ainda, pelo uso complementar dos blocos em desenho universal para aprendizagem como elementos químicos da tabela periódica, amparados pela patente br 10 2020 022931 1, que podem ser acoplados às plataformas (89a, 89b). o produto possui um botão (97) para cada elemento da tabela periódica que, quando pressionado, aciona a narração e a transcrição, em linguagem libras e comum, de características do elemento ou da substância selecionada, tal como nome, número atômico, massa, período e família, classificação e algumas aplicações. a tela também exibe ilustrações de aplicações dos elementos. este produto resolve a incapacidade de os produtos existentes atenderem adequadamente a mais de um tipo de deficiência simultaneamente, viabilizando a aprendizagem da química, permitindo o estudo de substâncias químicas e permitindo o transporte entre salas ou instituições por ser portátil. o produto possui legendas (9, 10, 91, 94, 95) em linguagem comum e no sistema de escrita braille, bem como um bloco legenda (108), que permitem que o usuário interaja de maneira independente com o produto. a tela interativa (151) permite a configuração do dispositivo (escolha de idiomas, controle de volume, tempo de resposta ao clique, atualizações) bem como a conexão com outros dispositivos como celulares ou computadores via protocolo de comunicação bluetooth.",LEONARDO DE OLIVEIRA BRANDT;;RODRIGO PULIDO ARCE;;SAMUEL CARLOS WIEDEMANN;;ANGELA PALOMA ZELLI WIEDEMANN,LEONARDO DE OLIVEIRA BRANDT;;RODRIGO PULIDO ARCE;;SAMUEL CARLOS WIEDEMANN;;ÂNGELA PALOMA ZELLI WIEDEMANN,,https://lens.org/068-397-007-130-461,Patent Application,no,0,0,1,1,0,,G09B23/24,,0,0,,,,DISCONTINUED
208,MX,A,MX 2011002380 A,119-335-820-133-790,2012-10-02,2012,MX 2011002380 A,2011-03-03,MX 2011002380 A,2011-03-03,MOLECULAR MARKER FOR DETECTING CERVICAL CANCER.,"Described is a diagnostic method of cervical cancer, which comprises: a) extracting the total RNA from a cervix biopsy sample in a human being; b) synthesising the cDNA from the total RNA, where said cDNA is used as a mould for performing a PCR in real time with a detection nucleotide probe which may perform a hybridisation under strict conditions with a target sequence or the complement thereof contained in the nucleotide sequence which encodes for the human protein or polypeptide of the subunit NaV1.6 of the sodium channels dependant on voltage, thus forming a stable hybrid for the probe: target detection; and c) determining if the hybrid is present in the sample, where the presence or absence of cervical cancer is determined by the identification and quantification of the probe:target hybrid, obtaining in such a manner the Ct values. In addition, an other method is described for the detection of the aforementioned disorders, which consists in a) having a cervix biopsy sample from a human being; b) processing said sample for being subjected to the immunohistochemical technique using an immunospecific antibody against a human protein or polypeptide of the subunit Nav1.6 of the sodium channels dependant on voltage; and c) detecting the formation of said immunological complex between the protein or polypeptide present in the sample, and the marked antibody.",UNIV MEXICO NACIONAL AUTONOMA,ARCE CINDY SHARON ORTIZ;;MARTINEZ JUAN CARLOS GOMORA;;PLATA EVERARDO HERNANDEZ;;RIVERA HERIBERTO MANUEL,,https://lens.org/119-335-820-133-790,Patent Application,no,0,0,2,2,0,,C07K14/00;;C07K16/00,,0,0,,,,ACTIVE
209,MX,B,MX 349669 B,166-177-403-121-522,2017-07-27,2017,MX 2011002380 A,2011-03-03,MX 2011002380 A,2011-03-03,MOLECULAR MARKER FOR DETECTING CERVICAL CANCER.,"Described is a diagnostic method of cervical cancer, which comprises: a) extracting the total RNA from a cervix biopsy sample in a human being; b) synthesising the cDNA from the total RNA, where said cDNA is used as a mould for performing a PCR in real time with a detection nucleotide probe which may perform a hybridisation under strict conditions with a target sequence or the complement thereof contained in the nucleotide sequence which encodes for the human protein or polypeptide of the subunit NaV1.6 of the sodium channels dependant on voltage, thus forming a stable hybrid for the probe: target detection; and c) determining if the hybrid is present in the sample, where the presence or absence of cervical cancer is determined by the identification and quantification of the probe:target hybrid, obtaining in such a manner the Ct values. In addition, an other method is described for the detection of the aforementioned disorders, which consists in a) having a cervix biopsy sample from a human being; b) processing said sample for being subjected to the immunohistochemical technique using an immunospecific antibody against a human protein or polypeptide of the subunit Nav1.6 of the sodium channels dependant on voltage; and c) detecting the formation of said immunological complex between the protein or polypeptide present in the sample, and the marked antibody.",UNIV MEXICO NAC AUTONOMA,CINDY SHARON ORTIZ ARCE;;JUAN CARLOS GÓMORA MARTÍNEZ;;EVERARDO HERNÁNDEZ PLATA;;HERIBERTO MANUEL RIVERA,,https://lens.org/166-177-403-121-522,Granted Patent,no,0,0,2,2,0,,C12Q1/68;;G01N33/50;;G01N33/574,,0,0,,,,ACTIVE
210,US,A1,US 2003/0177376 A1,066-765-867-950-199,2003-09-18,2003,US 35456803 A,2003-01-30,US 35456803 A;;US 35282402 P,2002-01-30,Framework for maintaining information security in computer networks,"
   A system is provided for controlling access to information technology assets in a computer network. The system includes a ticket manager server configured to generate tickets based on user data in a master database. A ticket manager client, resident on a workstation, is configured to receive tickets from the ticket manager server and distribute resource data obtained from the tickets to network security modules. The user data includes resource registers, each of which has a type field designating a particular security module, resource data for use by the designated security module, and an execution domain field that exclusively designates an execution environment in which the designated security module can use the resource data. 
",CORE SDI INC,ARCE VELLEGGIA IVAN FRANCISCO;;FUTORANSKY ARIEL;;RICHARTE GERARDO GABRIEL;;KARGIEMAN EMILIANO;;OCHOA CARLOS HERNAN,CORE SDI INCORPORATED (2005-01-28),https://lens.org/066-765-867-950-199,Patent Application,yes,16,56,4,4,0,G06F21/33;;G06F21/33,G06F/;;G06F11/30;;G06F12/14;;G06F21/00;;H04L9/00;;H04L9/32,713/189,0,0,,,,DISCONTINUED
211,BR,U8,BR 202021013683 U8,023-981-604-635-791,2023-03-07,2023,BR 202021013683 U,2021-07-12,BR 202021013683 U,2021-07-12,TABELA PERIÓDICA UNIVERSAL INCLUSIVA E INTERATIVA,"TABELA PERIÓDICA UNIVERSAL INCLUSIVA E INTERATIVA. A TABELA PERIÓDICA UNIVERSAL INCLUSIVA E INTERATIVA. É um produto desenvolvido por meio dos conceitos do Universal Design for Learning (UDL) para o ensino e a aprendizagem da Química. Composto por uma maleta com duas tampas (1A, 1B), uma base central (2), um sistema de trava (3), duas plataformas (89A, 89B) e um sistema eletrônico (90A, 90B) dotado de alto-falantes (48) e uma tela sensível ao toque (151), o produto permite que estudantes sem deficiência, da Educação Especial ou com necessidades específicas tenham acesso, simultaneamente, a uma série de informações referentes aos elementos químicos ou substâncias, seja pela narração de áudios específicos, pela transcrição em linguagem Libras ou ainda, pelo uso complementar dos BLOCOS EM DESENHO UNIVERSAL PARA APRENDIZAGEM COMO ELEMENTOS QUÍMICOS DA TABELA PERIÓDICA, amparados pela patente BR 10 2020 022931 1, que podem ser acoplados às plataformas (89A, 89B). O produto possui um botão (97) para cada elemento da Tabela Periódica que, quando pressionado, aciona a narração e a transcrição, em linguagem Libras e comum, de características do elemento ou da substância selecionada, tal como nome, número atômico, massa, período e família, classificação e algumas aplicações. A tela também exibe ilustrações de aplicações dos elementos. Este produto resolve a incapacidade de os produtos existentes atenderem adequadamente a mais de um tipo de deficiência simultaneamente, viabilizando a aprendizagem da Química, permitindo o estudo de substâncias químicas e permitindo o transporte entre salas ou instituições por ser portátil. O produto possui legendas (9, 10, 91, 94, 95) em linguagem comum e no sistema de escrita Braille, bem como um Bloco Legenda (108), que permitem que o usuário interaja de maneira independente com o produto. A tela interativa (151) permite a configuração do dispositivo (escolha de idiomas, controle de volume, tempo de resposta ao clique, atualizações) bem como a conexão com outros dispositivos como celulares ou computadores via protocolo de comunicação Bluetooth.",RODRIGO PULIDO ARCE;;LEONARDO DE OLIVEIRA BRANDT;;ANGELA PALOMA ZELLI WIEDEMANN;;SAMUEL CARLOS WIEDEMANN,RODRIGO PULIDO ARCE;;LEONARDO DE OLIVEIRA BRANDT;;ÂNGELA PALOMA ZELLI WIEDEMANN;;SAMUEL CARLOS WIEDEMANN,,https://lens.org/023-981-604-635-791,Patent Application,no,0,0,2,2,0,,G09B23/24,,0,0,,,,ACTIVE
212,WO,A3,WO 2003/065172 A3,097-823-750-095-923,2003-11-27,2003,US 0303054 W,2003-01-30,US 35282402 P;;US 35456803 A,2002-01-30,FRAMEWORK FOR MAINTAINING INFORMATION SECURITY IN COMPUTER NETWORKS,"A system, (100) is provided for controlling access to information technology assets in a computer network&period; The system includes a ticket manager server (130) configured to generate tickets based on user data in a master database&period; A ticket manager client, resident on a workstation (110), is configured to receive tickets from the ticket manager server and distribute resource data obtained from the tickets to network security modules&period; The user data includes resource registers, each of which has a type field designating a particular security module, resource data for use by the designated security module, and an execution domain field that exclusively designates an execution environment in which the designated security module can use the resource data&period;",CORE SDI INC,ARCE VELLEGIA IVAN FRANCISCO F;;FUTORANSKY ARIEL;;RICHARTE GERARDO GABRIEL;;KARGIEMAN EMILIANO;;OCHOA CARLOS HERNAN,,https://lens.org/097-823-750-095-923,Search Report,yes,4,0,4,4,0,G06F21/33;;G06F21/33,G06F/;;G06F11/30;;G06F12/14;;G06F21/00;;H04L9/00;;H04L9/32,,0,0,,,,PENDING
213,WO,A2,WO 2003/065172 A2,138-669-400-416-742,2003-08-07,2003,US 0303054 W,2003-01-30,US 35282402 P;;US 35456803 A,2002-01-30,FRAMEWORK FOR MAINTAINING INFORMATION SECURITY IN COMPUTER NETWORKS,"A system, (100) is provided for controlling access to information technology assets in a computer network&period; The system includes a ticket manager server (130) configured to generate tickets based on user data in a master database&period; A ticket manager client, resident on a workstation (110), is configured to receive tickets from the ticket manager server and distribute resource data obtained from the tickets to network security modules&period; The user data includes resource registers, each of which has a type field designating a particular security module, resource data for use by the designated security module, and an execution domain field that exclusively designates an execution environment in which the designated security module can use the resource data&period;",CORE SDI INC,ARCE VELLEGIA IVAN FRANCISCO F;;FUTORANSKY ARIEL;;RICHARTE GERARDO GABRIEL;;KARGIEMAN EMILIANO;;OCHOA CARLOS HERNAN,,https://lens.org/138-669-400-416-742,Patent Application,yes,0,0,4,4,0,G06F21/33;;G06F21/33,G06F/;;G06F11/30;;G06F12/14;;G06F21/00;;H04L9/00;;H04L9/32,,0,0,,,,PENDING
214,ES,A1,ES 2896313 A1,132-624-113-432-283,2022-02-24,2022,ES 202130644 A,2021-07-08,ES 202130644 A,2021-07-08,"System and method for the automated characterization of honey (Machine-translation by Google Translate, not legally binding)","System and method for the automated characterization of honey comprising: a digital microscopy robot (1), which performs the automatic scan of a honey sample; A processor (2), connected to the digital microscopy robot (1), with a specific application with ""autofocus"" system to run, manage and save image captures of the robot (1), gifted with communication with the cloud (N) to send and receive, in real time, the images and other data from the robot (1) and the processor (2); an artificial intelligence module (3) and computers integrated in the cloud (N), which performs the polynical analysis and crystallization of the images collected by the robot (1) and sent by the processor (2); and a web platform in the cloud (N) that allows users to access the service remotely. (Machine-translation by Google Translate, not legally binding)",SONICAT SYSTEMS S L,AHMED ELBARASHY BASEM GALAL;;COBO BREA CARLOS;;CARDELLACH LLISO PAU;;LOPEZ GONZALEZ EDUARD;;PERALES ARCE IRATXE;;PACHECO MARTINEZ ESTELA,,https://lens.org/132-624-113-432-283,Patent Application,no,0,0,1,1,0,A23L21/25;;G06N20/00,A23L21/25;;G06N20/00,,3,1,037-969-794-922-252,10.1109/mmvip.2008.4749537,"HE P ET AL. Honey Authentication with Machine Learning Augmented Bright-field Microscopy [arXiv]. arXiv 28 Dec. 2018 arXiv USA. , 28/12/2018, Páginas 6 pp.;;ALLEN G P; HODGSON R M; MARSLAND S R; FLENLEY J R. Machine vision for automated optical recognition and classification of pollen grains or other singulated microscopic objects. Mechatronics and Machine Vision in Practice, 2008. M2VIP 2008. 15th International Conference on, 20081202, IEEE, Piscataway, NJ, USA, 02/12/2008, Páginas 221 - 226 ISBN 978-1-4244-3779-5 ; ISBN 1-4244-3779-2,;;DAOOD AMAR ET AL. Pollen Grain Recognition Using Deep Learning. ICIAP: International Conference on Image Analysis and Processing, 17th International Conference, Naples, Italy, September 9-13, 2013. Proceedings; [Lecture Notes in Computer Science; Lect.Notes Computer], 20161210 Springer, Berlin, Heidelberg., 10/12/2016, Vol. 10072 Chap.30, Páginas 321 - 330 ISBN 978-3-642-17318-9 ; ISBN 3-642-17318-7, (DOI: 10.1007/978-3-319-50835-1_30)",DISCONTINUED
215,ES,A1,ES 2170006 A1,076-271-138-721-938,2002-07-16,2002,ES 200002073 A,2000-08-11,ES 200002073 A,2000-08-11,ENZYMATIC SYNTHESIS OF ANTIOXIDANT HYDROXYTYROSOL,"The reaction occurs in a medium buffered with phosphate in an aqueous medium, at neutral pH and at room temperature. Hence, the reaction medium consists of: tyrosol, as precursor (commercial) mushroom tyrosinase to catalyze the process and vitamin C in excess. Reaction starts after initial shaking. The reaction stops when the concentration of the initial tyrosol is exhausted. In order for the reaction to continue, it will suffice to add more tyrosol (always ensuring that the vitamin C/tyrosol ratio is more than 1). Once the desired concentration of hydroxytyrosol is obtained, it is filtered. The enzyme with molecular weight over twice the size of the pore is retained in the filter and can be used once again. This first extract, which is very enriched in antioxidant hydroxytyrosol with a high antioxidant capacity (in the present case, in combination with vitamin C), can already be used as a food additive.",CONSEJO SUPERIOR INVESTIGACION,ESPIN DE GEA JUAN CARLOS;;SOLER RIVAS CRISTINA;;WICHERS HARRY J;;TOMAS BARBERAN FRANCISCO A;;GARCIA VIGUERA CRISTINA;;FERRERES DE ARCE FEDERICO,,https://lens.org/076-271-138-721-938,Patent Application,no,1,1,6,6,0,A23D7/0056;;A23D7/0056;;A23L33/10;;A23L33/10;;C11B5/0035;;C11B5/0035;;C12P7/22;;C12P7/22,A23D7/005;;A23L33/10;;C11B5/00;;C12P7/22,,1,1,011-564-224-187-744,10564048;;10.1021/jf9809030,"CAPPASSO, R. et al. ""A highly convenient synthesis of hidroxytyrosol and its recovery from agricultural waste waters"", J. Agric. Food Chem., 1999, Vol. 47, no 4, paginas 1745-1748.",EXPIRED
216,ES,B1,ES 2170006 B1,198-546-026-263-737,2003-11-01,2003,ES 200002073 A,2000-08-11,ES 200002073 A,2000-08-11,SINTESIS ENZIMATICA DEL ANTIOXIDANTE HIDROXITIROSOL.,"Síntesis enzimática del antioxidante hidroxitirosol. La reacción transcurre en un medio tamponado con fosfato en medio acuoso, a pH neutro, y a temperatura ambiente. El medio de reacción, se compone por tanto de: tirosol, como precursor; tirosinasa de champiñón (comercial) para catalizar el proceso y vitamina C en exceso. Tras una agitación inicial, la reacción comienza. Cuando la concentración de tirosol inicial se agote la reacción se para. Para que continúe basta con añadir más tirosol (siempre cuidando que la relación vitamina C/tirosol sea mayor que 1). Cuando se obtenga la concentración de hidroxitirosol deseada, se filtra por una membrana. La enzima, de peso molecular más del doble del tamaño de poro, queda retenida en el filtro, y puede ser de nuevo reutilizada. Este primer extracto muy enriquecido en antioxidante hidroxitirosol, con una alta capacidad antioxidante, (en este caso, en combinación con vitamina C), ya es susceptible de utilizarse como aditivo alimentario.",CONSEJO SUPERIOR INVESTIGACION,ESPIN DE GEA JUAN CARLOS;;SOLER RIVAS CRISTINA;;WICHERS HARRY J;;TOMAS BARBERAN FRANCISCO A;;GARCIA VIGUERA CRISTINA;;FERRERES DE ARCE FEDERICO,,https://lens.org/198-546-026-263-737,Granted Patent,no,0,0,6,6,0,A23D7/0056;;A23D7/0056;;A23L33/10;;A23L33/10;;C11B5/0035;;C11B5/0035;;C12P7/22;;C12P7/22,A23D7/005;;A23L33/10;;C11B5/00;;C12P7/22,,0,0,,,,EXPIRED
217,WO,A1,WO 2012/136239 A1,105-743-081-620-599,2012-10-11,2012,EP 2011055179 W,2011-04-04,EP 2011055179 W,2011-04-04,AEROHEATING PROTECTION FOR A MISSILE ELECTRO - OPTICAL SEEKER,"This invention advances the related state-of-the-art by eliminating the physical EO window used by electro-optical imaging infrared seekers for tactical missiles and high-altitude endo-atmospheric interceptors, widely employed in integrated defense systems. This invention increases the probability of intercepting exo-atmospheric ballistic warheads by exo-atmospheric interceptors, and eliminates the existing altitude ""gap"" of interception, as well as the geographical limitations posed by the mesospheric Noctilucent Clouds. The problem of protecting an imaging EO sensor from aeroheating is solved in this invention by a special purpose device which is enabled immediately after the nose cone ejection event. The role of said device is to augment the sensor fixed sunshade and cavity lengths in the forward direction, and by doing so, the resulting new cavity enables the optimal injection of an optically inert gas into the new extended cavity in front of the sensor, thus effectively blocking the entry of the compressed hot air into the sensor cavity, while simultaneously avoiding any adverse effects of inducing flow instabilities in the flow as well as the disturbance of the injected gas flow on sensor structures. Having a greater length for the hot gas to penetrate, eliminates also the penetration of suspended particles in oncoming air stream.",SENER GRUPO DE INGENIERIA SA;;SANCHO PONCE JORGE;;HERRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL,SANCHO PONCE JORGE;;HERRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL,,https://lens.org/105-743-081-620-599,Patent Application,yes,3,2,7,7,0,F42B15/01;;F42B15/01;;F41G7/2253;;F41G7/2253;;F41G7/2293;;F41G7/2293;;F42B10/46;;F42B10/46;;G01J1/0271;;G02B27/0006;;G02B27/0006;;G02B27/0018;;G02B27/0018,F41G7/22,,1,0,,,"TIM GARNER: ""Technical Attachment"", INTERNATIONAL CONFERENCE ON SPACE PLANES AND HYPERSONIC SYSTEMS AND TECHNOLOGIES, 10 December 2001 (2001-12-10), pages 2002 - 31",PENDING
218,EP,A1,EP 2694909 A1,015-732-230-055-401,2014-02-12,2014,EP 11711902 A,2011-04-04,EP 2011055179 W,2011-04-04,AEROHEATING PROTECTION FOR A MISSILE ELECTRO-OPTICAL SEEKER,,SENER GRUPO DE INGENIERIA SA,SANCHO PONCE JORGE;;HERRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL,,https://lens.org/015-732-230-055-401,Patent Application,yes,0,0,7,7,0,F42B15/01;;F42B15/01;;F41G7/2253;;F41G7/2253;;F41G7/2293;;F41G7/2293;;F42B10/46;;F42B10/46;;G01J1/0271;;G02B27/0006;;G02B27/0006;;G02B27/0018;;G02B27/0018,F41G7/22;;F42B10/46;;F42B15/01;;G01J1/02;;G02B27/00,,1,0,,,See references of WO 2012136239A1,ACTIVE
219,PL,T3,PL 2694909 T3,164-673-223-149-958,2016-02-29,2016,PL 11711902 T,2011-04-04,EP 11711902 A;;EP 2011055179 W,2011-04-04,AEROHEATING PROTECTION FOR A MISSILE ELECTRO-OPTICAL SEEKER,,SENER GRUPO DE INGENIERIA SA,SANCHO PONCE JORGE;;HERRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL,,https://lens.org/164-673-223-149-958,Patent Application,no,0,0,7,7,0,F42B15/01;;F42B15/01;;F41G7/2253;;F41G7/2253;;F41G7/2293;;F41G7/2293;;F42B10/46;;F42B10/46;;G01J1/0271;;G02B27/0006;;G02B27/0006;;G02B27/0018;;G02B27/0018,F41G7/22;;F42B10/46;;F42B15/01;;G01J1/02;;G02B27/00,,0,0,,,,PENDING
220,EP,B1,EP 2694909 B1,151-595-386-421-829,2015-06-10,2015,EP 11711902 A,2011-04-04,EP 2011055179 W,2011-04-04,AEROHEATING PROTECTION FOR A MISSILE ELECTRO-OPTICAL SEEKER,,SENER GRUPO DE INGENIERIA SA,SANCHO PONCE JORGE;;HERRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL,,https://lens.org/151-595-386-421-829,Granted Patent,yes,2,0,7,7,0,F42B15/01;;F42B15/01;;F41G7/2253;;F41G7/2253;;F41G7/2293;;F41G7/2293;;F42B10/46;;F42B10/46;;G01J1/0271;;G02B27/0006;;G02B27/0006;;G02B27/0018;;G02B27/0018,F41G7/22;;F42B10/46;;F42B15/01;;G01J1/02;;G02B27/00,,0,0,,,,ACTIVE
221,AU,A,AU 2001/082147 A,098-957-516-540-902,2002-03-04,2002,AU 2001/082147 A,2001-08-02,ES 200002073 A;;ES 0100314 W,2000-08-11,Enzymatic synthesis of antioxidant hydroxytyrosol,,CONSEJO SUPERIOR INVESTIGACION,GEA JUAN CARLOS ESPIN DE;;BARBERAN FRANCISCO ABRAHAM DE;;VIGUERA MARIA CRISTINA GARCIA;;ARCE FEDERICO FERRERES DE;;RIVAS CRISTINA SOLER;;WICHERS HARRY J,,https://lens.org/098-957-516-540-902,Patent Application,no,0,0,6,6,0,A23D7/0056;;A23D7/0056;;A23L33/10;;A23L33/10;;C11B5/0035;;C11B5/0035;;C12P7/22;;C12P7/22,A23D7/005;;A23L33/10;;C11B5/00;;C12P7/22,,0,0,,,,PENDING
222,US,A1,US 2014/0014765 A1,101-830-475-870-769,2014-01-16,2014,US 201114110109 A,2011-04-04,EP 2011055179 W,2011-04-04,AEROHEATING OF SENSOR PROTECTED BY INTEGRATING DEVICE SEEKER (ASPIDS),"This invention advances the related state-of-the-art by eliminating the physical EO window used by electro-optical imaging infrared seekers for tactical missiles and high-altitude endo-atmospheric interceptors, widely employed in integrated defense systems. This invention increases the probability of intercepting exo-atmospheric ballistic warheads by exo-atmospheric interceptors, and eliminates the existing altitude “gap” of interception, as well as the geographical limitations posed by the mesospheric Noctilucent Clouds. The problem of protecting an imaging EO sensor from aeroheating is solved in this invention by a special purpose device which is enabled immediately after the nose cone ejection event. The role of said device is to augment the sensor fixed sunshade and cavity lengths in the forward direction, and by doing so, the resulting new cavity enables the optimal injection of an optically inert gas into the new extended cavity in front of the sensor, thus effectively blocking the entry of the compressed hot air into the sensor cavity, while simultaneously avoiding any adverse effects of inducing flow instabilities in the flow as well as the disturbance of the injected gas flow on sensor structures. Having a greater length for the hot gas to penetrate, eliminates also the penetration of suspended particles in oncoming air stream.",SANCHO PONCE JORGE;;HARRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL,SANCHO PONCE JORGE;;HARRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL,SENER GRUPO DE INGENIERIA S.A (2013-10-03),https://lens.org/101-830-475-870-769,Patent Application,yes,0,9,7,7,0,F42B15/01;;F42B15/01;;F41G7/2253;;F41G7/2253;;F41G7/2293;;F41G7/2293;;F42B10/46;;F42B10/46;;G01J1/0271;;G02B27/0006;;G02B27/0006;;G02B27/0018;;G02B27/0018,G01J1/02;;F42B15/01,244/3.16;;250/239,0,0,,,,INACTIVE
223,US,B2,US 8975564 B2,065-987-104-682-349,2015-03-10,2015,US 201114110109 A,2011-04-04,EP 2011055179 W,2011-04-04,Aeroheating of sensor protected by integrating device seeker (Aspids),"This invention advances the related state-of-the-art by eliminating the physical EO window used by electro-optical imaging infrared seekers for tactical missiles and high-altitude endo-atmospheric interceptors, widely employed in integrated defense systems. This invention increases the probability of intercepting exo-atmospheric ballistic warheads by exo-atmospheric interceptors, and eliminates the existing altitude “gap” of interception, as well as the geographical limitations posed by the mesospheric Noctilucent Clouds. The problem of protecting an imaging EO sensor from aeroheating is solved in this invention by a special purpose device which is enabled immediately after the nose cone ejection event. The role of said device is to augment the sensor fixed sunshade and cavity lengths in the forward direction, and by doing so, the resulting new cavity enables the optimal injection of an optically inert gas into the new extended cavity in front of the sensor, thus effectively blocking the entry of the compressed hot air into the sensor cavity, while simultaneously avoiding any adverse effects of inducing flow instabilities in the flow as well as the disturbance of the injected gas flow on sensor structures. Having a greater length for the hot gas to penetrate, eliminates also the penetration of suspended particles in oncoming air stream.",SANCHO PONCE JORGE;;HERRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL;;SENER GRUPO DE INGENIERIA SA,SANCHO PONCE JORGE;;HERRAIZ ALIJAS PEDRO JOSE;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSE MARIA;;RIBAS NIETO DANIEL,SENER GRUPO DE INGENIERIA S.A (2013-10-03),https://lens.org/065-987-104-682-349,Granted Patent,yes,21,0,7,7,0,F42B15/01;;F42B15/01;;F41G7/2253;;F41G7/2253;;F41G7/2293;;F41G7/2293;;F42B10/46;;F42B10/46;;G01J1/0271;;G02B27/0006;;G02B27/0006;;G02B27/0018;;G02B27/0018,F41G7/22;;F41G7/00;;F42B10/46;;F42B15/01;;G01J1/02;;G01J1/06;;G02B27/00,244/3.16;;244/3.1;;244/3.15;;359/601,3,0,,,"PCT/EP2011/055179 Written Opinion of the International Searching Authority, dated Oct. 4, 2013.;;PCT/EP2011/055179 International Search Report, dated Oct. 11, 2012.;;Garner,Tim; Technical Attachment. International Conference on Space Planes and Hypersonic Systems and Technologies: SR SSD 2002-31, Oct. 2002, NWS Spaceflight Meteorology Group, NASA Johnson Space Center.",INACTIVE
224,ES,T3,ES 2547065 T3,099-010-617-000-811,2015-10-01,2015,ES 11711902 T,2011-04-04,EP 2011055179 W,2011-04-04,Protección contra el calentamiento aerodinámico para cabeza buscadora electroóptica de misiles,"Un dispositivo de protección para una cabeza buscadora EO de misiles que comprende una pantalla fija (1) que puede estar montada rodeando un sensor de cabeza buscadora EO, formando la pantalla fija (1) una cavidad (7), caracterizado por comprender: al menos una pantalla desplegable (10) dispuesta para ser desplazada de manera telescópica con respecto a la pantalla fija (1) entre una primera posición, en la que la al menos una pantalla desplegable (10) sustancialmente no sobresale de la pantalla fija (1), y una segunda posición, en la que la al menos una pantalla desplegable (10) está desplegada con respecto a la pantalla fija (1) creando así una cavidad de mayor longitud (7) con respecto a la primera posición, al menos un receptáculo (15) para un gas de presurización ópticamente inerte, en el que en la segunda posición, el gas ópticamente inerte puede ser inyectado en el interior de un espacio encarado hacia adelante del sensor dentro de la cavidad (7), formando un patrón de flujo altamente estable (9).",SENER GRUPO DE INGENIERÍA S A,SANCHO PONCE JORGE;;HERRAIZ ALIJAS PEDRO JOSÉ;;REBOLO GOMEZ RAFAEL;;MIRAVET FUSTER CARLOS;;ARCE AGUINAGA AITOR;;FERNANDEZ IBARZ JOSÉ MARÍA;;RIBAS NIETO DANIEL,,https://lens.org/099-010-617-000-811,Granted Patent,no,0,0,7,7,0,F42B15/01;;F42B15/01;;F41G7/2253;;F41G7/2253;;F41G7/2293;;F41G7/2293;;F42B10/46;;F42B10/46;;G01J1/0271;;G02B27/0006;;G02B27/0006;;G02B27/0018;;G02B27/0018,F41G7/22;;F42B10/46;;F42B15/01;;G01J1/02;;G02B27/00,,0,0,,,,ACTIVE
225,US,A1,US 2003/0180833 A1,151-592-869-082-143,2003-09-25,2003,US 36491503 A,2003-02-11,ES 200002073 A;;ES 0100314 W,2000-08-11,Enzymatic synthesis of antioxidant hydroxytyrosol,"
   The reaction occurs in a medium buffered with phosphate in an aqueous medium, at neutral pH and at room temperature. Hence, the reaction medium consists of: tyrosol, as precursor; (commercial) mushroom tyrosinase to catalyze the process and vitamin C in excess. Reaction starts after initial shaking. The reaction stops when the concentration of the initial tyrosol is exhausted. In order for the reaction to continue, it will suffice to add more tyrosol (always ensuring that the vitamin C/tyrosol ratio is more than 1). Once the desired concentration of hydroxytyrosol is obtained, it is filtered. The enzyme with molecular weight over twice the size of the pore is retained in the filter and can be used once again. This first extract, which is very enriched in antioxidant hydroxytyrosol with a high antioxidant capacity (in the present case, in combination with vitamin C), can already be used as a food additive. 
",ESPIN DE GEA JUAN CARLOS;;DE TOMAS BARBERAN FRANCISCO ABRAHAM;;GARCIA VIGUERA MARIA CRISTINA;;FERRERES DE ARCE FEDERICO;;SOLER RIVAS CRISTINA;;WICHERS HARRY J.,ESPIN DE GEA JUAN CARLOS;;DE TOMAS BARBERAN FRANCISCO AB;;GARCIA VIGUERA MARIA CRISTINA;;FERRERES DE ARCE FEDERICO;;SOLER RIVAS CRISTINA;;WICHERS HARRY J,CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (2003-03-18),https://lens.org/151-592-869-082-143,Patent Application,yes,0,5,6,6,0,A23D7/0056;;A23D7/0056;;A23L33/10;;A23L33/10;;C11B5/0035;;C11B5/0035;;C12P7/22;;C12P7/22,A23D7/005;;A23L33/10;;C11B5/00;;C12P7/22,435/41,0,0,,,,DISCONTINUED
226,CU,A1,CU 22822 A1,184-939-577-465-73X,2003-01-29,2003,CU 1998134 A,1998-09-22,CU 1998134 A,1998-09-22,COMPOSICIONES Y MÉTODOS PARA INHIBIR LA FLORACIÓN DE LA CANA DE AZÚCAR,"La floración de la cana de azúcar puede inhibirse cuando se aplica sobre el follaje, composiciones que contienen cierta cantidad de 1,3-bis-(2,2,2-tricloro-1-hidroxietil) urea con o sin 2,2,2-tricloro-1-1 hidroxietil urea, convenientemente formuladas, después que el cultivo ha ""cerrado"" y antes de que se forme el primordio floral.",CUBANO INST INVEST,ZUAZNABAR ZUAZNABAR RAFAEL;;CABRERA RODRIGUEZ JUAN ADRIANO;;DIAZ DIAZ JUAN CARLOS;;DIAZ DE ARCE PEREIRA CALIXTO JUSTO;;TERRY BELEN JOSE;;MONTANO MARTINEZ RAMON LUIS,,https://lens.org/184-939-577-465-73X,Limited Patent,no,0,0,1,1,0,,A01N47/28,,0,0,,,,EXPIRED
227,WO,A1,WO 2002/016628 A1,025-479-761-058-712,2002-02-28,2002,ES 0100314 W,2001-08-02,ES 200002073 A,2000-08-11,ENZYMATIC SYNTHESIS OF ANTIOXIDANT HYDROXYTYROSOL,"Reaction occurs in a medium buffered with phosphate in an aqueous medium, at neutral pH and ambient temperature. Hence, the reaction medium consists of: tyrosol as precursor; (commercial) mushroom tyrosinase to catalyze the process and vitamin C in excess. Reaction starts after initial shaking. The reaction stops when the concentration of the initial tyrosol is exhausted. In order for reaction to continue, it will suffice to add more tyrosol (always ensuring that the vitamin C/tyrosol ratio is more than 1). Once the desired concentration of hydroxytyrosol, it is filtered. The enzyme with molecular weight over twice the size of the pore is retained in the filter and can be used once again. This first extract, which is very enriched in antioxidant hydroxytyrosol with a high antioxidant capacity (in the present case, in combination with vitamin C), can already be used as food additive.",CONSEJO SUPERIOR INVESTIGACION;;ESPIN DE GEA JUAN CARLOS;;TOMAS BARBERAN FRANCISCO ABRAH;;GARCIA VIGUERA MARIA CRISTINA;;FERRERES DE ARCE FEDERICO;;SOLER RIVAS CRISTINA;;WICHERS HARRY J,ESPIN DE GEA JUAN CARLOS;;DE TOMAS BARBERAN FRANCISCO AB;;GARCIA VIGUERA MARIA CRISTINA;;FERRERES DE ARCE FEDERICO;;SOLER RIVAS CRISTINA;;WICHERS HARRY J,,https://lens.org/025-479-761-058-712,Patent Application,yes,1,7,6,6,0,A23D7/0056;;A23D7/0056;;A23L33/10;;A23L33/10;;C11B5/0035;;C11B5/0035;;C12P7/22;;C12P7/22,A23D7/005;;A23L33/10;;C11B5/00;;C12P7/22,,2,2,018-773-715-592-379;;011-564-224-187-744,10.1021/jf001258b;;11312833;;10564048;;10.1021/jf9809030,"ESPIN J.C. ET AL.: ""Synthesis of the antioxidant hydroxytyrosol using tyrosinase as biocatalyst"", J. AGRIC. FOOD CHEM., vol. 49, no. 3, 2001, pages 1187 - 1193, XP001083568;;CAPASSO R. ET AL.: ""A highly convenient synthesis of hydroxytyrosol and its recovery from agricultural waste waters"", J. AGRIC. FOOD CHEM., vol. 47, no. 4, 1999, pages 1745 - 1748, XP001061462",PENDING
228,EP,A1,EP 1310562 A1,087-777-635-198-831,2003-05-14,2003,EP 01960746 A,2001-08-02,ES 0100314 W;;ES 200002073 A,2000-08-11,ENZYMATIC SYNTHESIS OF ANTIOXIDANT HYDROXYTYROSOL,"The reaction occurs in a medium buffered with phosphate in an aqueous medium, at neutral pH and at room temperature. Hence, the reaction medium consists of: tyrosol, as precursor; (commercial) mushroom tyrosinase to catalyze the process and vitamin C in excess. Reaction starts after initial shaking. The reaction stops when the concentration of the initial tyrosol is exhausted. In order for the reaction to continue, it will suffice to add more tyrosol (always ensuring that the vitamin C/tyrosol ratio is more than 1). Once the desired concentration of hydroxytyrosol is obtained, it is filtered. The enzyme with molecular weight over twice the size of the pore is retained in the filter and can be used once again. This first extract, which is very enriched in antioxidant hydroxytyrosol with a high antioxidant capacity (in the present case, in combination with vitamin C), can already be used as a food additive.",CONSEJO SUPERIOR INVESTIGACION,ESPIN DE GEA JUAN CARLOS;;DE TOMAS BARBERAN FRANCISCO A;;GARCIA VIGUERA MARIA C;;FERRERES DE ARCE FEDERICO;;SOLER RIVAS CRISTINA;;WICHERS HARRY J,,https://lens.org/087-777-635-198-831,Patent Application,yes,0,16,6,6,0,A23D7/0056;;A23D7/0056;;A23L33/10;;A23L33/10;;C11B5/0035;;C11B5/0035;;C12P7/22;;C12P7/22,A23D7/005;;A23L33/10;;C11B5/00;;C12P7/22,,1,0,,,See references of WO 0216628A1,DISCONTINUED
229,AR,A1,AR 093931 A1,031-984-068-695-830,2015-07-01,2015,AR P130104641 A,2013-12-12,AR P130104641 A,2013-12-12,"MECANISMO PARA REGULAR LA ACTIVIDAD DE LA ALDOSA REDUCTASA Y PARA PREVENIR LA FORMACION DE CATARATAS EN DIABETES MELLITUS, A PARTIR DE LA ASOCIACION DE LA ALDOSA REDUCTASA CON LA TUBULINA Y DE LA UTILIZACION DE 3-NITRO-L-TIROSINA Y TIROSINA","Mecanismo para la regulación de la actividad AR por Tub en condiciones de diabetes o elevada concentración de glucosa, a través de la regulación de la cantidad de complejo Tub/AR formado, el cual puede ser regulado a su vez por drogas como la 3-NTyr o la Tyr, que impidan la asociación directa entre estas dos proteínas y que mostraron ser capaces de impedir la formación del complejo Tub/AR, de activar la enzima AR y de prevenir la aparición de cataratas en ratas diabéticas. En el mecanismo descripto, las elevadas concentraciones intracelulares de glucosa actúan como un disparador de un estrés oxidativo/nitrosativo que conduce a la generación de especies reactivas de oxígeno y nitrógeno y a la nitración de la Tyr libre para producir 3-NTyr, la cual es rápidamente incorporada a la Tub para formar el isótopo de Tub 3-nitrotirosinado, que es el que preferentemente interacciona con la AR para formar el complejo Tub/AR. De esta forma se produce un incremento en la concentración de complejo Tub/AR y cuando éste polimeriza para formar MT la AR se activa reduciendo el exceso de glucosa a sorbitol, el cual induce la polimerización de más cantidad de Tub en MT, generándose de esta forma un círculo vicioso retroalimentado positivamente entre el incremento de la actividad AR y la formación de MT mientras persistan las condiciones de elevada glucosa. Como consecuencia de este circuito retroalimentado, mayor cantidad de Tub acetilada llega a la membrana plasmática para asociarse con la NKA e inhibirla.",UNIV NAC DE RIO CUARTO,MARINA R AMAIDEN;;GABRIELA PREVITALLI;;AYELEN D NIGRA;;VERONICA SANTANDER;;NOELIA E MONESTEROLO;;ALEXIS N CAMPETELLI;;CARLOS A ARCE;;CESAR H CASALE;;JUAN F RIVELLI ANTONELLI,,https://lens.org/031-984-068-695-830,Patent Application,no,0,0,1,1,0,,A61K38/43;;A61K38/03;;A61K38/44;;A61P27/12,,0,0,,,,DISCONTINUED
230,ES,B1,ES 2339839 B1,106-388-560-554-739,2011-03-10,2011,ES 200801835 A,2008-06-10,ES 200801835 A,2008-06-10,CAMPO DE COCCION,,BSH ELECTRODOMESTICOS ESPANA,ARCE GOMEZ EDUARDO;;PALACIOS VALDUEZA LUIS ANTONIO;;ABASCAL CARRERA LUIS ALBERTO;;BORBOLLA JIMENEZ EDUARDO;;PELAYO ALONSO CARLOS;;ALONSO SUSILLA JOSE LUIS;;GOMEZ GANDARILLAS JESUS;;LOPEZ RANERO SANTIAGO;;AGUADO VELA CESAR,,https://lens.org/106-388-560-554-739,Granted Patent,no,0,0,2,2,0,F24C15/10;;F24C15/107;;F24C15/10;;F24C15/107,F24C15/10,,0,0,,,,INACTIVE
231,PE,Z,PE 20201126 Z,187-073-505-066-996,2020-10-22,2020,PE 2020000898 U,2020-07-02,PE 2020000898 U,2020-07-02,TACHO DE BASURA COMPRESOR CON COMPARTIMIENTO PARA RECICLAJE,"Un tacho de basura compresor con compartimento para reciclaje, comprendido por un deposito de forma preferentemente triangular, aunque puede variar su forma; donde se realizara la compresion de residuos generales a traves de un sistema de hidraulico-mecanico, el cual consistira en una camara de compresion que, accionada mediante una palanca giratoria, se realizara la compresion con la placa deslizable. Al exterior del deposito se encontrara compartimentos exteriores de diferentes formas y tamanos para el deposito de residuos reciclables.",YARIN ACHACHAGUA ANWAR JULIO;;MAYHUASCA GUERRA JORGE VICTOR;;COVENAS LALUPU JOSE;;VILCA TANTAPOMA MANUEL EDUARDO;;PAREDES PAREDES PERVIS;;SURICHAQUI TIZA BEATRIZ SILVIA;;GAMBOA CRUZADO JAVIER ARTURO;;CASTANEDA CARRANZA JULIO ALBERTO;;GOMEZ ARCE RICARDO MARTIN;;DURAN CARHUAMACA AMANDA;;GAMARRA MORENO JUAN;;PAUCAR CARLOS GUILLERMO;;JIMENEZ GARCIA JESUS ALBERTO;;RAMIREZ ERAZO RAMON;;INCHE MITMA JORGE LUIS,YARIN ACHACHAGUA ANWAR JULIO;;MAYHUASCA GUERRA JORGE VICTOR;;COVENAS LALUPU JOSE;;VILCA TANTAPOMA MANUEL EDUARDO;;PAREDES PAREDES PERVIS;;SURICHAQUI TIZA BEATRIZ SILVIA;;GAMBOA CRUZADO JAVIER ARTURO;;CASTANEDA CARRANZA JULIO ALBERTO;;GOMEZ ARCE RICARDO MARTIN;;DURAN CARHUAMACA AMANDA;;GAMARRA MORENO JUAN;;PAUCAR CARLOS GUILLERMO;;JIMENEZ GARCIA JESUS ALBERTO;;RAMIREZ ERAZO RAMON;;INCHE MITMA JORGE LUIS,,https://lens.org/187-073-505-066-996,Patent Application,no,0,0,1,1,0,,B30B13/00;;B30B15/30,,0,0,,,,PENDING
